<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>AI/ML in Pharmacometrics — Interactive Explorer</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link href="https://fonts.googleapis.com/css2?family=DM+Sans:ital,opsz,wght@0,9..40,300;0,9..40,400;0,9..40,500;0,9..40,600;0,9..40,700;1,9..40,300;1,9..40,400&family=JetBrains+Mono:wght@400;500&family=Fraunces:ital,opsz,wght@0,9..144,300;0,9..144,600;0,9..144,800;1,9..144,300&display=swap" rel="stylesheet">
<style>
:root {
  --bg: #0c0f14;
  --bg-card: #141820;
  --bg-card-hover: #1a2030;
  --bg-surface: #111520;
  --border: #1e2738;
  --border-active: #3a7bfd;
  --text: #e2e8f0;
  --text-dim: #7a8ba8;
  --text-muted: #4a5568;
  --accent: #3a7bfd;
  --accent-glow: rgba(58,123,253,0.15);
  --heat-0: #141820;
  --heat-1: #0d2847;
  --heat-2: #134080;
  --heat-3: #1a5ab8;
  --heat-4: #2474e8;
  --heat-5: #3a8fff;
  --green: #34d399;
  --amber: #fbbf24;
  --rose: #f87171;
  --radius: 8px;
}
* { margin: 0; padding: 0; box-sizing: border-box; }
html { scroll-behavior: smooth; }
body { font-family: 'DM Sans', sans-serif; background: var(--bg); color: var(--text); line-height: 1.6; min-height: 100vh; }
::selection { background: var(--accent); color: white; }
.container { max-width: 1400px; margin: 0 auto; padding: 0 24px; }
header { padding: 48px 0 32px; border-bottom: 1px solid var(--border); }
header .eyebrow { font-family: 'JetBrains Mono', monospace; font-size: 11px; letter-spacing: 2px; text-transform: uppercase; color: var(--accent); margin-bottom: 12px; }
header h1 { font-family: 'Fraunces', serif; font-size: clamp(28px, 4vw, 42px); font-weight: 800; line-height: 1.15; color: var(--text); margin-bottom: 12px; }
header h1 span { color: var(--accent); }
header .subtitle { color: var(--text-dim); font-size: 15px; max-width: 600px; margin-bottom: 24px; }
.stats-row { display: flex; gap: 32px; flex-wrap: wrap; }
.stat { display: flex; flex-direction: column; }
.stat-value { font-family: 'JetBrains Mono', monospace; font-size: 28px; font-weight: 500; color: var(--text); }
.stat-label { font-size: 12px; color: var(--text-muted); text-transform: uppercase; letter-spacing: 1px; }
.links-row { display: flex; gap: 12px; margin-top: 16px; flex-wrap: wrap; }
.link-btn { display: inline-flex; align-items: center; gap: 6px; padding: 8px 16px; background: var(--bg-card); border: 1px solid var(--border); border-radius: 6px; color: var(--text-dim); text-decoration: none; font-size: 13px; font-family: 'JetBrains Mono', monospace; transition: all 0.2s; }
.link-btn:hover { border-color: var(--accent); color: var(--accent); }
.link-btn svg { width: 16px; height: 16px; }
.section-title { font-family: 'Fraunces', serif; font-size: 22px; font-weight: 600; margin: 48px 0 8px; color: var(--text); }
.section-desc { color: var(--text-dim); font-size: 14px; margin-bottom: 24px; }
.active-filter { display: none; align-items: center; gap: 12px; padding: 12px 16px; background: var(--accent-glow); border: 1px solid var(--border-active); border-radius: var(--radius); margin-bottom: 20px; flex-wrap: wrap; }
.active-filter.visible { display: flex; }
.filter-tag { display: inline-flex; align-items: center; gap: 6px; background: var(--bg-card); border: 1px solid var(--border-active); padding: 4px 12px; border-radius: 20px; font-size: 13px; color: var(--accent); font-family: 'JetBrains Mono', monospace; }
.filter-tag .type-label { font-size: 10px; text-transform: uppercase; letter-spacing: 1px; color: var(--text-muted); margin-right: 4px; }
.clear-btn { margin-left: auto; background: none; border: 1px solid var(--border); color: var(--text-dim); padding: 4px 12px; border-radius: 20px; font-size: 12px; cursor: pointer; font-family: 'DM Sans', sans-serif; transition: all 0.2s; }
.clear-btn:hover { border-color: var(--rose); color: var(--rose); }
.heatmap-wrap { overflow-x: auto; border: 1px solid var(--border); border-radius: var(--radius); background: var(--bg-surface); padding: 2px; }
.heatmap-wrap::-webkit-scrollbar { height: 8px; }
.heatmap-wrap::-webkit-scrollbar-track { background: var(--bg-card); }
.heatmap-wrap::-webkit-scrollbar-thumb { background: var(--border); border-radius: 4px; }
table.heatmap { border-collapse: separate; border-spacing: 2px; width: max-content; min-width: 100%; }
table.heatmap th { font-family: 'JetBrains Mono', monospace; font-size: 11px; font-weight: 500; color: var(--text-dim); padding: 8px 6px; white-space: nowrap; position: sticky; background: var(--bg-surface); z-index: 2; cursor: pointer; transition: color 0.2s; user-select: none; }
table.heatmap th:hover { color: var(--accent); }
table.heatmap th.col-header { top: 0; writing-mode: vertical-lr; transform: rotate(180deg); text-align: left; height: 160px; vertical-align: bottom; }
table.heatmap th.row-header { left: 0; text-align: right; padding-right: 12px; max-width: 220px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
table.heatmap th.corner { top: 0; left: 0; z-index: 3; }
table.heatmap th.active { color: var(--accent); font-weight: 700; }
table.heatmap td { width: 44px; height: 38px; text-align: center; font-family: 'JetBrains Mono', monospace; font-size: 12px; font-weight: 500; border-radius: 4px; cursor: pointer; transition: all 0.15s; position: relative; user-select: none; }
table.heatmap td:hover { outline: 2px solid var(--accent); outline-offset: -1px; z-index: 1; }
table.heatmap td.active { outline: 2px solid #fff; outline-offset: -1px; z-index: 1; }
table.heatmap td.zero { color: var(--text-muted); opacity: 0.4; }
table.heatmap td.row-total, table.heatmap th.total-header { font-weight: 600; border-left: 2px solid var(--border); color: var(--text-dim); background: var(--bg-surface) !important; cursor: default; }
table.heatmap td.row-total:hover { outline: none; }
.paper-count { font-family: 'JetBrains Mono', monospace; font-size: 13px; color: var(--text-muted); margin-bottom: 16px; }
.paper-count strong { color: var(--accent); }
.search-box { width: 100%; max-width: 400px; padding: 10px 16px; background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius); color: var(--text); font-family: 'DM Sans', sans-serif; font-size: 14px; margin-bottom: 20px; transition: border-color 0.2s; }
.search-box:focus { outline: none; border-color: var(--accent); }
.search-box::placeholder { color: var(--text-muted); }
.toggle-row { display: flex; gap: 8px; margin-bottom: 16px; flex-wrap: wrap; }
.toggle-btn { padding: 6px 14px; font-size: 12px; font-family: 'JetBrains Mono', monospace; background: var(--bg-card); border: 1px solid var(--border); border-radius: 20px; color: var(--text-dim); cursor: pointer; transition: all 0.2s; }
.toggle-btn:hover { border-color: var(--text-dim); }
.toggle-btn.active { border-color: var(--accent); color: var(--accent); background: var(--accent-glow); }
.papers-grid { display: flex; flex-direction: column; gap: 8px; margin-bottom: 80px; }
.paper-card { padding: 16px 20px; background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius); transition: all 0.2s; animation: fadeIn 0.3s ease; }
@keyframes fadeIn { from { opacity: 0; transform: translateY(8px); } to { opacity: 1; transform: translateY(0); } }
.paper-card:hover { border-color: #2a3a55; background: var(--bg-card-hover); }
.paper-title { font-size: 14px; font-weight: 500; line-height: 1.45; margin-bottom: 8px; }
.paper-title a { color: var(--text); text-decoration: none; transition: color 0.2s; }
.paper-title a:hover { color: var(--accent); }
.paper-meta { display: flex; gap: 8px; flex-wrap: wrap; margin-bottom: 8px; }
.tag { font-family: 'JetBrains Mono', monospace; font-size: 10px; padding: 3px 8px; border-radius: 4px; letter-spacing: 0.3px; }
.tag-app { background: rgba(52,211,153,0.12); color: var(--green); border: 1px solid rgba(52,211,153,0.2); }
.tag-meth { background: rgba(59,130,246,0.12); color: #60a5fa; border: 1px solid rgba(59,130,246,0.2); }
.tag-date { background: rgba(251,191,36,0.08); color: var(--amber); border: 1px solid rgba(251,191,36,0.15); }
.tag-review { background: rgba(248,113,113,0.1); color: var(--rose); border: 1px solid rgba(248,113,113,0.2); }
.paper-summary { font-size: 13px; color: var(--text-dim); line-height: 1.55; }
.no-results { text-align: center; padding: 48px 20px; color: var(--text-muted); font-size: 14px; }
footer { padding: 32px 0; border-top: 1px solid var(--border); color: var(--text-muted); font-size: 12px; text-align: center; }
footer a { color: var(--text-dim); text-decoration: none; }
footer a:hover { color: var(--accent); }
@media (max-width: 768px) { .container { padding: 0 12px; } header { padding: 32px 0 24px; } .stats-row { gap: 20px; } .stat-value { font-size: 22px; } }
</style>
</head>
<body>
<div class="container">
  <header>
    <div class="eyebrow">Open Research Compendium</div>
    <h1>AI/ML in <span>Pharmacometrics</span></h1>
    <p class="subtitle">An interactive explorer of research papers on artificial intelligence and machine learning applications in pharmacometrics and clinical pharmacology.</p>
    <div class="stats-row" id="stats"></div>
    <div class="links-row">
      <a href="https://github.com/victoriapb/awesome-ai-ml-pharmacometrics/" class="link-btn" target="_blank">
        <svg viewBox="0 0 24 24" fill="currentColor"><path d="M12 0C5.37 0 0 5.37 0 12c0 5.31 3.435 9.795 8.205 11.385.6.105.825-.255.825-.57 0-.285-.015-1.23-.015-2.235-3.015.555-3.795-.735-4.035-1.41-.135-.345-.72-1.41-1.23-1.695-.42-.225-1.02-.78-.015-.795.945-.015 1.62.87 1.845 1.23 1.08 1.815 2.805 1.305 3.495.99.105-.78.42-1.305.765-1.605-2.67-.3-5.46-1.335-5.46-5.925 0-1.305.465-2.385 1.23-3.225-.12-.3-.54-1.53.12-3.18 0 0 1.005-.315 3.3 1.23.96-.27 1.98-.405 3-.405s2.04.135 3 .405c2.295-1.56 3.3-1.23 3.3-1.23.66 1.65.24 2.88.12 3.18.765.84 1.23 1.905 1.23 3.225 0 4.605-2.805 5.625-5.475 5.925.435.375.81 1.095.81 2.22 0 1.605-.015 2.895-.015 3.3 0 .315.225.69.825.57A12.02 12.02 0 0024 12c0-6.63-5.37-12-12-12z"/></svg>
        GitHub
      </a>
      <a href="https://www.zotero.org/groups/6377183/ai-ml-pharmacometrics/library" class="link-btn" target="_blank">
        <svg viewBox="0 0 24 24" fill="currentColor"><path d="M3 3h18v2H6.5L18 17.5V18H3v-2h13L4 4.5V3z"/></svg>
        Zotero Library
      </a>
    </div>
  </header>
  <h2 class="section-title">Research Landscape</h2>
  <p class="section-desc">Click any cell to filter papers by application × methodology. Click row/column headers to filter by a single dimension.</p>
  <div class="active-filter" id="activeFilter">
    <span style="font-size:12px; color:var(--text-dim);">Filtering:</span>
    <div id="filterTags"></div>
    <button class="clear-btn" onclick="clearFilters()">Clear all</button>
  </div>
  <div class="heatmap-wrap"><table class="heatmap" id="heatmap"></table></div>
  <h2 class="section-title" id="papersSection">Papers</h2>
  <input type="text" class="search-box" id="searchBox" placeholder="Search titles, summaries...">
  <div class="toggle-row" id="toggleRow">
    <button class="toggle-btn active" onclick="toggleReview('all')">All papers</button>
    <button class="toggle-btn" onclick="toggleReview('original')">Original research</button>
    <button class="toggle-btn" onclick="toggleReview('review')">Reviews & perspectives</button>
  </div>
  <div class="paper-count" id="paperCount"></div>
  <div class="papers-grid" id="papersGrid"></div>
</div>
<footer><div class="container">Built for <a href="https://github.com/victoriapb/awesome-ai-ml-pharmacometrics/" target="_blank">awesome-ai-ml-pharmacometrics</a> · Data curated via PubMed + Claude classification · Last updated <span id="lastUpdated"></span></div></footer>
<script>
const DATA = {"papers":[{"id":0,"title":"Machine learning-integrated electrochemical sensing of ciprofloxacin for digital point-of-care therapeutic drug monitoring.","url":"https://pubmed.ncbi.nlm.nih.gov/41361653/","methodologies":["Ensemble learning","Supervised learning","Tree-based models","Neural networks"],"applications":["Adherence to drug regimen"],"published":"2025Dec09","summary":"Machine learning models (MLP, SVM, decision tree, random forest) are integrated with electrochemical sensors to accurately quantify ciprofloxacin in urine for therapeutic drug monitoring.","is_review":false},{"id":1,"title":"Leveraging large language models in pharmacometrics: evaluation of NONMEM output interpretation and simulation capabilities.","url":"https://pubmed.ncbi.nlm.nih.gov/40464844/","methodologies":["LLM"],"applications":["Automation of PK/PD modeling"],"published":"2025Jun04","summary":"This study evaluates large language models (Claude, ChatGPT, Gemini, Llama) for automating pharmacometric tasks including generating model diagrams, tables, and reports from NONMEM outputs.","is_review":false},{"id":2,"title":"Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders: One Run Is All You Need.","url":"https://pubmed.ncbi.nlm.nih.gov/41186137/","methodologies":["Model selection","Deep learning","Hybrid mechanistic\u2013ML models"],"applications":["Automation of PK/PD modeling","Covariate selection / confounding adjustment"],"published":"2025Dec","summary":"A VAE framework is developed for NLME modeling that automates parameter estimation and covariate selection in pharmacometrics within a single run.","is_review":false},{"id":3,"title":"Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/41637692/","methodologies":["Deep learning","Feature selection","Neural networks"],"applications":["Automation of PK/PD modeling","Covariate selection / confounding adjustment","Pharmacokinetic modeling"],"published":"2026Feb","summary":"Neural networks with stochastic gates are used for automated covariate selection in population pharmacokinetics modeling to efficiently identify relevant covariates.","is_review":false},{"id":4,"title":"Shap-Cov: An Explainable Machine Learning Based Workflow for Rapid Covariate Identification in Population Modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/40601439/","methodologies":["Supervised learning","Explainable AI"],"applications":["Automation of PK/PD modeling","Covariate selection / confounding adjustment","Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025Aug","summary":"The paper presents Shap-Cov, an explainable ML workflow using SHAP analysis for automated covariate identification in population PK/PD modeling with uncertainty quantification.","is_review":false},{"id":5,"title":"Assessing the Potential of Generative Artificial Intelligence Models to Assist Experts in the Development of Pharmacokinetic Models.","url":"https://pubmed.ncbi.nlm.nih.gov/40922744/","methodologies":["LLM"],"applications":["Automation of PK/PD modeling"],"published":"2025Jul","summary":"This study explores using generative AI models to assist experts in developing scripts for pharmacokinetic models, specifically for constructing population PK models.","is_review":false},{"id":6,"title":"Automatic detection of arterial input function for brain DCE-MRI in multi-site cohorts.","url":"https://pubmed.ncbi.nlm.nih.gov/40808286/","methodologies":["Deep learning"],"applications":["Automation of PK/PD modeling","Pharmacokinetic modeling"],"published":"2025Dec","summary":"A deep learning model is developed to automatically extract arterial input functions from DCE-MRI images for quantitative pharmacokinetic modeling in multi-site cohorts.","is_review":false},{"id":7,"title":"Learning Chemotherapy Drug Action via Universal Physics-Informed Neural Networks.","url":"https://pubmed.ncbi.nlm.nih.gov/40244511/","methodologies":["Deep learning","Mechanism-informed machine learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Automation of PK/PD modeling","Pharmacodynamic modeling"],"published":"2025Apr","summary":"The paper applies Universal Physics-Informed Neural Networks to learn unknown components of differential equations modeling chemotherapy pharmacodynamics in QSP.","is_review":false},{"id":8,"title":"Opportunities for AI-based Model-informed Drug Development: A Comparative Analysis of NONMEM and AI-based Models for Population Pharmacokinetic Prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/41254220/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Automation of PK/PD modeling","Pharmacokinetic modeling"],"published":"2025Nov18","summary":"This study compares AI/ML models including deep learning and neural ODEs against traditional NONMEM for population pharmacokinetic modeling to evaluate predictive performance improvements.","is_review":false},{"id":9,"title":"A machine learning approach to population pharmacokinetic modelling automation.","url":"https://pubmed.ncbi.nlm.nih.gov/40745042/","methodologies":["Model selection"],"applications":["Automation of PK/PD modeling","Pharmacokinetic modeling"],"published":"2025Jul31","summary":"This paper presents an automated machine learning approach using optimization algorithms (pyDarwin) to streamline population pharmacokinetic model development for extravascular drugs.","is_review":false},{"id":10,"title":"Fully Automated Deep Learning Enabled Miniature Mass Spectrometry System for Psychoactive Therapeutic Drug Monitoring.","url":"https://pubmed.ncbi.nlm.nih.gov/40405757/","methodologies":["Deep learning"],"applications":["Automation of PK/PD modeling","Endpoint / biomarker assessment"],"published":"2025Aug","summary":"Deep learning U-net algorithm automates peak area recognition in miniature mass spectrometry for psychoactive drug monitoring with >98% identification accuracy.","is_review":false},{"id":11,"title":"QSP-Copilot: An AI-Augmented Platform for Accelerating Quantitative Systems Pharmacology Model Development.","url":"https://pubmed.ncbi.nlm.nih.gov/41159846/","methodologies":["AI Agents","LLM"],"applications":["Automation of PK/PD modeling"],"published":"2025Nov","summary":"QSP-Copilot uses large language models and multi-agent systems to automate quantitative systems pharmacology model development workflows, reducing development time by 40%.","is_review":false},{"id":12,"title":"Accelerating virtual patient generation with a Bayesian optimization and machine learning surrogate model.","url":"https://pubmed.ncbi.nlm.nih.gov/39630593/","methodologies":["Bayesian ML","Surrogate modeling"],"applications":["Automation of PK/PD modeling","Precision medicine / optimized treatment regimen"],"published":"2025Mar","summary":"The paper uses Bayesian optimization with machine learning surrogate models to accelerate virtual patient generation for QSP model validation in clinical trial simulations.","is_review":false},{"id":13,"title":"From chemical to mechanism-driven quality control of Glehniae Radix: spectrum effect - chemometrics-pharmacology integration decoding antioxidant-anti-inflammatory crosstalk.","url":"https://pubmed.ncbi.nlm.nih.gov/40922625/","methodologies":["Tree-based models","Feature selection"],"applications":["Covariate selection / confounding adjustment","Drug toxicity prediction"],"published":"2025Sep25","summary":"Random forest algorithm is used to optimize spectrum-effect relationships and predict bioactive constituents for quality control of Glehniae Radix herbal medicine.","is_review":false},{"id":14,"title":"AI-NLME: A New Artificial Intelligence-Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo-Controlled Clinical Trials.","url":"https://pubmed.ncbi.nlm.nih.gov/40898887/","methodologies":["Neural networks"],"applications":["Covariate selection / confounding adjustment","Enrichment design"],"published":"2025Sep","summary":"Proposes AI-NLME approach using artificial neural networks to estimate probability of non-specific treatment response for controlling confounding effects in clinical trials.","is_review":false},{"id":15,"title":"Uncovering Population PK Covariates from VAE-Generated Latent Spaces.","url":"https://pubmed.ncbi.nlm.nih.gov/41336851/","methodologies":["Unsupervised learning","Deep learning","Feature selection"],"applications":["Covariate selection / confounding adjustment","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Jul","summary":"Uses VAEs and LASSO regression to identify key covariates from PK profiles for improved population pharmacokinetic modeling and personalized dosing strategies.","is_review":false},{"id":16,"title":"Preparation of aspirin inhalable powder by ultrasound-intensified anti-solvent crystallization for pulmonary drug delivery.","url":"https://pubmed.ncbi.nlm.nih.gov/40680606/","methodologies":["Tree-based models","Explainable AI"],"applications":["Covariate selection / confounding adjustment"],"published":"2025Sep","summary":"Decision Tree Regressor with Shapley Value analysis was used to elucidate the influence of critical process parameters in aspirin inhalable powder preparation.","is_review":false},{"id":17,"title":"Improving Genotype Imputation in High-Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning Approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/41407383/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Covariate selection / confounding adjustment","Data imputation","Precision medicine / optimized treatment regimen"],"published":"2025Dec17","summary":"The paper develops a multiple imputation framework using machine learning approaches including random forest and penalized regression for genotype imputation and covariate selection in pharmacogenomics.","is_review":false},{"id":18,"title":"Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors.","url":"https://pubmed.ncbi.nlm.nih.gov/40871097/","methodologies":["Supervised learning"],"applications":["Covariate selection / confounding adjustment","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Aug20","summary":"Machine learning is used to identify factors influencing individual clearance in a PBPK population model for end-stage renal disease patients to enable precision dosing.","is_review":false},{"id":19,"title":"Utilization of Machine Learning Approaches for Drug Clearance Prediction and Population Pharmacokinetic Covariate Analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/40968579/","methodologies":["Tree-based models","Explainable AI","Neural networks","Supervised learning","Deep learning"],"applications":["Covariate selection / confounding adjustment","Pharmacokinetic modeling"],"published":"2025Sep","summary":"This study applies multiple ML models including CNNs and gradient boosting with SHAP-based XAI for drug clearance prediction and covariate analysis in population pharmacokinetics.","is_review":false},{"id":20,"title":"Microdose Cocktail Study Reveals the Activity and Key Influencing Factors of OATP1B, P-Gp, BCRP, and CYP3A in End-Stage Renal Disease Patients.","url":"https://pubmed.ncbi.nlm.nih.gov/39789999/","methodologies":["Supervised learning"],"applications":["Covariate selection / confounding adjustment","Pharmacokinetic modeling"],"published":"2025May","summary":"Machine learning models were used alongside population pharmacokinetic modeling to identify key factors influencing drug transporter/enzyme activities in ESRD patients.","is_review":false},{"id":21,"title":"MMPK: A Multimodal Deep Learning Framework to Predict Human Oral Pharmacokinetic Parameters.","url":"https://pubmed.ncbi.nlm.nih.gov/40741939/","methodologies":["Deep learning","Supervised learning"],"applications":["Data imputation","Pharmacokinetic modeling"],"published":"2025Aug14","summary":"MMPK uses multimodal deep learning to predict human oral pharmacokinetic parameters by integrating molecular graphs, substructures, and SMILES sequences.","is_review":false},{"id":22,"title":"Molecular features of human pathological tau distinguish tauopathy-associated dementias.","url":"https://pubmed.ncbi.nlm.nih.gov/41616780/","methodologies":["Unsupervised learning","Supervised learning"],"applications":["Discovery of subpatient groups","Endpoint / biomarker assessment","Patient risk stratification / management"],"published":"2026Feb05","summary":"Uses unsupervised and supervised ML to identify distinct molecular features of pathological tau protein for disease stratification and biomarker discovery across tauopathies.","is_review":false},{"id":23,"title":"Machine learning-guided clinical pharmacist interventions improve treatment outcomes in tuberculosis patients: a precision medicine approach.","url":"https://pubmed.ncbi.nlm.nih.gov/41487272/","methodologies":["Unsupervised learning"],"applications":["Discovery of subpatient groups","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Machine learning techniques are used to identify TB patient subtypes and optimize clinical pharmacist interventions for precision medicine treatment approaches.","is_review":false},{"id":24,"title":"Network-based disease fingerprinting with neuroinflammation PET imaging.","url":"https://pubmed.ncbi.nlm.nih.gov/41282214/","methodologies":["Unsupervised learning","Supervised learning"],"applications":["Discovery of subpatient groups","Endpoint / biomarker assessment","RWD phenotyping"],"published":"2025Oct21","summary":"Machine learning classifiers are applied to network-based TSPO PET imaging data to identify disease-specific neuroinflammatory patterns and classify different neurological conditions.","is_review":false},{"id":25,"title":"Virtual patients inspired by multiomics predict the efficacy of an anti-IFN\u03b1 mAb in cutaneous lupus.","url":"https://pubmed.ncbi.nlm.nih.gov/39925417/","methodologies":["Unsupervised learning","Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":["Discovery of subpatient groups","Outcome prediction","Patient risk stratification / management","Precision medicine / optimized treatment regimen"],"published":"2025Feb21","summary":"Uses multiomics clustering to identify patient subgroups, then applies ML with mechanistic modeling to predict anti-IFN\u03b1 antibody treatment responses in virtual lupus patients.","is_review":false},{"id":26,"title":"Robust temporal knowledge inference via pathway snapshots with liquid neural network.","url":"https://pubmed.ncbi.nlm.nih.gov/40349883/","methodologies":["Neural networks","Time-series modeling","Reinforcement learning","Deep learning","AI Agents"],"applications":["Disease progression modeling","Pharmacokinetic modeling"],"published":"2025Sep","summary":"The paper develops liquid neural network-based AI agents for temporal knowledge inference in disease pathways and drug pharmacokinetic processes using imitation learning.","is_review":false},{"id":27,"title":"Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/40654807/","methodologies":["Tree-based models","Hybrid mechanistic\u2013ML models","Neural networks","Ensemble learning","Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025May07","summary":"Combines machine learning algorithms with population PK Bayesian methods to improve infliximab concentration predictions in pediatric Crohn's disease patients for better dose individualization.","is_review":false},{"id":28,"title":"FormulationLAI: A physiology-based machine learning framework for accelerated development of long-acting injectable formulations.","url":"https://pubmed.ncbi.nlm.nih.gov/41260272/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2026Jan10","summary":"The paper presents a computational framework integrating ML with PBPK modeling and MD simulations to accelerate long-acting injectable formulation development and optimization.","is_review":false},{"id":29,"title":"Comparison of Machine Learning Algorithms and Bayesian Estimation in Predicting Tacrolimus Concentration in Tunisian Kidney Transplant Patients During the Early Post-Transplant Period.","url":"https://pubmed.ncbi.nlm.nih.gov/40338501/","methodologies":["Deep learning","Tree-based models","Time-series modeling"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025May","summary":"Compares XGBoost and LSTM machine learning algorithms with Bayesian modeling for predicting tacrolimus concentrations to optimize dosing in kidney transplant patients.","is_review":false},{"id":30,"title":"Multicycle Dosimetric Behavior and Dose-Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40274371/","methodologies":["Deep learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Jun02","summary":"Deep learning algorithm used for kidney segmentation in dosimetric analysis to develop personalized dosimetry-guided PRRT treatments for neuroendocrine tumors.","is_review":false},{"id":31,"title":"Concentration monitoring and dose optimization for infliximab in Crohn's disease patients: a machine learning-based covariate ensemble model.","url":"https://pubmed.ncbi.nlm.nih.gov/41438746/","methodologies":["Ensemble learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Machine learning ensemble model developed to predict infliximab trough concentrations and optimize dosing for Crohn's disease patients in real-time.","is_review":false},{"id":32,"title":"Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/40791331/","methodologies":["Deep learning","Reinforcement learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Jul18","summary":"Deep Q-Networks are used to automate and optimize infliximab dosing decisions for pediatric Crohn's disease patients by learning optimal strategies through reinforcement learning.","is_review":false},{"id":33,"title":"A Comparison of AI and Population PK Models to Predict the Concentrations of Antiepileptic Drugs Using Therapeutic Drug Monitoring Records.","url":"https://pubmed.ncbi.nlm.nih.gov/41127895/","methodologies":["Deep learning","Supervised learning","Ensemble learning","Tree-based models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Oct","summary":"This study compares AI models (including ensemble and deep learning methods) with population PK models to predict antiepileptic drug concentrations using TDM data.","is_review":false},{"id":34,"title":"Development of Co-Amorphous Systems for Inhalation Therapy-Part 2: In Silico Guided Co-Amorphous Rifampicin-Moxifloxacin and -Ethambutol Formulations.","url":"https://pubmed.ncbi.nlm.nih.gov/41155974/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Drug repurposing"],"published":"2025Oct16","summary":"Machine learning tool identifies promising API combinations for tuberculosis therapy, combined with PBPK modeling to optimize co-amorphous formulations for inhalation delivery.","is_review":false},{"id":35,"title":"Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment.","url":"https://pubmed.ncbi.nlm.nih.gov/40456293/","methodologies":["Tree-based models","Explainable AI","Ensemble learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Jun02","summary":"Develops ensemble ML model using gradient boosting algorithms with SHAP interpretation to predict valproic acid concentrations for optimized epilepsy treatment dosing.","is_review":false},{"id":36,"title":"Automated quality assurance of imaging dose and protocol adherence in computed tomography radiotherapy planning using TotalSegmentator-based segmentation.","url":"https://pubmed.ncbi.nlm.nih.gov/41313446/","methodologies":["Deep learning"],"applications":["Dose selection / optimization"],"published":"2025Nov28","summary":"The paper uses TotalSegmentator-based deep learning segmentation to automate quality assurance of CT imaging doses and protocol adherence in radiotherapy planning.","is_review":false},{"id":37,"title":"Machine Learning-Based Algorithm for Tacrolimus Dose Optimization in Hospitalized Kidney Transplant Patients.","url":"https://pubmed.ncbi.nlm.nih.gov/41374329/","methodologies":["Tree-based models","Explainable AI","Neural networks","Supervised learning","Ensemble learning","Deep learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Nov21","summary":"ML models (XGBoost, CatBoost, LightGBM, MLP) with ensemble approach predict tacrolimus concentrations for precision dosing optimization in kidney transplant patients.","is_review":false},{"id":38,"title":"Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients.","url":"https://pubmed.ncbi.nlm.nih.gov/41626576/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Machine learning models are used to predict optimal ceftaroline dosage for pediatric patients to enable individualized therapy and overcome age-related physiological variability.","is_review":false},{"id":39,"title":"Dose-time-concentration prediction method based on GRU-TCN with temporal-channel attention.","url":"https://pubmed.ncbi.nlm.nih.gov/41201288/","methodologies":["Deep learning","Neural networks","Time-series modeling"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Nov07","summary":"The paper develops a GRU-TCN deep learning model with attention mechanisms for predicting drug concentration-time profiles to support precision dosing decisions.","is_review":false},{"id":40,"title":"Machine learning approach for personalized vancomycin steady-state trough concentration prediction: a superior approach over Bayesian population pharmacokinetic model.","url":"https://pubmed.ncbi.nlm.nih.gov/40575776/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Machine learning model developed to predict vancomycin steady-state trough concentrations for personalized dosing, compared against traditional Bayesian population PK approaches.","is_review":false},{"id":41,"title":"Machine learning-based prediction model for teicoplanin plasma concentrations in adults with liver disease using real-world data.","url":"https://pubmed.ncbi.nlm.nih.gov/41424785/","methodologies":["Deep learning","Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2025","summary":"Machine learning and deep learning techniques are used to construct a prediction model for teicoplanin plasma concentrations in liver disease patients using real-world data.","is_review":false},{"id":42,"title":"AI-driven ANN and RSM-CCD integrated optimization of cinnarizine-domperidone bilayer tablet: In-vitro evaluation and in-silico PBPK modeling using GastroPlus\u00ae.","url":"https://pubmed.ncbi.nlm.nih.gov/41546579/","methodologies":["Neural networks","Surrogate modeling"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2026Feb","summary":"The paper uses artificial neural networks (ANN) integrated with response surface methodology to optimize cinnarizine-domperidone bilayer tablet formulation with PBPK modeling validation.","is_review":false},{"id":43,"title":"Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40336661/","methodologies":["Supervised learning","Explainable AI"],"applications":["Dose selection / optimization","Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025","summary":"Uses interpretable machine learning to predict high-dose methotrexate blood concentrations in osteosarcoma patients for early exposure prediction and toxicity prevention.","is_review":false},{"id":44,"title":"Forecasting anesthetic depth using an auto-regressive transformer in propofol infusion during the induction phase.","url":"https://pubmed.ncbi.nlm.nih.gov/40522504/","methodologies":["Deep learning","Time-series modeling"],"applications":["Dose selection / optimization","Pharmacodynamic modeling"],"published":"2025Oct","summary":"The paper uses auto-regressive transformers to forecast depth of anesthesia for optimizing propofol dosing during anesthesia induction phase.","is_review":false},{"id":45,"title":"Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/41133517/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Oct20","summary":"The paper combines population pharmacokinetic modeling with machine learning techniques to optimize mycophenolate dosing for renal transplant patients.","is_review":false},{"id":46,"title":"Predicting Vancomycin Clearance in Neonates and Infants by Integrating Machine Learning and Metabolomics With Population Pharmacokinetics.","url":"https://pubmed.ncbi.nlm.nih.gov/40616641/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Jul","summary":"Machine learning methods, particularly Gradient Boosting Regressor, are used to predict vancomycin clearance in neonates by integrating clinical covariates and metabolomics data.","is_review":false},{"id":47,"title":"Estimation of Overall Cyclosporine Exposure Using Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40698833/","methodologies":["Supervised learning","Tree-based models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2025Dec01","summary":"XGBoost machine learning models are developed to predict cyclosporine AUC using blood concentrations and compared against traditional Bayesian estimation methods.","is_review":false},{"id":48,"title":"Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer.","url":"https://pubmed.ncbi.nlm.nih.gov/40379920/","methodologies":["Deep learning"],"applications":["Dose selection / optimization","Drug toxicity prediction"],"published":"2025May16","summary":"AI-generated 3D body composition analysis is used to predict chemotherapy dose modifications and adverse events in rectal cancer patients receiving neoadjuvant therapy.","is_review":false},{"id":49,"title":"Combined Experimental and Computational Approaches for Ternary Solid Dispersions to Enhance the Oral Bioavailability of Penfluridol.","url":"https://pubmed.ncbi.nlm.nih.gov/41471061/","methodologies":["Tree-based models"],"applications":["Dose selection / optimization"],"published":"2025Nov30","summary":"Random forest regression was used to optimize the formulation composition of ternary solid dispersions to enhance penfluridol's oral bioavailability.","is_review":false},{"id":50,"title":"Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing.","url":"https://pubmed.ncbi.nlm.nih.gov/40734640/","methodologies":["Model selection","Supervised learning","Ensemble learning","Tree-based models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Oct","summary":"ML-based XGBoost model selects and averages population PK models for individualized vancomycin dosing, outperforming single-model approaches in precision dosing applications.","is_review":false},{"id":51,"title":"nnDoseNet: Intuitive and flexible deep learning framework to train and evaluate radiotherapy dose prediction models.","url":"https://pubmed.ncbi.nlm.nih.gov/41151501/","methodologies":["Deep learning"],"applications":["Dose selection / optimization"],"published":"2025Nov","summary":"The paper presents a deep learning framework for training and evaluating radiotherapy dose prediction models to optimize treatment planning.","is_review":false},{"id":52,"title":"Mechanism-informed machine learning for individualized tacrolimus dose adjustment in the early post-kidney transplant period.","url":"https://pubmed.ncbi.nlm.nih.gov/41531243/","methodologies":["Mechanism-informed machine learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2026Jan13","summary":"The paper develops mechanism-informed ML models to optimize individualized tacrolimus dosing in kidney transplant patients during the early post-transplant period.","is_review":false},{"id":53,"title":"Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/40885855/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Nov","summary":"The paper develops a hybrid approach combining machine learning with population PK-based Bayesian methods to improve infliximab concentration predictions in pediatric Crohn's disease patients.","is_review":false},{"id":54,"title":"Explainable cluster-based learning for prediction of postprandial glycemic events and insulin dose optimization in type 1 diabetes.","url":"https://pubmed.ncbi.nlm.nih.gov/40956852/","methodologies":["Tree-based models","Explainable AI","Unsupervised learning","Ensemble learning","Supervised learning"],"applications":["Dose selection / optimization","Outcome prediction","Patient risk stratification / management","Precision medicine / optimized treatment regimen"],"published":"2025Sep","summary":"Uses cluster-based ensemble ML with explainable AI to predict postprandial glycemic events and optimize insulin dosing in type 1 diabetes patients.","is_review":false},{"id":55,"title":"Beyond Algorithms: Machine Learning and Clinical Determinants of Voriconazole Plasma Levels in Therapeutic Drug Monitoring.","url":"https://pubmed.ncbi.nlm.nih.gov/41288921/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Drug toxicity prediction","Precision medicine / optimized treatment regimen"],"published":"2025Nov25","summary":"Machine learning is used to predict subtherapeutic or supratherapeutic voriconazole plasma levels for therapeutic drug monitoring optimization.","is_review":false},{"id":56,"title":"Optimizing Tacrolimus Dosing During Hospitalization After Kidney Transplantation: A Comparative Model Analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/40165354/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Dose selection / optimization"],"published":"2025Apr01","summary":"This study compares XGBoost, Elastic Net, and Linear Regression models to optimize tacrolimus dosing in kidney transplant patients during early hospitalization.","is_review":false},{"id":57,"title":"Deep learning-based automatic dose optimization for brachytherapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40532513/","methodologies":["Deep learning"],"applications":["Dose selection / optimization"],"published":"2025Nov","summary":"Deep learning is used for dose prediction and inverse optimization algorithms to improve brachytherapy treatment planning quality and dose optimization.","is_review":false},{"id":58,"title":"Targeting the glabellar frown lines with OnabotulinumtoxinA: In-silico evidence supporting concentrated, low-volume injection protocols.","url":"https://pubmed.ncbi.nlm.nih.gov/40907830/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":["Dose selection / optimization","Drug toxicity prediction","Pharmacodynamic modeling","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Nov","summary":"Uses machine learning for off-target risk prediction integrated with mechanistic PK/PD modeling to optimize BoNT-A dosing protocols for glabellar frown line treatment.","is_review":false},{"id":59,"title":"Development of a patient-specific cone-beam computed tomography dose optimization model using machine learning in image-guided radiation therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40982207/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization"],"published":"2025Dec","summary":"Machine learning model using support vector regression to predict optimal patient-specific CBCT radiation doses that minimize exposure while maintaining image quality.","is_review":false},{"id":60,"title":"Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data.","url":"https://pubmed.ncbi.nlm.nih.gov/40459932/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2026Feb01","summary":"This study develops an ensemble ML model to predict infliximab pharmacokinetics in pediatric Crohn disease patients using synthetic and real-world data for individualized dosing optimization.","is_review":false},{"id":61,"title":"PlasmoBridge: Stable hotspot engineering and targeted Surface-enhanced Raman spectroscopy (SERS) monitoring of methotrexate.","url":"https://pubmed.ncbi.nlm.nih.gov/41082836/","methodologies":["Deep learning"],"applications":["Dose selection / optimization","Drug toxicity prediction","Precision medicine / optimized treatment regimen"],"published":"2026Jan15","summary":"The paper uses convolutional neural networks to enhance spectral analysis accuracy for methotrexate therapeutic drug monitoring via SERS technology.","is_review":false},{"id":62,"title":"TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.","url":"https://pubmed.ncbi.nlm.nih.gov/40934473/","methodologies":["Supervised learning","Feature selection"],"applications":["Dose selection / optimization","Outcome prediction"],"published":"2025Sep23","summary":"Develops a hybrid kernel machine combining molecular features and compositional data to predict nanoparticle formulation outcomes and optimize drug delivery systems.","is_review":false},{"id":63,"title":"DeepTDM: Deep Learning-Based Prediction of Sequential Therapeutic Drug Monitoring Levels of Vancomycin.","url":"https://pubmed.ncbi.nlm.nih.gov/41220794/","methodologies":["Deep learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Deep learning is used to predict sequential vancomycin therapeutic drug monitoring levels in critically ill patients to optimize dosing and improve treatment outcomes.","is_review":false},{"id":64,"title":"Improving Vancomycin Through Level Prediction with Machine Learning: A Comparative Study of Feature Selection and Model Performance.","url":"https://pubmed.ncbi.nlm.nih.gov/41336096/","methodologies":["Tree-based models","Explainable AI","Feature selection","Ensemble learning","Supervised learning"],"applications":["Dose selection / optimization","Drug toxicity prediction","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Jul","summary":"Machine learning models (Random Forest, LightGBM, XGBoost) are used to predict vancomycin trough levels for individualized dosing, outperforming traditional Bayesian methods.","is_review":false},{"id":65,"title":"Value Decomposition-Based Multi-Agent Learning for Anesthetics Collaborative Control.","url":"https://pubmed.ncbi.nlm.nih.gov/40828726/","methodologies":["Tree-based models","AI Agents","Reinforcement learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Aug19","summary":"Multi-agent deep reinforcement learning framework for personalized collaborative control of multiple anesthetics (propofol and remifentanil) in closed-loop TIVA systems.","is_review":false},{"id":66,"title":"Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosing.","url":"https://pubmed.ncbi.nlm.nih.gov/41369581/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2026Jan07","summary":"Machine learning models, specifically support vector machines, were developed to predict dalbavancin plasma concentrations for individualized redosing decisions in clinical practice.","is_review":false},{"id":67,"title":"Applying exposure-response analysis to enhance Mycophenolate Mofetil dosing precision in pediatric patients with immune-mediated renal diseases by machine learning models.","url":"https://pubmed.ncbi.nlm.nih.gov/40447059/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Exposure\u2013response analysis","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Aug01","summary":"Machine learning models are applied to develop pharmacokinetic models for mycophenolic acid and optimize MMF dosing in pediatric patients with immune-mediated renal diseases.","is_review":false},{"id":68,"title":"Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41189499/","methodologies":["Deep learning","Reinforcement learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2026Feb","summary":"Deep Q-Network reinforcement learning is used to automate and optimize infliximab dosing decisions for pediatric Crohn's disease patients using population PK models.","is_review":false},{"id":69,"title":"Machine learning approach for dosage individualization of azithromycin in children with community-acquired pneumonia.","url":"https://pubmed.ncbi.nlm.nih.gov/40181615/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Aug","summary":"Machine learning is used to predict azithromycin AUC0-24 in children with pneumonia to enable individualized dosing regimens.","is_review":false},{"id":70,"title":"Machine learning-assisted tacrolimus dose optimization in childhood- onset systemic lupus erythematosus through population pharmacokinetic modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/40684660/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Sep","summary":"Machine learning algorithms are integrated with population pharmacokinetic modeling to predict individualized tacrolimus dosing for optimized therapy in childhood-onset systemic lupus erythematosus.","is_review":false},{"id":71,"title":"Precision Dosing in Presence of Multiobjective Therapies by Integrating Reinforcement Learning and PK-PD Models: Application to Givinostat Treatment of Polycythemia Vera.","url":"https://pubmed.ncbi.nlm.nih.gov/40325832/","methodologies":["Hybrid mechanistic\u2013ML models","Reinforcement learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Jun","summary":"The paper integrates Q-Learning reinforcement learning with PK-PD models to develop adaptive dosing protocols for givinostat treatment in polycythemia vera patients.","is_review":false},{"id":72,"title":"Precision dosing of voriconazole in immunocompromised children under 2 years: integrated machine learning and population pharmacokinetic modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/41031158/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"The paper integrates machine learning with population pharmacokinetic modeling to develop individualized voriconazole dosing strategies for immunocompromised children under 2 years.","is_review":false},{"id":73,"title":"Nephrocast-V: A Deep Learning Model for the Prediction of Vancomycin Trough Concentration Using Electronic Health Record Data.","url":"https://pubmed.ncbi.nlm.nih.gov/41025800/","methodologies":["Deep learning"],"applications":["Dose selection / optimization","Outcome prediction","Precision medicine / optimized treatment regimen"],"published":"2026Jan","summary":"A deep learning model is developed to predict vancomycin trough concentrations using electronic health record data to optimize therapeutic dosing.","is_review":false},{"id":74,"title":"Using Machine Learning for the Discovery and Development of Multitarget Flavonoid-Based Functional Products in MASLD.","url":"https://pubmed.ncbi.nlm.nih.gov/41226123/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Dose selection / optimization","Drug repurposing","Drug toxicity prediction"],"published":"2025Oct22","summary":"Machine learning ensemble methods (Random Forest, XGBoost, CatBoost) are used to predict bioactivity of flavonoids against MASLD targets for nutraceutical product development.","is_review":false},{"id":75,"title":"Optimizing Dosing Strategies in Cell Therapy With Machine Learning and Exposure-Response Integration.","url":"https://pubmed.ncbi.nlm.nih.gov/41369984/","methodologies":["Tree-based models"],"applications":["Dose selection / optimization","Exposure\u2013response analysis"],"published":"2026Jan-Feb","summary":"The paper proposes a random forest-based seamless phase I/II design that integrates toxicity, efficacy, and cellular kinetics data for optimal dose selection in cell therapy.","is_review":false},{"id":76,"title":"A Real-Time Plasma Concentration Prediction Model for Voriconazole in Elderly Patients via Machine Learning Combined with Population Pharmacokinetics.","url":"https://pubmed.ncbi.nlm.nih.gov/40401163/","methodologies":["Hybrid mechanistic\u2013ML models","Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"Machine learning combined with population pharmacokinetics to develop a real-time plasma concentration prediction model for voriconazole in elderly patients.","is_review":false},{"id":77,"title":"Dosing prediction of valproic acid in pediatric patients with epilepsy: population pharmacokinetic model or machine learning model?","url":"https://pubmed.ncbi.nlm.nih.gov/40617982/","methodologies":["Neural networks"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2025Sep","summary":"This study compares population pharmacokinetic models with neural networks to predict valproic acid concentrations and optimize dosing in pediatric epilepsy patients.","is_review":false},{"id":78,"title":"Optimizing Initial Vancomycin Dosing in Hospitalized Patients Using Machine Learning Approach for Enhanced Therapeutic Outcomes: Algorithm Development and Validation Study.","url":"https://pubmed.ncbi.nlm.nih.gov/40163845/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Mar31","summary":"Machine learning approach is used to develop and validate an algorithm for optimizing initial vancomycin dosing in hospitalized patients to enhance therapeutic outcomes.","is_review":false},{"id":79,"title":"A deep learning model to predict dose distributions for breast cancer radiotherapy.","url":"https://pubmed.ncbi.nlm.nih.gov/39937302/","methodologies":["Deep learning"],"applications":["Dose selection / optimization"],"published":"2025Feb12","summary":"A 3D U-Net deep learning model is developed to predict dose distributions for breast cancer radiotherapy treatment planning.","is_review":false},{"id":80,"title":"Deep reinforcement learning for multi-targets propofol dosing.","url":"https://pubmed.ncbi.nlm.nih.gov/40045084/","methodologies":["Deep learning","Reinforcement learning"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Jun","summary":"This paper applies deep reinforcement learning (TD3 algorithm) to automate propofol dosing for maintaining multiple physiological parameters within safe ranges during anesthesia.","is_review":false},{"id":81,"title":"RSM and AI based machine learning for quality by design development of rivaroxaban push-pull osmotic tablets and its PBPK modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/40050302/","methodologies":["Neural networks","Surrogate modeling"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2025Mar07","summary":"ANN-based machine learning is used alongside RSM to optimize rivaroxaban osmotic tablet formulations, with PBPK modeling to predict in vivo performance.","is_review":false},{"id":82,"title":"Long short-term memory algorithm for personalized tacrolimus dosing: A simple and effective time series forecasting approach post-lung transplantation.","url":"https://pubmed.ncbi.nlm.nih.gov/39510206/","methodologies":["Deep learning","Neural networks","Time-series modeling"],"applications":["Dose selection / optimization","Precision medicine / optimized treatment regimen"],"published":"2025Mar","summary":"Uses LSTM neural networks for time series forecasting to predict tacrolimus trough levels and optimize dosing in lung transplant patients.","is_review":false},{"id":83,"title":"Estimation of Ganciclovir Exposure in Adults Transplant Patients by Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40021573/","methodologies":["Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling"],"published":"2025Feb28","summary":"Machine learning algorithms are trained and validated to accurately estimate ganciclovir AUC0-24h exposure in solid organ transplant patients for improved dosing.","is_review":false},{"id":84,"title":"Machine learning and population pharmacokinetics: a hybrid approach for optimizing vancomycin therapy in sepsis patients.","url":"https://pubmed.ncbi.nlm.nih.gov/40162774/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models","Tree-based models"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Mar31","summary":"This study compares PPK, Bayesian, ML, and hybrid PPK-ML models for predicting vancomycin AUC24 to optimize dosing in sepsis patients using machine learning approaches.","is_review":false},{"id":85,"title":"Comparing Scientific Machine Learning With Population Pharmacokinetic and Classical Machine Learning Approaches for Prediction of Drug Concentrations.","url":"https://pubmed.ncbi.nlm.nih.gov/39921335/","methodologies":["Hybrid mechanistic\u2013ML models","Supervised learning"],"applications":["Dose selection / optimization","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025Apr","summary":"The paper compares a scientific machine learning framework (MMPK-SciML) with classical ML and population PK models for predicting drug plasma concentrations using fluorouracil and sunitinib datasets.","is_review":false},{"id":86,"title":"AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40543907/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Aug","summary":"AI-driven virtual screening platform was used to discover and prioritize novel brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.","is_review":false},{"id":87,"title":"In-silico investigation integrated with machine learning to identify potential inhibitors targeting AKT2: Key driver of cancer cell progression and metastasis.","url":"https://pubmed.ncbi.nlm.nih.gov/40305999/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Jul","summary":"Machine learning is integrated with in-silico methods to identify potential AKT2 inhibitors for cancer treatment, focusing on drug discovery and repurposing applications.","is_review":false},{"id":88,"title":"Discovery of Mangifera indica-based natural inhibitors against TEM-1 \u03b2-lactamase from Escherichia coli using machine learning approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/41297205/","methodologies":["Deep learning","Neural networks"],"applications":["Drug repurposing"],"published":"2026Feb","summary":"Deep learning neural network trained on 220 compounds to identify Mangifera indica phytochemicals as potential TEM-1 \u03b2-lactamase inhibitors for antimicrobial resistance.","is_review":false},{"id":89,"title":"Discovery of selective TLR9 antagonists via machine learning-driven structural modeling and experimental validation.","url":"https://pubmed.ncbi.nlm.nih.gov/41371528/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2026Jan","summary":"Machine learning QSAR classifiers combined with molecular modeling to discover novel selective TLR9 antagonist compounds for therapeutic applications.","is_review":false},{"id":90,"title":"DualPG-DTA: A Large Language Model-Powered Graph Neural Network Framework for Enhanced Drug-Target Affinity Prediction and Discovery of Novel CDK9 Inhibitors Exhibiting in Vivo Anti-Leukemia Activity.","url":"https://pubmed.ncbi.nlm.nih.gov/41589601/","methodologies":["Deep learning","LLM","Neural networks"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Jan27","summary":"DualPG-DTA uses large language models and graph neural networks to predict drug-target binding affinity, successfully identifying a novel CDK9 inhibitor for leukemia treatment.","is_review":false},{"id":91,"title":"Single nucleus RNA sequencing profile analysis to reveal cell type specific common molecular drivers of Parkinson's disease and therapeutic agents.","url":"https://pubmed.ncbi.nlm.nih.gov/40715263/","methodologies":["Unsupervised learning"],"applications":["Drug repurposing"],"published":"2025Jul25","summary":"Uses unsupervised clustering methods (scVI) on single-nucleus RNA sequencing data to identify molecular drivers of Parkinson's disease and suggest repurposed therapeutic drugs.","is_review":false},{"id":92,"title":"Biomarker discovery and drug repurposing in hepatocellular carcinoma through transcriptomics, machine learning, network pharmacology, and molecular dynamics.","url":"https://pubmed.ncbi.nlm.nih.gov/41671946/","methodologies":["Tree-based models","Explainable AI","Feature selection","Ensemble learning","Supervised learning"],"applications":["Drug repurposing","Endpoint / biomarker assessment","Patient risk stratification / management"],"published":"2026Feb08","summary":"Uses machine learning classifiers (XGBoost, Random Forest, SVM, Logistic Regression) with SHAP explainability to identify HCC biomarkers and explore drug repurposing opportunities.","is_review":false},{"id":93,"title":"In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19.","url":"https://pubmed.ncbi.nlm.nih.gov/40561178/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2025","summary":"The paper uses machine learning regression models including Decision Tree, XGBoost, and ensemble methods to predict binding affinities for drug repurposing against COVID-19 viral proteins.","is_review":false},{"id":94,"title":"Multi-omics pan-cancer profiling of CDK2 and in silico identification of plant-derived inhibitors using machine learning approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/41058670/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Oct02","summary":"Machine learning approaches are used to screen and identify plant-derived CDK2 inhibitors for cancer treatment through cheminformatics and predictive modeling.","is_review":false},{"id":95,"title":"Generating 3D Binding Molecules Using Shape-Conditioned Diffusion Models with Guidance.","url":"https://pubmed.ncbi.nlm.nih.gov/41255553/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025May","summary":"DiffSMol uses diffusion models to generate 3D binding molecules based on ligand shapes and protein pockets for drug development applications.","is_review":false},{"id":96,"title":"Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii.","url":"https://pubmed.ncbi.nlm.nih.gov/41471330/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Dec02","summary":"Machine learning models based on chemical fingerprints were used for virtual screening to discover enzyme inhibitors against multidrug-resistant Acinetobacter baumannii.","is_review":false},{"id":97,"title":"Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemia.","url":"https://pubmed.ncbi.nlm.nih.gov/41666760/","methodologies":["Unsupervised learning","Supervised learning"],"applications":["Drug repurposing"],"published":"2026Feb05","summary":"Machine learning guided drug discovery using unsupervised clustering for scaffold identification and QSAR modeling to develop menin-MLL inhibitors for acute myeloid leukemia treatment.","is_review":false},{"id":98,"title":"In silico investigation of the efficacy of benzopyrazine derivatives on breast cancer by VEGFR2 inhibition using ML/DL based CADD software.","url":"https://pubmed.ncbi.nlm.nih.gov/41237486/","methodologies":["Deep learning","Neural networks"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Jan","summary":"Uses ML/DL-based CADD software to investigate benzopyrazine derivatives as VEGFR2 inhibitors for breast cancer treatment through QSAR modeling and AI-based synthesizability prediction.","is_review":false},{"id":99,"title":"Computational Screening and Cytotoxic Analysis of Beta vulgaris L. phytoconstituents as potent Dengue virus-NS5 Polymerase inhibitors.","url":"https://pubmed.ncbi.nlm.nih.gov/40645353/","methodologies":["Unsupervised learning","Supervised learning","Feature selection"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Oct","summary":"Machine learning is used for data preprocessing, gene expression analysis, and pathway enrichment to identify Beta vulgaris phytoconstituents as potential dengue virus NS5 inhibitors.","is_review":false},{"id":100,"title":"Omics Integration Uncovers Mechanisms Associated with HIV Viral Load and Potential Therapeutic Insights.","url":"https://pubmed.ncbi.nlm.nih.gov/40766151/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Jul30","summary":"Machine learning network biology tools (GRIN and MENTOR) integrate multi-omic datasets to identify biological mechanisms associated with HIV viral load and drug repurposing candidates.","is_review":false},{"id":101,"title":"Drug repurposing targeting COVID-19 3CL protease using molecular docking and machine learning regression approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/40436944/","methodologies":["Supervised learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2025May28","summary":"The paper uses machine learning regression models, particularly Decision Tree Regression, combined with molecular docking to identify potential COVID-19 drug candidates.","is_review":false},{"id":102,"title":"Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2.","url":"https://pubmed.ncbi.nlm.nih.gov/40779912/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2025Sep","summary":"Random forest models were built to predict ENT1/ENT2 transporter inhibition, leading to identification of FDA-approved drugs as potential repurposed inhibitors.","is_review":false},{"id":103,"title":"AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness.","url":"https://pubmed.ncbi.nlm.nih.gov/41497266/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2026","summary":"AI-driven de novo design uses deep learning to create novel BRAF inhibitors with improved binding affinity and drug-likeness properties for cancer treatment.","is_review":false},{"id":104,"title":"Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation.","url":"https://pubmed.ncbi.nlm.nih.gov/40893439/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Aug","summary":"Machine learning methods are used for virtual screening with WHALES descriptors to identify novel dopamine transporter inhibitors for drug repurposing applications.","is_review":false},{"id":105,"title":"Breaking resistance with machine and deep learning: A computational intelligence hunt for AmvR (TetR) inhibitors in Acinetobacterbaumannii.","url":"https://pubmed.ncbi.nlm.nih.gov/41442824/","methodologies":["Deep learning","Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Mar","summary":"Machine learning models (RF, SVM, KNN, XGBoost) and CNN deep learning were used to screen natural compounds for AmvR inhibitors against multidrug-resistant Acinetobacter baumannii.","is_review":false},{"id":106,"title":"Identification of novel Menin-MLL interaction inhibitors targeting leukemia using in-silico virtual screening and structure-based drug design approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/41386877/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Dec","summary":"The paper uses machine learning (PSICHIC model) for binding affinity prediction in virtual screening to identify novel Menin-MLL interaction inhibitors for leukemia treatment.","is_review":false},{"id":107,"title":"Transfer Learning for Heterocycle Retrosynthesis.","url":"https://pubmed.ncbi.nlm.nih.gov/40729356/","methodologies":["Deep learning","Neural networks"],"applications":["Drug repurposing"],"published":"2025Aug11","summary":"The paper uses transfer learning with deep neural networks to improve retrosynthesis prediction models for heterocycle formation in drug discovery applications.","is_review":false},{"id":108,"title":"Potential Inhibitors of SARS-CoV-2 Developed through Machine Learning, Molecular Docking, and MD Simulation.","url":"https://pubmed.ncbi.nlm.nih.gov/40464176/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Jun03","summary":"Machine learning is used alongside molecular docking and MD simulation to identify potential SARS-CoV-2 inhibitors targeting the ACE2-spike protein interaction.","is_review":false},{"id":109,"title":"Support vector machine classification-guided identification of novel monoamine oxidase-B inhibitors via structure-based modeling to treat neurodegenerative diseases.","url":"https://pubmed.ncbi.nlm.nih.gov/40825424/","methodologies":["Deep learning","Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2025Sep","summary":"SVM classification models with molecular fingerprints were used to screen FDA-approved drugs for repurposing as novel MAO-B inhibitors to treat neurodegenerative diseases.","is_review":false},{"id":110,"title":"Machine learning guided virtual screening of FDA approved drugs targeting GSK-3\u03b2 in Alzheimer's disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41354678/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Dec07","summary":"Machine learning models, particularly Random Forest, are used to screen FDA-approved drugs for repurposing as GSK-3\u03b2 inhibitors in Alzheimer's disease treatment.","is_review":false},{"id":111,"title":"Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.","url":"https://pubmed.ncbi.nlm.nih.gov/40446543/","methodologies":["Unsupervised learning","Feature selection"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Jul","summary":"AI-driven network modeling and multi-omics integration are used to identify and characterize a dual-target inhibitor for ovarian cancer treatment.","is_review":false},{"id":112,"title":"A machine learning-Assisted QSAR and integrative computational combined with network pharmacology approach for rational identification of tankyrase inhibitors in colon adenocarcinoma.","url":"https://pubmed.ncbi.nlm.nih.gov/40945215/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Oct","summary":"Machine learning with random forest classification and feature selection is used for QSAR modeling to identify novel tankyrase inhibitors for colon cancer treatment.","is_review":false},{"id":113,"title":"An integrative computational approach for identification of NLRP3 inhibitors through machine learning, docking, dynamics and DFT analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/41461937/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Dec29","summary":"Machine learning models, particularly Random Forest, are used for virtual screening to identify phytochemical NLRP3 inhibitors for neuroinflammation treatment.","is_review":false},{"id":114,"title":"Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations.","url":"https://pubmed.ncbi.nlm.nih.gov/40233673/","methodologies":["Deep learning","Neural networks"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Jun","summary":"CNN-based QSAR models and machine learning are used to computationally screen natural products as potential TDO inhibitors for Parkinson's disease treatment.","is_review":false},{"id":115,"title":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial.","url":"https://pubmed.ncbi.nlm.nih.gov/40461817/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Aug","summary":"This paper reports clinical trial results for rentosertib, a TNIK inhibitor discovered using generative AI for treating idiopathic pulmonary fibrosis.","is_review":false},{"id":116,"title":"Deep learning and molecular dynamics reveal promising EZH2 inhibitors for epigenetic cancer targeting.","url":"https://pubmed.ncbi.nlm.nih.gov/41237543/","methodologies":["Deep learning","Reinforcement learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Feb","summary":"Deep learning generative model (REINVENT) with reinforcement learning identifies novel EZH2 inhibitors for cancer treatment through molecular generation and screening.","is_review":false},{"id":117,"title":"Halicin: A New Approach to Antibacterial Therapy, a Promising Avenue for the Post-Antibiotic Era.","url":"https://pubmed.ncbi.nlm.nih.gov/40723999/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Jul11","summary":"This paper evaluates halicin, an anti-diabetic compound repurposed as an antibiotic through AI screening, testing its antibacterial activity against multidrug-resistant bacteria.","is_review":false},{"id":118,"title":"Developing inhibitors of the guanosine triphosphate hydrolysis accelerating activity of Regulator of G protein Signaling-14.","url":"https://pubmed.ncbi.nlm.nih.gov/40667230/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Aug09","summary":"The paper uses structure-guided virtual screening, ligand docking, and deep learning-based scoring to develop inhibitors of RGS14 protein for drug discovery.","is_review":false},{"id":119,"title":"AI-assisted identification of innovative phytochemicals from Aizoon canariense aimed at brachyury protein in chordoma: a computational strategy.","url":"https://pubmed.ncbi.nlm.nih.gov/41419749/","methodologies":["Deep learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Dec19","summary":"AI-assisted drug discovery approach used to optimize phytochemicals from Aizoon canariense for targeting TBXT protein in chordoma treatment.","is_review":false},{"id":120,"title":"Elucidation of Artemisinin as a Potent GSK3\u03b2 Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds.","url":"https://pubmed.ncbi.nlm.nih.gov/40573222/","methodologies":["Supervised learning","Feature selection","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025May31","summary":"Machine learning models (SVM, RF, KNN) with feature selection were used for virtual screening to identify artemisinin as a potent GSK3\u03b2 inhibitor for neurodegenerative disorders.","is_review":false},{"id":121,"title":"Deep learning-guided discovery of selective JAK2-JH2 allosteric inhibitors: integration of MLP predictive modeling, BREED-based library design, and computational validation.","url":"https://pubmed.ncbi.nlm.nih.gov/41404389/","methodologies":["Deep learning","Neural networks"],"applications":["Drug repurposing"],"published":"2025","summary":"Deep learning MLP model trained on JAK2 compounds to predict and discover selective allosteric inhibitors through computational screening and molecular design.","is_review":false},{"id":122,"title":"Neurotherapeutics across blood-brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41079713/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025","summary":"Machine learning models are used to predict blood-brain barrier permeability and CNS activity for screening neurotherapeutic molecules in neurodegenerative disease drug discovery.","is_review":false},{"id":123,"title":"Crystal engineering optimizes emodin-tetramethylpyrazine combination: From cocrystal design to in vivo anti-colitis efficacy assessment.","url":"https://pubmed.ncbi.nlm.nih.gov/41323843/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Dec","summary":"Machine learning was used to assess cocrystallization propensity for rational design of an emodin-tetramethylpyrazine cocrystal to improve bioavailability for ulcerative colitis treatment.","is_review":false},{"id":124,"title":"Bioactive structures for inhibitors of Candida auris polymerase enzyme by artificial intelligence.","url":"https://pubmed.ncbi.nlm.nih.gov/40247646/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Apr","summary":"The paper uses AI and de novo drug design to create new bioactive compounds as potential inhibitors of C. auris polymerase enzyme.","is_review":false},{"id":125,"title":"AI-powered literature mining reveals the therapeutic significance of GLP-1 receptor: Simulation of natural agonist candidates based on molecular dynamics.","url":"https://pubmed.ncbi.nlm.nih.gov/41389576/","methodologies":["Deep learning","Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Apr","summary":"AI-integrated pipeline using BioBERT text mining and ML-guided ADMET profiling to identify natural GLP-1 receptor agonist candidates through virtual screening and molecular dynamics.","is_review":false},{"id":126,"title":"Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/41221054/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025","summary":"The paper uses AI for drug repurposing of natural depsipeptides for anti-breast cancer therapy, incorporating clinical trial simulation and multimodal health records analysis.","is_review":false},{"id":127,"title":"Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40229949/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Precision medicine / optimized treatment regimen"],"published":"2025Aug","summary":"Machine learning is used alongside systems pharmacology to design optimal drug combinations for overcoming temozolomide resistance in glioblastoma treatment.","is_review":false},{"id":128,"title":"Ai derivation and exploration of antibiotic class spaces.","url":"https://pubmed.ncbi.nlm.nih.gov/41546122/","methodologies":["Unsupervised learning"],"applications":["Drug repurposing"],"published":"2026Jan16","summary":"AI methods are used to systematically explore and generate compounds within antibiotic chemical spaces for automated discovery of new antibiotic candidates.","is_review":false},{"id":129,"title":"AI-Driven Discovery and Optimization of Positive Allosteric Modulators for NMDA Receptors: Potential Applications in Depression.","url":"https://pubmed.ncbi.nlm.nih.gov/40741898/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Aug14","summary":"AI-assisted optimization and structure-based virtual screening were used to discover and optimize positive allosteric modulators for NMDA receptors as potential antidepressants.","is_review":false},{"id":130,"title":"Exploring the mechanism of Stephania tetrandra S. Moore in the treatment of cisplatin resistance against ovarian cancer through integration of network pharmacology and molecular docking.","url":"https://pubmed.ncbi.nlm.nih.gov/41239601/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Nov14","summary":"Machine learning algorithms were integrated to identify core targets for Stephania tetrandra treatment of cisplatin-resistant ovarian cancer through network pharmacology analysis.","is_review":false},{"id":131,"title":"An innovative machine learning-based QSAR approach for prediction and structural analysis of novel/repurposed acid ceramidase (ASAH1) inhibitors for glioblastoma therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40682750/","methodologies":["Tree-based models","Explainable AI","Feature selection","Ensemble learning","Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Jul19","summary":"ML-QSAR approach using extra trees regressor and SHAP analysis to predict and identify novel ASAH1 inhibitors for glioblastoma therapy through virtual screening.","is_review":false},{"id":132,"title":"Designing new hit series of JAK3 inhibitors using generative AI, reinforcement learning, and molecular dynamics.","url":"https://pubmed.ncbi.nlm.nih.gov/41125009/","methodologies":["Deep learning","Reinforcement learning"],"applications":["Drug repurposing"],"published":"2025Nov","summary":"This paper uses generative AI and reinforcement learning to design novel JAK3 inhibitors, generating new molecular scaffolds and optimizing compounds for drug development.","is_review":false},{"id":133,"title":"Targeting the core: C9ORF72 antagonists as pioneers in amyotrophic lateral sclerosis therapy-a computational and machine learning based approach.","url":"https://pubmed.ncbi.nlm.nih.gov/41282964/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025","summary":"Uses machine learning-based tools for high throughput virtual screening to identify potential C9ORF72 agonists as therapeutic compounds for ALS treatment.","is_review":false},{"id":134,"title":"Integration of artificial intelligence and high-content screening enabled identification of drugs for long-term treatment of cerebral cavernous malformation disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41427327/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Dec11","summary":"AI integrated with high-content screening to identify existing drugs for repurposing as long-term treatments for cerebral cavernous malformation disease.","is_review":false},{"id":135,"title":"Artificial Intelligence Driven Virtual Screening and Molecular Docking Approaches Identified LIFR, BTG2, EPHX2, and PAK3 as Targets and BI-2536, AP-24534, and AZ-628 as Repurposed Drugs for PDAC.","url":"https://pubmed.ncbi.nlm.nih.gov/41605175/","methodologies":["Deep learning","Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2026Jan28","summary":"AI algorithms including SVM, logistic regression, random forest, XGB, and CNN are used for gene ranking and identification of differentially expressed genes in PDAC for drug repurposing.","is_review":false},{"id":136,"title":"Decoding the gut microbiota metabolite-matrix metalloproteinase-3 axis in breast cancer: a multi-omics and network pharmacology study.","url":"https://pubmed.ncbi.nlm.nih.gov/40946247/","methodologies":["Supervised learning","Explainable AI"],"applications":["Drug repurposing","Endpoint / biomarker assessment","Precision medicine / optimized treatment regimen"],"published":"2025Sep14","summary":"This study uses machine learning with SHAP explainability to identify gut microbiota metabolites as potential therapeutic targets for breast cancer treatment via MMP3 axis.","is_review":false},{"id":137,"title":"Unveiling Berberine analogues as potential inhibitors of Escherichia coli FtsZ through machine learning molecular docking and molecular dynamics approach.","url":"https://pubmed.ncbi.nlm.nih.gov/40287515/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Apr26","summary":"Machine learning is used to screen berberine analogues for drug-likeness and toxicity prediction, combined with molecular docking to identify potential FtsZ inhibitors.","is_review":false},{"id":138,"title":"AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era.","url":"https://pubmed.ncbi.nlm.nih.gov/41524971/","methodologies":["Deep learning","Neural networks","Reinforcement learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Jan12","summary":"AI-driven pipeline using deep reinforcement learning, GANs, and VAEs to generate and screen novel peptide-like molecules for endometrial cancer treatment.","is_review":false},{"id":139,"title":"Computational Evaluation of Potential c-Abl Kinase Inhibitors for Parkinson's Disease: QSAR, Docking, Bioisosteric Replacement, ADMET, and MD Simulations.","url":"https://pubmed.ncbi.nlm.nih.gov/41148549/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Dec","summary":"Machine learning-based QSAR modeling is used to identify and optimize potential c-Abl kinase inhibitors for Parkinson's disease treatment through computational screening and evaluation.","is_review":false},{"id":140,"title":"Integrated machine learning and deep learning-based virtual screening framework identifies novel natural GSK-3\u03b2 inhibitors for Alzheimer's disease.","url":"https://pubmed.ncbi.nlm.nih.gov/40668407/","methodologies":["Deep learning","Supervised learning","Explainable AI","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Jul16","summary":"Integrates random forest and deep learning for virtual screening to identify natural GSK-3\u03b2 inhibitors for Alzheimer's disease using SHAP for model interpretability.","is_review":false},{"id":141,"title":"Uralenol, Glycyrol, and Abyssinone II as potent inhibitors of fibroblast growth factor receptor 2 from anti-cancer plants: A deep learning and molecular dynamics approach.","url":"https://pubmed.ncbi.nlm.nih.gov/41615925/","methodologies":["Deep learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026","summary":"Deep learning models are used to predict pIC50 values and identify potential FGFR2 inhibitors from phytochemicals for cancer treatment applications.","is_review":false},{"id":142,"title":"Machine learning-guided identification and simulation-based validation of potent JAK3 inhibitors for cancer therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/41385500/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025","summary":"Machine learning classifiers, particularly Random Forest, are used to virtually screen compounds and identify novel JAK3 inhibitors for cancer therapy through computational drug discovery.","is_review":false},{"id":143,"title":"Developing inhibitors of the guanosine triphosphate hydrolysis accelerating activity of Regulator of G protein Signaling-14.","url":"https://pubmed.ncbi.nlm.nih.gov/40848973/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Oct","summary":"The paper uses structure-guided virtual screening, ligand docking, and deep learning-based scoring to develop inhibitors of RGS14 protein for drug discovery.","is_review":false},{"id":144,"title":"Integrating machine learning with in silico studies and Quantum Chemistry: Exploring novel compounds through multiscale screening targeting the CDK2 enzyme.","url":"https://pubmed.ncbi.nlm.nih.gov/40639010/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Sep","summary":"Random forest machine learning is used to screen 477,975 molecules for potential CDK2 enzyme inhibitors, integrating ML with molecular docking and quantum chemistry studies.","is_review":false},{"id":145,"title":"Deep Supramolecular Language Processing for Co-Crystal Prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40358977/","methodologies":["Deep learning","Explainable AI"],"applications":["Drug repurposing"],"published":"2025Jul","summary":"DeepCocrystal uses deep learning to predict co-crystal formation for improving drug physicochemical properties, with explainable AI to understand decision-making processes.","is_review":false},{"id":146,"title":"Discovery of novel polymyxin E adjuvants against Acinetobacter baumannii guided by a stacking-based machine learning model.","url":"https://pubmed.ncbi.nlm.nih.gov/41522627/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing"],"published":"2026Jan04","summary":"Machine learning stacking model combining random forest and gradient boosting to screen compounds for polymyxin E adjuvants against antibiotic-resistant bacteria.","is_review":false},{"id":147,"title":"AI fragment based optimization of saffron and chamomile phytochemicals as aryl hydrocarbon receptor inhibitors for dementia therapy an integrated computational approach.","url":"https://pubmed.ncbi.nlm.nih.gov/40784071/","methodologies":["Deep learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2026Feb","summary":"AI generative models are used to optimize phytochemicals from saffron and chamomile as aryl hydrocarbon receptor inhibitors for dementia therapy through fragment-based optimization.","is_review":false},{"id":148,"title":"Integrated AI and machine learning pipeline identifies novel WEE1 kinase inhibitors for targeted cancer therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40106128/","methodologies":["Unsupervised learning","Feature selection"],"applications":["Drug repurposing"],"published":"2025Aug","summary":"AI-driven pipeline using MORLD platform, UMAP dimensionality reduction, and K-means clustering to identify novel WEE1 kinase inhibitors for targeted cancer therapy.","is_review":false},{"id":149,"title":"Drug repurposing through Biophysical Insights: Focus on Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase Dual Inhibitors.","url":"https://pubmed.ncbi.nlm.nih.gov/40133710/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Sep","summary":"This paper uses machine learning analysis alongside molecular docking to repurpose FDA-approved drugs as dual IDO1/TDO inhibitors for cancer treatment.","is_review":false},{"id":150,"title":"Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor.","url":"https://pubmed.ncbi.nlm.nih.gov/39663371/","methodologies":["Deep learning"],"applications":["Drug repurposing"],"published":"2025Nov","summary":"The paper uses a multimodel multimodal generative AI platform to design a gut-restricted PHD inhibitor for treating inflammatory bowel disease.","is_review":false},{"id":151,"title":"Pan-cancer analysis of CDC7 in human tumors: Integrative multi-omics insights and discovery of novel marine-based inhibitors through machine learning and computational approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/40120182/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Drug toxicity prediction","Outcome prediction"],"published":"2025May","summary":"Machine learning is used to screen marine-derived compounds for CDC7 inhibitors and predict their toxicity, combined with pan-cancer analysis of CDC7 as a therapeutic target.","is_review":false},{"id":152,"title":"Unveiling the molecular mechanisms of Haitang-Xiaoyin Mixture in psoriasis treatment based on bioinformatics, network pharmacology, machine learning, and molecular docking verification.","url":"https://pubmed.ncbi.nlm.nih.gov/39993869/","methodologies":["Supervised learning"],"applications":["Drug repurposing"],"published":"2025Apr","summary":"The paper uses machine learning alongside bioinformatics and network pharmacology to identify molecular mechanisms and targets of a traditional Chinese medicine for psoriasis treatment.","is_review":false},{"id":153,"title":"Therapeutic Mechanisms of Medicine Food Homology Plants in Alzheimer's Disease: Insights from Network Pharmacology, Machine Learning, and Molecular Docking.","url":"https://pubmed.ncbi.nlm.nih.gov/40076742/","methodologies":["Unsupervised learning"],"applications":["Drug repurposing"],"published":"2025Feb27","summary":"Uses hierarchical clustering to group small molecules from medicinal plants and applies machine learning algorithms to predict binding capabilities for Alzheimer's disease treatment.","is_review":false},{"id":154,"title":"Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach.","url":"https://pubmed.ncbi.nlm.nih.gov/40095248/","methodologies":["Supervised learning"],"applications":["Drug repurposing","Pharmacokinetic modeling"],"published":"2025Aug","summary":"Machine learning and AI were used for pharmacokinetics optimization in discovering novel PDE4D inhibitors from dark chemical matter for psoriasis treatment.","is_review":false},{"id":155,"title":"Integrating machine learning and structural dynamics to explore B-cell lymphoma-2 inhibitors for chronic lymphocytic leukemia therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/39786521/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug repurposing"],"published":"2025Aug","summary":"Machine learning models (Random Forest, SVM, ANN) are used to screen and identify novel BCL-2 inhibitors from ChEMBL database for chronic lymphocytic leukemia therapy.","is_review":false},{"id":156,"title":"Machine Learning-Based High-Throughput Screening, Molecular Modeling and Quantum Chemical Analysis to Investigate Mycobacterium tuberculosis MetRS Inhibitors.","url":"https://pubmed.ncbi.nlm.nih.gov/39996268/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug repurposing","Drug toxicity prediction"],"published":"2025Jul","summary":"Machine learning algorithms including Random Forest, Extra Trees, and Nu-Support Vector are used in a voting classifier to screen 10 million molecules for Mtb MetRS inhibitors.","is_review":false},{"id":157,"title":"MolP-PC: a multi-view fusion and multi-task learning framework for drug ADMET property prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/41260779/","methodologies":["Deep learning","Ensemble learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Nov","summary":"Deep learning framework using multi-view fusion and multi-task learning to predict drug ADMET properties from molecular representations.","is_review":false},{"id":158,"title":"Advancing ADMET prediction through multiscale fragment-aware pretraining with MSformer-ADMET.","url":"https://pubmed.ncbi.nlm.nih.gov/41021261/","methodologies":["Deep learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Aug31","summary":"MSformer-ADMET uses Transformer-based deep learning with multiscale fragment-aware pretraining to predict ADMET properties for drug development.","is_review":false},{"id":159,"title":"Design, synthesis, deep learning-guided prediction, and biological evaluation of novel pyridine-thiophene-based imine-benzalacetophenone hybrids as promising antimicrobial agent.","url":"https://pubmed.ncbi.nlm.nih.gov/41186782/","methodologies":["Deep learning","Explainable AI","Neural networks"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025Nov04","summary":"Deep learning neural network with SHAP analysis predicts antimicrobial activity (pMIC values) of novel pyridine-thiophene hybrid compounds for drug development.","is_review":false},{"id":160,"title":"Expert-Guided Substructure Information Bottleneck for Molecular Property Prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40702819/","methodologies":["Deep learning","Ensemble learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Aug11","summary":"Proposes ESIB-Mol framework combining Mixture of Experts with Information Bottleneck principle for molecular property prediction using substructure-specific experts.","is_review":false},{"id":161,"title":"In silico evaluation of pharmacokinetic properties and molecular docking for the identification of potential anticancer compounds.","url":"https://pubmed.ncbi.nlm.nih.gov/40803051/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Feb","summary":"The paper uses in silico methods including QSAR/SAR/QSPR for predicting ADME-Tox properties and identifying potential anticancer compounds through molecular docking.","is_review":false},{"id":162,"title":"Discovery of Bergamotanes against Hepatic Ischemia-Reperfusion Injury Based on DeepSAT Technology from Paraconiothyrium sp. H-B.","url":"https://pubmed.ncbi.nlm.nih.gov/41283635/","methodologies":["Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025Dec10","summary":"The paper uses DeepSAT, a neural network-based tool for HSQC spectrum analysis, to guide discovery of bergamotane compounds with hepatoprotective effects against liver injury.","is_review":false},{"id":163,"title":"Pushing the boundaries of few-shot learning for low-data drug discovery with a Bayesian meta-learning hypernetwork framework.","url":"https://pubmed.ncbi.nlm.nih.gov/40814226/","methodologies":["Deep learning","Bayesian ML"],"applications":["Drug toxicity prediction"],"published":"2025Jul02","summary":"Meta-Mol uses Bayesian meta-learning with hypernetworks for few-shot learning to predict molecular properties in drug discovery with limited data.","is_review":false},{"id":164,"title":"MetaboGNN: predicting liver metabolic stability with graph neural networks and cross-species data.","url":"https://pubmed.ncbi.nlm.nih.gov/40903787/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Sep03","summary":"MetaboGNN uses Graph Neural Networks with contrastive learning to predict liver metabolic stability across species, improving drug discovery predictions.","is_review":false},{"id":165,"title":"Discovery of newer 1,3,4-Oxadiazole clubbed Isoindoline-1,3-dione derivatives as potential anticancer agents: Design, machine learning, synthesis, molecular docking, ADMET, DFT and MD simulation.","url":"https://pubmed.ncbi.nlm.nih.gov/40306097/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Oct","summary":"Machine learning is used to predict IC50 values for anticancer drug candidates in the design and discovery of novel 1,3,4-Oxadiazole clubbed Isoindoline-1,3-dione derivatives.","is_review":false},{"id":166,"title":"Explainable Reasoning Path Inference of Anti-Cancer Drug Sensitivity on Genomic Knowledge Graph via Macro-Micro Agent Collaborative Reinforcement Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40920533/","methodologies":["Deep learning","AI Agents","Explainable AI","Reinforcement learning"],"applications":["Drug toxicity prediction","Precision medicine / optimized treatment regimen"],"published":"2025Nov-Dec","summary":"The paper develops a dual-agent reinforcement learning system using knowledge graphs to predict anticancer drug sensitivity with explainable reasoning paths for precision medicine.","is_review":false},{"id":167,"title":"Machine Learning Models and Structure-Based Antibacterial Drug Discovery of the Key ABC Transporter Maltose-Binding Protein A.","url":"https://pubmed.ncbi.nlm.nih.gov/40583298/","methodologies":["Supervised learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025Jun","summary":"ML-QSAR models using GFA, SVM, and ANN predict antibacterial activity of quinoline-based MsbA inhibitors to discover new drugs against multidrug-resistant bacteria.","is_review":false},{"id":168,"title":"Computer-Aided optimization of quinazoline-based Aurora kinase inhibitors for enhanced metabolic stability.","url":"https://pubmed.ncbi.nlm.nih.gov/41512537/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2026Mar05","summary":"Machine learning models were used to predict metabolic sites of quinazoline-based Aurora kinase inhibitors to guide optimization for enhanced metabolic stability.","is_review":false},{"id":169,"title":"Prediction of Internal Exposures after Virtual Oral Doses of Disparate Chemicals in Rats and Humans Using Simplified Physiologically Based Pharmacokinetic Models with In Silico-Generated Input Parameters.","url":"https://pubmed.ncbi.nlm.nih.gov/40628652/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Jul21","summary":"Uses machine learning to generate PBPK model input parameters from chemical descriptors for predicting internal exposures of diverse compounds in rats and humans.","is_review":false},{"id":170,"title":"RCAN-DDI: Relation-aware cross adversarial network for drug-drug interaction prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/41079788/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025Sep","summary":"The paper proposes RCAN-DDI, a deep learning model using adversarial networks to predict drug-drug interactions by integrating structural and topological drug features.","is_review":false},{"id":171,"title":"Research on the optimization model of anti-breast cancer candidate drugs based on machine learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40276676/","methodologies":["Tree-based models","Explainable AI","Feature selection","Ensemble learning","Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025","summary":"Machine learning models including Random Forest, LightGBM, and XGBoost with SHAP explainability are used to optimize anti-breast cancer drug candidates for biological activity and ADMET properties.","is_review":false},{"id":172,"title":"Prediction of pharmacokinetic/pharmacodynamic properties of aldosterone synthase inhibitors at drug discovery stage using an artificial intelligence-physiologically based pharmacokinetic model.","url":"https://pubmed.ncbi.nlm.nih.gov/40356995/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025","summary":"An AI-PBPK model integrating machine learning with classical PBPK modeling is developed to predict PK/PD properties of aldosterone synthase inhibitors for drug discovery screening.","is_review":false},{"id":173,"title":"Guided Ensemble Stacking Method for Predicting Biological Activities of Compounds.","url":"https://pubmed.ncbi.nlm.nih.gov/41457256/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug toxicity prediction"],"published":"2025Dec","summary":"The paper develops a guided ensemble stacking ML approach combining multiple algorithms to predict compound biological activities for improved drug discovery.","is_review":false},{"id":174,"title":"A multi-compartment physiologically based pharmacokinetic (PBPK) model coupled with Fourier-ARIMA (auto regressive integrated moving average) for estimation and prediction of polychlorinated biphenyls (PCB) concentration in tuna.","url":"https://pubmed.ncbi.nlm.nih.gov/40577972/","methodologies":["Hybrid mechanistic\u2013ML models","Time-series modeling"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Sep","summary":"The paper develops a hybrid PBPK-Fourier-ARIMA model to predict PCB concentrations in tuna tissues, combining mechanistic modeling with time-series analysis for contamination forecasting.","is_review":false},{"id":175,"title":"A Machine Learning-Empowered Quantitative Structure-Activity Relationship Model for Predicting the Plasma Half-life of Drugs in Dogs.","url":"https://pubmed.ncbi.nlm.nih.gov/41254440/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Nov18","summary":"Deep neural networks and supervised ML algorithms are used to build QSAR models predicting drug plasma half-life in dogs from chemical structure descriptors.","is_review":false},{"id":176,"title":"Integrative Profiling for BBB Permeability Using Capillary Electrochromatography, Experimental Physicochemical Parameters, and Ensemble Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/41516205/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Dec28","summary":"The paper uses ensemble machine learning methods including k-NN and time series classification to predict blood-brain barrier permeability from experimental data.","is_review":false},{"id":177,"title":"Analytical and machine learning approaches identify a sea star steroid with promising activity for COVID-19 therapeutic development.","url":"https://pubmed.ncbi.nlm.nih.gov/41057530/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025Oct07","summary":"The paper develops a machine learning-based web application to predict IC50 values of SARS-CoV-2 inhibitors for drug discovery screening.","is_review":false},{"id":178,"title":"IQSPred-PLM: An Interpretable Quorum Sensing Peptides Prediction Model Based on Protein Language Model.","url":"https://pubmed.ncbi.nlm.nih.gov/40859107/","methodologies":["Deep learning","Explainable AI","LLM","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025Aug26","summary":"The paper presents IQSPred-PLM, which uses protein language models (ESM-2) and CNNs to predict quorum sensing peptides for understanding bacterial regulation mechanisms.","is_review":false},{"id":179,"title":"Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials.","url":"https://pubmed.ncbi.nlm.nih.gov/40215447/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Outcome prediction","Patient risk stratification / management","Survival analysis"],"published":"2025Apr","summary":"Machine learning models analyze early toxicity trajectories to predict cetuximab concentration and survival outcomes in metastatic colorectal cancer patients.","is_review":false},{"id":180,"title":"Machine learning approaches for assessing medication transfer to human breast milk.","url":"https://pubmed.ncbi.nlm.nih.gov/40240653/","methodologies":["Supervised learning","Feature selection","Tree-based models","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Apr16","summary":"Machine learning algorithms including KNN, Random Forest, SVM, and Neural Networks are used to predict milk/plasma drug concentration ratios for breastfeeding safety assessment.","is_review":false},{"id":181,"title":"Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World Data.","url":"https://pubmed.ncbi.nlm.nih.gov/41208554/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models","Tree-based models"],"applications":["Drug toxicity prediction","Patient risk stratification / management"],"published":"2026Feb","summary":"PKPD-informed labeling strategy enhances machine learning models (logistic regression, XGBoost, TabPFN) for predicting docetaxel-induced severe neutropenia using real-world data.","is_review":false},{"id":182,"title":"Multimodal profiling of Pepcan-CB1 receptor structure-activity relationships: integrating molecular dynamics simulations, biological profiling, and the deep learning model MuMoPepcan.","url":"https://pubmed.ncbi.nlm.nih.gov/41005111/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025Oct","summary":"Deep learning model MuMoPepcan integrates molecular dynamics simulations with experimental data to predict pepcan peptide bioactivity for CB1 receptor drug discovery.","is_review":false},{"id":183,"title":"Integrating Pharmacokinetics and Quantitative Systems Pharmacology Approaches in Generative Drug Design.","url":"https://pubmed.ncbi.nlm.nih.gov/40343729/","methodologies":["Supervised learning","Reinforcement learning"],"applications":["Drug toxicity prediction","Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025May26","summary":"The paper integrates AI/ML methods including reinforcement learning and QSPR models in a generative drug design framework to optimize both PK properties and receptor affinity.","is_review":false},{"id":184,"title":"QSAR Prediction of BBB Permeability Based on Machine Learning upon PETBD: A Novel Data Set of PET Tracers.","url":"https://pubmed.ncbi.nlm.nih.gov/41494098/","methodologies":["Supervised learning","Feature selection","Explainable AI","Tree-based models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Jan22","summary":"Machine learning models, particularly extreme gradient boosting, predict blood-brain barrier permeability and brain drug concentrations using a novel PET tracer dataset.","is_review":false},{"id":185,"title":"Prediction of plasma concentration-time profiles in mice using deep neural network integrated with pharmacokinetic models.","url":"https://pubmed.ncbi.nlm.nih.gov/40250502/","methodologies":["Deep learning","Explainable AI","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025May15","summary":"Deep neural networks integrated with two-compartmental PK models to predict plasma concentration-time profiles in mice using chemical structure and ADME features.","is_review":false},{"id":186,"title":"In-silico identification of a Doxorubicin alternative with reduced cardiotoxicity informed by LLM-assisted modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/41223606/","methodologies":["Tree-based models","Explainable AI","LLM"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Jan","summary":"LLM-assisted pipeline with random forest and SHAP for predicting ADME/ADMET properties to identify safer doxorubicin alternatives with reduced cardiotoxicity.","is_review":false},{"id":187,"title":"New Machine Learning Models for Predicting the Organic Cation Transporters OCT1, OCT2, and OCT3 Uptake.","url":"https://pubmed.ncbi.nlm.nih.gov/41048715/","methodologies":["Supervised learning","Ensemble learning","Tree-based models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Sep30","summary":"Machine learning models using decision tree ensemble algorithms predict organic cation transporter uptake to forecast pharmacokinetic liabilities in drug development.","is_review":false},{"id":188,"title":"LLM-Enhanced Multimodal Framework for Drug-Drug Interaction Prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/41153642/","methodologies":["Deep learning","LLM"],"applications":["Drug toxicity prediction"],"published":"2025Sep26","summary":"A multimodal deep learning framework integrating chemical structure, BioBERT embeddings, and protein data to predict drug-drug interactions with high accuracy.","is_review":false},{"id":189,"title":"Machine-Learning Framework to Predict the Performance of Lipid Nanoparticles for Nucleic Acid Delivery.","url":"https://pubmed.ncbi.nlm.nih.gov/40267508/","methodologies":["Supervised learning","Feature selection","Ensemble learning","Tree-based models"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025May19","summary":"Machine learning framework using multiple algorithms and molecular features to predict lipid nanoparticle activity and cell viability for nucleic acid delivery applications.","is_review":false},{"id":190,"title":"Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies.","url":"https://pubmed.ncbi.nlm.nih.gov/40625205/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Patient risk stratification / management","Pharmacokinetic modeling"],"published":"2025Nov","summary":"AI model developed to predict tyrosine kinase inhibitors at risk of malabsorption in patients with specific conditions and identify bioavailability enhancement strategies.","is_review":false},{"id":191,"title":"ADME-drug-likeness: enriching molecular foundation models via pharmacokinetics-guided multi-task learning for drug-likeness prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40662819/","methodologies":["Deep learning","Neural networks","Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Jul01","summary":"Deep learning pipeline enhances molecular foundation models via sequential ADME multi-task learning to improve drug-likeness prediction by incorporating pharmacokinetic factors.","is_review":false},{"id":192,"title":"Curated CYP450 Interaction Dataset: Covering the Majority of Phase I Drug Metabolism.","url":"https://pubmed.ncbi.nlm.nih.gov/40813405/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Aug14","summary":"The paper presents a curated CYP450 interaction dataset and develops ML models including Graph Convolutional Networks to predict drug-enzyme interactions for metabolism prediction.","is_review":false},{"id":193,"title":"Computational approaches in drug chemistry leveraging python powered QSPR study of antimalaria compounds by using artificial neural networks.","url":"https://pubmed.ncbi.nlm.nih.gov/40456832/","methodologies":["Tree-based models","Neural networks","Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Jun02","summary":"Uses artificial neural networks and random forest to predict physicochemical properties of antimalarial compounds through QSPR modeling with molecular descriptors.","is_review":false},{"id":194,"title":"Virtual screening of sweet peptides from milk protein and molecular dynamics simulations mechanism analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/41421526/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Dec18","summary":"Machine learning models predict sweet and bitter taste properties of milk-derived peptides, combined with molecular docking and dynamics simulations for virtual screening.","is_review":false},{"id":195,"title":"An Integrated AI-PBPK Platform for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter-Species Extrapolation.","url":"https://pubmed.ncbi.nlm.nih.gov/40418625/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Oct","summary":"Develops an integrated AI-PBPK platform using machine learning to predict drug properties from molecular structures, which feeds into PBPK models for human PK prediction.","is_review":false},{"id":196,"title":"Fitness Landscape for Antibodies 2: Benchmarking Reveals That Protein AI Models Cannot Yet Consistently Predict Developability Properties.","url":"https://pubmed.ncbi.nlm.nih.gov/41497662/","methodologies":["Deep learning","Supervised learning"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025Dec27","summary":"This paper benchmarks 30 AI models including protein language models on predicting antibody developability properties using the largest public therapeutic antibody dataset (FLAb2).","is_review":false},{"id":197,"title":"Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity.","url":"https://pubmed.ncbi.nlm.nih.gov/40815278/","methodologies":["Deep learning"],"applications":["Drug toxicity prediction"],"published":"2025Sep","summary":"The paper uses AlphaFold3 deep learning algorithm alongside computational docking to predict protein-protein interactions for engineered therapeutic targeting proteins.","is_review":false},{"id":198,"title":"De novo drug design and biological evaluation of coumarin-pyrimidine co-drug derivatives as diabetic inhibitors: expanding a multi-algorithm approach with the integration of machine learning in pharmaceutical research.","url":"https://pubmed.ncbi.nlm.nih.gov/40656568/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Jul10","summary":"Machine learning is integrated into de novo drug design for coumarin-pyrimidine derivatives as diabetic inhibitors, including toxicity prediction using web-based servers.","is_review":false},{"id":199,"title":"Antagonistic Trends Between Binding Affinity and Drug-Likeness in SARS-CoV-2 Mpro Inhibitors Revealed by Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40733553/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Pharmacodynamic modeling"],"published":"2025Jun30","summary":"Machine learning models (SVM and Logistic Regression) classify SARS-CoV-2 Mpro inhibitors based on IC50 data to reveal antagonistic trends between binding affinity and drug-likeness.","is_review":false},{"id":200,"title":"Improving Absorption, Distribution, Metabolism, and Excretion Property Predictions by Integrating Public and Proprietary Data.","url":"https://pubmed.ncbi.nlm.nih.gov/41290196/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Jan","summary":"This study uses supervised learning and multitask models to predict ADME properties by integrating public and proprietary datasets for improved drug discovery.","is_review":false},{"id":201,"title":"Convolutional neural network-assisted screening of natural product inhibitors against Naja naja venom: insights from molecular docking, molecular dynamics simulations and ADMET profiling.","url":"https://pubmed.ncbi.nlm.nih.gov/41459409/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2026","summary":"Uses convolutional neural networks (GraphDTA with GINConvNet) for virtual screening of natural compounds against snake venom proteins to identify potential antivenom candidates.","is_review":false},{"id":202,"title":"Prediction of Permeability and Efflux Using Multitask Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/41280832/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Nov18","summary":"This paper uses multitask graph neural networks to predict cell membrane permeability and efflux endpoints for drug discovery applications.","is_review":false},{"id":203,"title":"High-Throughput Physiologically Based Pharmacokinetic Model for Rodent Pharmacokinetics Prediction Using Machine Learning-Predicted Inputs and a Large In Vivo Pharmacokinetics Data Set.","url":"https://pubmed.ncbi.nlm.nih.gov/41617209/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Jan30","summary":"The paper develops a high-throughput PBPK model (SwiftPK) that uses machine learning to predict in vitro parameters from chemical structures for rodent pharmacokinetic prediction.","is_review":false},{"id":204,"title":"Enhancing the Predictive Power of Macrocyclic Drug Permeability by Knowledge Distillation from Analogous Pretraining Data.","url":"https://pubmed.ncbi.nlm.nih.gov/41420604/","methodologies":["Deep learning","Explainable AI","Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2026Jan08","summary":"Multi_DDPP uses deep learning with knowledge distillation to predict macrocyclic drug membrane permeability from 2D molecular structures, improving drug development efficiency.","is_review":false},{"id":205,"title":"DrugAppy - An end-to-end deep learning framework for computational drug discovery.","url":"https://pubmed.ncbi.nlm.nih.gov/41110298/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Nov","summary":"DrugAppy combines deep learning with computational chemistry methods for end-to-end drug discovery, predicting pharmacokinetics and activity against cancer targets.","is_review":false},{"id":206,"title":"Toxicity assessment of doxycycline-aided artificial intelligence-assisted drug design targeting candidate 16S rRNA methyltransferase gene.","url":"https://pubmed.ncbi.nlm.nih.gov/41272886/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Nov21","summary":"AI-assisted drug design is used to assess toxicity of doxycycline targeting 16S rRNA methyltransferase for treating antibiotic-resistant infections.","is_review":false},{"id":207,"title":"Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-Informed Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40460056/","methodologies":["Supervised learning","Explainable AI","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Jun17","summary":"ML framework predicts nanoparticle toxicity by integrating PBPK modeling with binary classification models to enable rational design of safer inorganic nanoparticles.","is_review":false},{"id":208,"title":"SF-Rx: A Multioutput Deep Neural Network-Based Framework Predicting Drug-Drug Interaction under Realistic Conditions for Safe Prescription.","url":"https://pubmed.ncbi.nlm.nih.gov/40310752/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025May12","summary":"A deep neural network framework predicts drug-drug interactions using structural similarity and PK/PD features with federated learning for safe prescription.","is_review":false},{"id":209,"title":"QSPR analysis of physico-chemical and pharmacological properties of medications for Parkinson's treatment utilizing neighborhood degree-based topological descriptors.","url":"https://pubmed.ncbi.nlm.nih.gov/40374678/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025May15","summary":"Uses machine learning with topological descriptors in QSPR analysis to predict physico-chemical and pharmacological properties of Parkinson's disease medications.","is_review":false},{"id":210,"title":"Substrate Specificity of the Organic Cation Transporters MATE1 and MATE2K and Functional Overlap with OCT1 and OCT2.","url":"https://pubmed.ncbi.nlm.nih.gov/40512599/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction"],"published":"2025Jun26","summary":"Machine learning classifiers using 15 physicochemical parameters were used to predict substrates of organic cation transporters MATE1, MATE2K, OCT1, and OCT2.","is_review":false},{"id":211,"title":"Deep learning model enables the discovery of a novel BET inhibitor YD-851.","url":"https://pubmed.ncbi.nlm.nih.gov/40779884/","methodologies":["Deep learning"],"applications":["Drug toxicity prediction"],"published":"2025Sep","summary":"Deep learning models were used for scaffold hopping and rational design of carboline derivatives as BET inhibitors, leading to discovery of YD-851 with improved efficacy and reduced toxicity.","is_review":false},{"id":212,"title":"Combining Retip Retention Time Prediction with High-Resolution Mass Spectrometry: A Systematic Analysis of Schisandra chinensis-Evodia Conducted for the First Time.","url":"https://pubmed.ncbi.nlm.nih.gov/41379647/","methodologies":["Deep learning","Tree-based models","Ensemble learning"],"applications":["Drug toxicity prediction"],"published":"2025Dec23","summary":"The paper uses machine learning models (Random Forest, XGBoost, LightGBM, neural networks) to predict retention times for systematic identification of herbal medicine compounds.","is_review":false},{"id":213,"title":"Improving the potency prediction for chemically modified siRNAs through insights from molecular modeling of individual sequence positions.","url":"https://pubmed.ncbi.nlm.nih.gov/40171444/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Outcome prediction"],"published":"2025Mar11","summary":"Machine learning is used to predict siRNA biological activity by correlating molecular modeling properties with experimental potency data for rational drug design.","is_review":false},{"id":214,"title":"Development of Machine Learning and Chemical Language Model-Based QSAR Models for Predicting Drug Residue Depletion Half-Lives in Plasma and Tissues of Cattle Across Various Administration Routes.","url":"https://pubmed.ncbi.nlm.nih.gov/41442152/","methodologies":["Neural networks","Supervised learning","Ensemble learning","LLM","Deep learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Dec24","summary":"Machine learning and chemical language models (ImprovedChemBERTa) are used to predict drug depletion half-lives in cattle plasma and tissues for food safety applications.","is_review":false},{"id":215,"title":"MWB_Analyzer: An Automated Embedded System for Real-Time Quantitative Analysis of Morphine Withdrawal Behaviors in Rodents.","url":"https://pubmed.ncbi.nlm.nih.gov/40711031/","methodologies":["Deep learning","Supervised learning"],"applications":["Drug toxicity prediction","Endpoint / biomarker assessment"],"published":"2025Jul14","summary":"The paper presents MWB_Analyzer, an automated system using YOLO-based deep learning to quantitatively assess morphine withdrawal behaviors in rodents for toxicological evaluation.","is_review":false},{"id":216,"title":"DeepMetab: a comprehensive and mechanistically informed graph learning framework for end-to-end drug metabolism prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40963553/","methodologies":["Deep learning","Mechanism-informed machine learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Oct15","summary":"DeepMetab uses graph neural networks with mechanistic knowledge to predict CYP450-mediated drug metabolism through integrated substrate profiling, site identification, and metabolite generation.","is_review":false},{"id":217,"title":"Development of an artificial intelligence-enhanced warfarin interaction checker platform.","url":"https://pubmed.ncbi.nlm.nih.gov/40127068/","methodologies":["LLM"],"applications":["Drug toxicity prediction","Patient risk stratification / management"],"published":"2025Mar","summary":"Development of a bilingual AI web application using GPT-4 API to identify potential warfarin drug interactions through text, picture, or voice input for patient safety.","is_review":false},{"id":218,"title":"Meta-MolNet: A Cross-Domain Benchmark for Few Examples Drug Discovery.","url":"https://pubmed.ncbi.nlm.nih.gov/40038923/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Mar","summary":"Introduces Meta-MolNet benchmark and Meta-GAT algorithm using graph attention networks with meta-learning for cross-domain molecular property prediction in drug discovery.","is_review":false},{"id":219,"title":"MMDDI-SSE: A Novel Multi-Modal Feature Fusion Model With Static Subgraph Embedding for Drug-Drug Interaction Event Prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40067720/","methodologies":["Unsupervised learning","Deep learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025Aug","summary":"A multi-modal deep learning model using graph autoencoders and static subgraph embedding to predict drug-drug interaction events by fusing sequence and graph representations.","is_review":false},{"id":220,"title":"Deep Learning-Assisted SERS for Therapeutic Drug Monitoring of Clozapine in Serum on Plasmonic Metasurfaces.","url":"https://pubmed.ncbi.nlm.nih.gov/40111434/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction","Precision medicine / optimized treatment regimen"],"published":"2025Apr02","summary":"Deep learning with artificial neural networks is integrated with SERS for rapid therapeutic drug monitoring of clozapine and metabolites in human serum.","is_review":false},{"id":221,"title":"Refined ADME Profiles for ATC Drug Classes.","url":"https://pubmed.ncbi.nlm.nih.gov/40142973/","methodologies":["Supervised learning"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Feb28","summary":"Machine learning models are developed to predict ADME properties of small molecules and analyze their distributions across different ATC drug classes to guide drug discovery.","is_review":false},{"id":222,"title":"Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-informed Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40034433/","methodologies":["Supervised learning","Explainable AI","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Feb18","summary":"ML framework predicts nanoparticle toxicity by integrating PBPK modeling with binary classification models to enable rational design of safer inorganic nanoparticles.","is_review":false},{"id":223,"title":"Predicting Liver-Related In Vitro Endpoints with Machine Learning to Support Early Detection of Drug-Induced Liver Injury.","url":"https://pubmed.ncbi.nlm.nih.gov/40064588/","methodologies":["Supervised learning","Ensemble learning"],"applications":["Drug toxicity prediction"],"published":"2025Apr21","summary":"Machine learning models using multi-task learning and ensemble methods to predict liver-related in vitro endpoints for early detection of drug-induced liver injury.","is_review":false},{"id":224,"title":"Predictive modeling of pediatric drug-induced liver injury: Dynamic classifier selection with clustering analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/40123880/","methodologies":["Unsupervised learning","Ensemble learning"],"applications":["Drug toxicity prediction"],"published":"2025Jan-Dec","summary":"The paper develops predictive models for pediatric drug-induced liver injury using dynamic classifier selection combined with clustering analysis to improve early identification.","is_review":false},{"id":225,"title":"Discovering Severe Adverse Reactions From Pharmacokinetic Drug-Drug Interactions Through Literature Analysis and Electronic Health Record Verification.","url":"https://pubmed.ncbi.nlm.nih.gov/39585167/","methodologies":["Deep learning","Supervised learning"],"applications":["Drug toxicity prediction","Postmarketing surveillance"],"published":"2025Apr","summary":"Uses NLP techniques including Named Entity Recognition and Relation Extraction to discover severe adverse drug reactions from drug-drug interactions through literature mining and EHR validation.","is_review":false},{"id":226,"title":"MONSTROUS: a web-based chemical-transporter interaction profiler.","url":"https://pubmed.ncbi.nlm.nih.gov/40078284/","methodologies":["Deep learning","Neural networks"],"applications":["Drug toxicity prediction"],"published":"2025","summary":"Develops MONSTROUS web tool using graph convolutional neural networks and similarity methods to predict chemical-transporter interactions for drug screening.","is_review":false},{"id":227,"title":"Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK-Based Approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/40091606/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Mar","summary":"This study compares ML approaches integrated with empirical and mechanistic PK models to predict complete plasma concentration-time profiles in rats prior to synthesis.","is_review":false},{"id":228,"title":"Advancing exposure science through artificial intelligence: Neural ordinary differential equations for predicting blood concentrations of volatile organic compounds.","url":"https://pubmed.ncbi.nlm.nih.gov/39978105/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Drug toxicity prediction","Pharmacokinetic modeling"],"published":"2025Mar01","summary":"Neural ODEs are used to predict blood concentrations of volatile organic compounds, outperforming traditional PBPK models for toxicological forecasting and risk assessment.","is_review":false},{"id":229,"title":"Functional Ultrasound Imaging Combined with Machine Learning for Whole-Brain Analysis of Drug-Induced Hemodynamic Changes.","url":"https://pubmed.ncbi.nlm.nih.gov/40895074/","methodologies":["Deep learning","Explainable AI","Neural networks","Supervised learning"],"applications":["Endpoint / biomarker assessment","Pharmacodynamic modeling"],"published":"2025Aug19","summary":"This paper compares CNN, SVM, and ViT machine learning approaches combined with functional ultrasound imaging to analyze pharmacodynamics of MK-801 drug effects on whole-brain hemodynamics.","is_review":false},{"id":230,"title":"[A GA-BP neural network model based on spectrum-effect relationship for assessing spectrum-effect score and quality evaluation of Cassia seeds extract].","url":"https://pubmed.ncbi.nlm.nih.gov/41139439/","methodologies":["Neural networks"],"applications":["Endpoint / biomarker assessment"],"published":"2025Oct20","summary":"The paper develops a GA-BP neural network model to assess spectrum-effect relationships for quality control of Cassia seeds extract using spectrum-effect scoring.","is_review":false},{"id":231,"title":"Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative Adversarial Networks.","url":"https://pubmed.ncbi.nlm.nih.gov/41347917/","methodologies":["Deep learning"],"applications":["Endpoint / biomarker assessment","Outcome prediction","Pharmacokinetic modeling"],"published":"2026Jan","summary":"A conditional GAN is developed to rapidly translate DCE-MRI data to pharmacokinetic permeability maps for evaluating breast cancer chemotherapy response.","is_review":false},{"id":232,"title":"High-Resolution MRI Using Artificial Intelligence-Assisted Acceleration and Radial Dynamic Contrast Enhancement for Improved Detection of Pituitary Microadenomas in Cushing's Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41663207/","methodologies":["Deep learning"],"applications":["Endpoint / biomarker assessment"],"published":"2026Feb09","summary":"AI-assisted compressed sensing is applied to MRI imaging to improve spatial and temporal resolution for better detection of pituitary microadenomas in Cushing's disease.","is_review":false},{"id":233,"title":"Analysis of Crosstalk Between Pathogens and Immune System in Human Airway Mucus via Machine Learning-Enhanced DIA Mass Spectrometry.","url":"https://pubmed.ncbi.nlm.nih.gov/41104598/","methodologies":["Supervised learning"],"applications":["Endpoint / biomarker assessment"],"published":"2025Nov","summary":"Machine learning is used to enhance mass spectrometry analysis by matching low-abundance spectra to predicted peptide spectra for proteomic analysis of pathogen-immune interactions.","is_review":false},{"id":234,"title":"Leveraging AI for facioscapulohumeral muscular dystrophy prediction and omics biomarker identification.","url":"https://pubmed.ncbi.nlm.nih.gov/41256551/","methodologies":["Supervised learning","Feature selection","Tree-based models"],"applications":["Endpoint / biomarker assessment","Outcome prediction"],"published":"2025Oct03","summary":"This paper develops ML models using Random Forest and SVM-RFE to predict FSHD from multi-omics data and identify key biomarker features for disease classification.","is_review":false},{"id":235,"title":"A myocardial reorientation method based on feature point detection for quantitative analysis of PET myocardial perfusion imaging.","url":"https://pubmed.ncbi.nlm.nih.gov/40367541/","methodologies":["Deep learning","Neural networks"],"applications":["Endpoint / biomarker assessment"],"published":"2025Aug","summary":"This paper develops a CNN for automatic reorientation of cardiac PET images to enable quantitative analysis of myocardial perfusion imaging.","is_review":false},{"id":236,"title":"Large Language Models for Clinical Trial Protocol Assessments.","url":"https://pubmed.ncbi.nlm.nih.gov/41121745/","methodologies":["LLM"],"applications":["Endpoint / biomarker assessment"],"published":"2026Feb","summary":"This paper evaluates the utility of large language models (GPT-4o) for reviewing statistical analysis plans and PK-PD components of clinical trial protocols.","is_review":false},{"id":237,"title":"Ribociclib derivative Rib-CA suppresses breast cancer progression via p53-dependent apoptosis.","url":"https://pubmed.ncbi.nlm.nih.gov/40675394/","methodologies":["Supervised learning"],"applications":["Endpoint / biomarker assessment"],"published":"2025Oct","summary":"Machine learning was used to identify CACHD1 and LAGE3 as potential biomarkers for a novel ribociclib derivative's mechanism of action in breast cancer treatment.","is_review":false},{"id":238,"title":"Unsupervised Deep Learning for Blood-Brain Barrier Leakage Detection in Diffuse Glioma Using Dynamic Contrast-enhanced MRI.","url":"https://pubmed.ncbi.nlm.nih.gov/40172325/","methodologies":["Unsupervised learning","Deep learning"],"applications":["Endpoint / biomarker assessment"],"published":"2025May","summary":"Develops an unsupervised deep learning autoencoder framework to detect blood-brain barrier leakage in glioma patients using dynamic contrast-enhanced MRI without pharmacokinetic models.","is_review":false},{"id":239,"title":"Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/41265377/","methodologies":["Supervised learning","Feature selection","Ensemble learning","Tree-based models"],"applications":["Endpoint / biomarker assessment","Outcome prediction","Patient risk stratification / management","Survival analysis"],"published":"2025Dec","summary":"Machine learning framework combining random forest, LASSO regression, and Cox modeling to identify metabolomic and lipidomic biomarkers predicting survival in HCC patients.","is_review":false},{"id":240,"title":"Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson's disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41611872/","methodologies":["Supervised learning"],"applications":["Endpoint / biomarker assessment","Outcome prediction"],"published":"2026Jan29","summary":"Machine learning was used to develop a 30-protein urinary panel that classifies LRRK2 G2019S carriers in Parkinson's disease with high accuracy across independent cohorts.","is_review":false},{"id":241,"title":"Analyzing patient perspectives with large language models: a cross-sectional study of sentiment and thematic classification on exception from informed consent.","url":"https://pubmed.ncbi.nlm.nih.gov/39979559/","methodologies":["LLM"],"applications":["Endpoint / biomarker assessment"],"published":"2025Feb20","summary":"This study evaluates large language models (LLMs) including GPT-4 for analyzing patient sentiment and thematic classification in exception from informed consent interviews.","is_review":false},{"id":242,"title":"Ultra-low-dose coronary CT angiography via super-resolution deep learning reconstruction: impact on image quality, coronary plaque, and stenosis analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/39891682/","methodologies":["Deep learning"],"applications":["Endpoint / biomarker assessment"],"published":"2025Aug","summary":"The paper uses super-resolution deep learning reconstruction to reduce radiation exposure in coronary CT angiography while maintaining image quality for plaque and stenosis analysis.","is_review":false},{"id":243,"title":"Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses.","url":"https://pubmed.ncbi.nlm.nih.gov/40358139/","methodologies":["Supervised learning","Explainable AI"],"applications":["Exposure\u2013response analysis","Outcome prediction","Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025Jun","summary":"Machine learning models predict paroxetine treatment remission using PK/PD data, with SHAP values explaining feature contributions for depression outcome prediction.","is_review":false},{"id":244,"title":"A Hybrid Diffusion Model Enhances Multiparametric 3D Photoacoustic Computed Tomography.","url":"https://pubmed.ncbi.nlm.nih.gov/41126760/","methodologies":["Deep learning"],"applications":["Other/General"],"published":"2026Jan","summary":"The paper develops a hybrid diffusion model to enhance 3D photoacoustic computed tomography imaging quality using fewer ultrasound transducers for biological and pharmacokinetic studies.","is_review":false},{"id":245,"title":"Accuracy and teachability of artificial intelligence chatbots in solving pharmaceutical calculations: a descriptive study.","url":"https://pubmed.ncbi.nlm.nih.gov/40493330/","methodologies":["LLM"],"applications":["Other/General"],"published":"2025Aug","summary":"This study evaluates the accuracy of AI chatbots (LLMs) in performing pharmaceutical calculations for pharmacy education and practice.","is_review":false},{"id":246,"title":"Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system.","url":"https://pubmed.ncbi.nlm.nih.gov/40896228/","methodologies":[],"applications":["Other/General"],"published":"2025","summary":"This paper conducts a traditional pharmacovigilance analysis of Zuranolone safety using FAERS database without employing AI/ML methods.","is_review":false},{"id":247,"title":"Deep learning-based bone removal in head and neck computed tomography angiography: a comparative study with conventional algorithms.","url":"https://pubmed.ncbi.nlm.nih.gov/41209247/","methodologies":["Deep learning"],"applications":["Other/General"],"published":"2025Nov01","summary":"This study evaluates a deep learning-based algorithm for bone removal in head and neck CT angiography compared to conventional methods for improved diagnostic imaging.","is_review":false},{"id":248,"title":"Low-Dose CT Quality Assurance at Scale: Automated Detection of Overscanning, Underscanning, and Image Noise.","url":"https://pubmed.ncbi.nlm.nih.gov/41598306/","methodologies":[],"applications":["Other/General"],"published":"2026Jan16","summary":"This paper focuses on automated quality assurance for low-dose CT lung screening using AI for image segmentation and noise assessment, which is outside the scope of pharmacometrics and drug development applications.","is_review":false},{"id":249,"title":"Plasmonic Fiber Optic Sensing Platform for Point-of-Care Pharmacokinetic Monitoring of Platinum Chemotherapeutics: Toward Ultratrace Multi-omics Precision Chemotherapy Management.","url":"https://pubmed.ncbi.nlm.nih.gov/40726318/","methodologies":[],"applications":["Other/General"],"published":"2025Aug22","summary":"This paper develops a plasmonic fiber-optic sensing platform for pharmacokinetic monitoring of platinum chemotherapeutics without using AI/ML methods.","is_review":false},{"id":250,"title":"State-of-the-art 32\u00a0cm field-of-view digital PET/CT system: preliminary study for protocols optimization and DRLs update.","url":"https://pubmed.ncbi.nlm.nih.gov/41626940/","methodologies":["Deep learning"],"applications":["Other/General"],"published":"2026Feb02","summary":"This paper evaluates a PET/CT system's performance including deep learning reconstruction for image quality enhancement, focusing on protocol optimization and diagnostic reference levels.","is_review":false},{"id":251,"title":"Diagnostic performance of four AI tools in pharmacology MCQs: Accuracy, sensitivity, and specificity.","url":"https://pubmed.ncbi.nlm.nih.gov/41401168/","methodologies":["LLM"],"applications":["Other/General"],"published":"2025","summary":"This paper evaluates the diagnostic performance of four AI tools on pharmacology multiple-choice questions, assessing their accuracy, sensitivity, and specificity.","is_review":false},{"id":252,"title":"Highly Precise Prediction of Micro- and Supra-pKa Based on 3D Descriptors Integrating Non-Covalent Interactions.","url":"https://pubmed.ncbi.nlm.nih.gov/39904757/","methodologies":[],"applications":["Other/General"],"published":"2025Apr11","summary":"This paper presents H-SPOC, a 3D descriptor-based computational method for pKa prediction that does not appear to use AI/ML techniques but rather molecular modeling approaches.","is_review":false},{"id":253,"title":"Correction to \"Comparing Scientific Machine Learning With Population Pharmacokinetic and Classical Machine Learning Approaches for Prediction of Drug\u00a0Concentrations\".","url":"https://pubmed.ncbi.nlm.nih.gov/40134374/","methodologies":[],"applications":["Other/General"],"published":"2025Apr","summary":"This is a correction to a previously published paper and contains no substantive content to classify for AI/ML methods or applications.","is_review":false},{"id":254,"title":"Meta-Analysis and Machine Learning Prediction of Protein Corona Composition across Nanoparticle Systems in Biological Media.","url":"https://pubmed.ncbi.nlm.nih.gov/41031442/","methodologies":["Tree-based models","Explainable AI","Ensemble learning"],"applications":["Outcome prediction"],"published":"2025Nov04","summary":"Uses interpretable machine learning models (LightGBM and XGBoost) to predict protein corona composition on nanoparticles based on physicochemical parameters.","is_review":false},{"id":255,"title":"Proteolysis-targeting Chimera efficacy prediction using a deep-learning-QSP model.","url":"https://pubmed.ncbi.nlm.nih.gov/41521293/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Outcome prediction","Pharmacodynamic modeling"],"published":"2026Jan12","summary":"Deep learning models are integrated with QSP modeling to predict PROTAC efficacy parameters (DC50 and Dmax) for targeted protein degradation therapeutics.","is_review":false},{"id":256,"title":"Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI.","url":"https://pubmed.ncbi.nlm.nih.gov/40631989/","methodologies":["Deep learning"],"applications":["Outcome prediction","Pharmacokinetic modeling"],"published":"2025Sep","summary":"Deep learning is used for pharmacokinetic quantification of DCE MRI to predict pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.","is_review":false},{"id":257,"title":"Gut microbiota and metabolites related intra-patient variability of tacrolimus pharmacokinetics predicted adverse one-year outcomes following kidney transplantation.","url":"https://pubmed.ncbi.nlm.nih.gov/40913864/","methodologies":["Tree-based models","Supervised learning"],"applications":["Outcome prediction","Patient risk stratification / management"],"published":"2025Nov14","summary":"Random forest model used to classify kidney transplant patients into high/low tacrolimus variability groups based on gut microbiota and metabolites to predict adverse outcomes.","is_review":false},{"id":258,"title":"Predicting lymphatic transport potential using graph transformer based on limited historical data from in vivo studies.","url":"https://pubmed.ncbi.nlm.nih.gov/40393527/","methodologies":["Deep learning"],"applications":["Outcome prediction"],"published":"2025Aug10","summary":"The paper uses graph transformer deep learning to predict lymphatic transport potential of drugs based on limited historical in vivo data from 185 compounds.","is_review":false},{"id":259,"title":"Integrative Machine Learning Model Leveraging DCE-MRI and PSA Values for Advanced Risk Stratification in Prostate Cancer.","url":"https://pubmed.ncbi.nlm.nih.gov/41203263/","methodologies":["Supervised learning"],"applications":["Outcome prediction","Patient risk stratification / management"],"published":"2025Nov07","summary":"Machine learning model integrates DCE-MRI pharmacokinetic parameters with PSA values to predict ISUP grade metastatic risk groups for prostate cancer risk stratification.","is_review":false},{"id":260,"title":"Integrating artificial intelligence and physiologically based pharmacokinetic modeling to predict in vitro and in vivo fate of amorphous solid dispersions.","url":"https://pubmed.ncbi.nlm.nih.gov/40825400/","methodologies":["Hybrid mechanistic\u2013ML models","Supervised learning"],"applications":["Outcome prediction","Pharmacokinetic modeling"],"published":"2025Oct10","summary":"This paper integrates AI with PBPK modeling using TabPFN to predict molecular dissolution and systemic absorption of amorphous solid dispersions for drug development.","is_review":false},{"id":261,"title":"Machine Learning Prediction and Validation of Plasma Concentration-Time Profiles.","url":"https://pubmed.ncbi.nlm.nih.gov/40345671/","methodologies":["Tree-based models","Supervised learning"],"applications":["Outcome prediction","Pharmacokinetic modeling"],"published":"2025Jun02","summary":"This study uses Random Forest models to predict plasma concentration-time profiles for remifentanil, demonstrating high accuracy on both virtual and real-world data sets.","is_review":false},{"id":262,"title":"Numerical modeling and prediction of late estimated glomerular filtration rate in kidney transplant recipients based on machine learning models and the Monte Carlo simulation method.","url":"https://pubmed.ncbi.nlm.nih.gov/41562636/","methodologies":["Supervised learning","Surrogate modeling"],"applications":["Outcome prediction","Pharmacodynamic modeling"],"published":"2026Jan22","summary":"Machine learning models combined with Monte Carlo simulation are used to predict late estimated glomerular filtration rate in kidney transplant recipients on tacrolimus.","is_review":false},{"id":263,"title":"Design, synthesis and anti-gastric cancer activity of stable Bisamide curcumin analogues.","url":"https://pubmed.ncbi.nlm.nih.gov/40749269/","methodologies":["Tree-based models"],"applications":["Outcome prediction"],"published":"2025Sep","summary":"The paper uses random forest algorithm to establish QSAR models for predicting anti-gastric cancer activity of bisamide curcumin analogues.","is_review":false},{"id":264,"title":"Personalized Prediction of Clozapine Treatment Response Using Therapeutic Drug Monitoring Data in Japanese Patients with Treatment-Resistant Schizophrenia.","url":"https://pubmed.ncbi.nlm.nih.gov/41227287/","methodologies":["Tree-based models","Explainable AI"],"applications":["Outcome prediction","Precision medicine / optimized treatment regimen"],"published":"2025Nov06","summary":"Random forest model predicts clozapine treatment response in schizophrenia patients using TDM data, with SHAP analysis for model interpretability.","is_review":false},{"id":265,"title":"A simulation-based framework for modeling and prediction of personalized blood pressure trajectories in hypertensive patients after antihypertensive treatment.","url":"https://pubmed.ncbi.nlm.nih.gov/40209154/","methodologies":["Gaussian processes"],"applications":["Outcome prediction","Pharmacodynamic modeling","Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025","summary":"The paper develops a simulation framework for blood pressure trajectories using PK/PD modeling and evaluates Gaussian processes for predicting steady-state blood pressure under treatment.","is_review":false},{"id":266,"title":"Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort.","url":"https://pubmed.ncbi.nlm.nih.gov/41671043/","methodologies":["Supervised learning"],"applications":["Outcome prediction"],"published":"2026Feb11","summary":"The paper develops a serum proteomics-based predictive model using supervised learning to predict primary nonresponse to infliximab in pediatric inflammatory bowel disease.","is_review":false},{"id":267,"title":"A translational multimodal machine-learning prototype predicting valproate response in epilepsy treatment.","url":"https://pubmed.ncbi.nlm.nih.gov/40909818/","methodologies":["Supervised learning","Feature selection"],"applications":["Outcome prediction","Precision medicine / optimized treatment regimen"],"published":"2025Aug27","summary":"Develops a multimodal machine learning classifier integrating genetic and in-vitro data to predict valproate treatment response in epilepsy patients for personalized treatment decisions.","is_review":false},{"id":268,"title":"Comparison of time-series models for predicting physiological metrics under sedation.","url":"https://pubmed.ncbi.nlm.nih.gov/39470955/","methodologies":["Deep learning","Neural networks","Time-series modeling"],"applications":["Outcome prediction","Pharmacodynamic modeling"],"published":"2025Jun","summary":"Compares statistical and deep learning time-series models (LSTM, GRU, TCN, Transformers) for predicting bispectral index to assess sedation depth during surgery.","is_review":false},{"id":269,"title":"Global Deep Forecasting with Patient-Specific Pharmacokinetics.","url":"https://pubmed.ncbi.nlm.nih.gov/37965077/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Time-series modeling"],"applications":["Outcome prediction","Patient risk stratification / management","Pharmacokinetic modeling"],"published":"2025Feb12","summary":"A hybrid global-local deep learning architecture with PK encoder forecasts blood glucose levels by incorporating patient-specific pharmacokinetic properties for improved accuracy.","is_review":false},{"id":270,"title":"Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.","url":"https://pubmed.ncbi.nlm.nih.gov/40045658/","methodologies":["Supervised learning","Neural networks"],"applications":["Outcome prediction","Patient risk stratification / management"],"published":"2025May","summary":"The paper uses artificial neural networks and item response theory to classify Parkinson's disease patients versus subjects without dopaminergic deficits using MDS-UPDRS scores.","is_review":false},{"id":271,"title":"Representation meets optimization: Training PINNs and PIKANs for gray-box discovery in systems pharmacology.","url":"https://pubmed.ncbi.nlm.nih.gov/41447950/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2026Jan15","summary":"Compares Physics-Informed Neural Networks (PINNs) and Physics-Informed Kolmogorov-Arnold Networks (PIKANs) for gray-box system identification in pharmacokinetic and pharmacodynamic modeling.","is_review":false},{"id":272,"title":"Functional ultrasound imaging combined with machine learning for whole-brain analysis of drug-induced hemodynamic changes.","url":"https://pubmed.ncbi.nlm.nih.gov/40948602/","methodologies":["Deep learning","Explainable AI","Neural networks","Supervised learning"],"applications":["Pharmacodynamic modeling"],"published":"2025","summary":"The paper uses CNN, SVM, and ViT machine learning approaches with functional ultrasound imaging to analyze pharmacodynamics of dizocilpine (MK-801) for whole-brain hemodynamic analysis.","is_review":false},{"id":273,"title":"Representation Meets Optimization: Training PINNs and PIKANs for Gray-Box Discovery in Systems Pharmacology.","url":"https://pubmed.ncbi.nlm.nih.gov/40297233/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025Apr10","summary":"Compares Physics-Informed Neural Networks (PINNs) and Physics-Informed Kolmogorov-Arnold Networks (PIKANs) for gray-box system identification in pharmacology modeling.","is_review":false},{"id":274,"title":"A machine learning model (Sol_ME) assisted development of a unit-dose lipid formulation for apalutamide: formulation, pharmacokinetics, and pharmacodynamics evaluation.","url":"https://pubmed.ncbi.nlm.nih.gov/40858184/","methodologies":["Supervised learning"],"applications":["Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2025Nov10","summary":"A machine learning model (Sol_ME) is used to assist in developing a lipid-based formulation for apalutamide with PK/PD evaluation for prostate cancer treatment.","is_review":false},{"id":275,"title":"Neural Controlled Differential Equation and Its Application in Pharmacokinetics and Pharmacodynamics.","url":"https://pubmed.ncbi.nlm.nih.gov/41241764/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Pharmacodynamic modeling","Pharmacokinetic modeling"],"published":"2026Jan","summary":"This paper investigates neural controlled differential equations (NCDE) for data-driven PK/PD modeling, combining differential equation dynamics with ML flexibility.","is_review":false},{"id":276,"title":"State-space models are accurate and efficient neural operators for dynamical systems.","url":"https://pubmed.ncbi.nlm.nih.gov/41447828/","methodologies":["Deep learning","Mechanism-informed machine learning","Neural networks"],"applications":["Pharmacodynamic modeling"],"published":"2025Dec19","summary":"The paper introduces Mamba state-space models for physics-informed machine learning of dynamical systems, with application to tumor growth modeling in quantitative systems pharmacology.","is_review":false},{"id":277,"title":"Adaptive AI framework for pharmacokinetics using GATs, transformers, and AutoML.","url":"https://pubmed.ncbi.nlm.nih.gov/41160339/","methodologies":["Deep learning","Ensemble learning","Neural networks"],"applications":["Pharmacokinetic modeling"],"published":"2025Oct29","summary":"The paper presents an adaptive AI framework combining graph attention networks, transformers, and AutoML for real-time pharmacokinetic parameter prediction in drug discovery.","is_review":false},{"id":278,"title":"Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data.","url":"https://pubmed.ncbi.nlm.nih.gov/40566189/","methodologies":["Deep learning","Explainable AI","Neural networks"],"applications":["Pharmacokinetic modeling"],"published":"2025Jun05","summary":"Neural ODEs are used as an alternative to traditional compartmental models for pharmacokinetic modeling of Dalbavancin, with SHAP analysis for model explainability.","is_review":false},{"id":279,"title":"PKSmart: an open-source computational model to predict intravenous pharmacokinetics of small molecules.","url":"https://pubmed.ncbi.nlm.nih.gov/41013647/","methodologies":["Supervised learning","Tree-based models"],"applications":["Pharmacokinetic modeling"],"published":"2025Sep26","summary":"Develops Random Forest machine learning models to predict human pharmacokinetic parameters from molecular structure and animal PK data for drug discovery.","is_review":false},{"id":280,"title":"Prediction of Intravenous Pharmacokinetic Parameters across Multiple Species by a Multifidelity Deep Learning Framework.","url":"https://pubmed.ncbi.nlm.nih.gov/41493218/","methodologies":["Deep learning","Supervised learning"],"applications":["Pharmacokinetic modeling"],"published":"2026Jan26","summary":"A multifidelity deep learning framework using transfer learning to predict intravenous pharmacokinetic parameters across multiple species from molecular structures.","is_review":false},{"id":281,"title":"Uncertainty estimates in pharmacokinetic modelling of DCE-MRI.","url":"https://pubmed.ncbi.nlm.nih.gov/41371063/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Ensemble learning","Neural networks"],"applications":["Pharmacokinetic modeling"],"published":"2026Mar","summary":"The paper uses ensemble neural networks with uncertainty estimation to improve pharmacokinetic parameter quantification in DCE-MRI compared to conventional methods.","is_review":false},{"id":282,"title":"Enhancing Chemical Prediction in Plasma Protein Binding: A Deep Learning Model Combining Molecular Descriptors and Fingerprint Representation With Attention Mechanisms.","url":"https://pubmed.ncbi.nlm.nih.gov/40811414/","methodologies":["Deep learning"],"applications":["Pharmacokinetic modeling"],"published":"2025Mar-Apr","summary":"A deep learning model combining molecular descriptors, fingerprints, and graph features with attention mechanisms to predict plasma protein binding properties of drug molecules.","is_review":false},{"id":283,"title":"Pixel-level transformer GAN for enhanced parametric mapping of DCE MRI analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/40891183/","methodologies":["Deep learning"],"applications":["Pharmacokinetic modeling"],"published":"2025Sep","summary":"The paper uses transformer GAN deep learning to enhance parametric mapping for DCE-MRI pharmacokinetic analysis in cancer diagnosis and monitoring.","is_review":false},{"id":284,"title":"Improved pharmacokinetic parameter estimation from DCE-MRI via spatial-temporal information-driven unsupervised learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40987314/","methodologies":["Unsupervised learning","Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":["Pharmacokinetic modeling"],"published":"2025Oct07","summary":"The paper develops STUDE, an unsupervised deep learning method combining CNNs and Vision Transformers to improve pharmacokinetic parameter estimation from DCE-MRI data.","is_review":false},{"id":285,"title":"Machine learning enabled multiscale model for nanoparticle margination and physiology based pharmacokinetics.","url":"https://pubmed.ncbi.nlm.nih.gov/40657536/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models"],"applications":["Pharmacokinetic modeling"],"published":"2025Jul","summary":"DeepONet neural network is integrated with mechanistic models to predict nanoparticle margination and biodistribution for targeted drug delivery applications.","is_review":false},{"id":286,"title":"Oral bioavailability property prediction based on task similarity transfer learning.","url":"https://pubmed.ncbi.nlm.nih.gov/40928678/","methodologies":["Deep learning","Transfer learning","Neural networks"],"applications":["Pharmacokinetic modeling"],"published":"2025Sep10","summary":"The paper develops a transfer learning framework using graph neural networks and transformers to predict human oral bioavailability from molecular structures and physicochemical properties.","is_review":false},{"id":287,"title":"Fraction-based Linear Extrapolation (FLEX) Method for Predicting Human Pharmacokinetic Clearance: Advanced Allometric Scaling Method and Machine Learning Approach.","url":"https://pubmed.ncbi.nlm.nih.gov/40931222/","methodologies":["Supervised learning"],"applications":["Pharmacokinetic modeling"],"published":"2025Sep","summary":"The paper develops a machine learning approach combined with advanced allometric scaling to predict human pharmacokinetic clearance using the FLEX method.","is_review":false},{"id":288,"title":"Deep learning-assisted SERS platform for label-free detection of celecoxib in serum using ag@Pt@porous silicon Bragg mirror composite substrate.","url":"https://pubmed.ncbi.nlm.nih.gov/41242102/","methodologies":["Deep learning"],"applications":["Pharmacokinetic modeling"],"published":"2026Mar05","summary":"Deep learning models (GoogleNet, ResNet, VGG) are used to classify blood drug concentrations of celecoxib from SERS spectral data for therapeutic drug monitoring.","is_review":false},{"id":289,"title":"Deep learning enhances reliability of dynamic contrast-enhanced MRI in diffuse gliomas: bypassing post-processing and providing uncertainty maps.","url":"https://pubmed.ncbi.nlm.nih.gov/40252095/","methodologies":["Deep learning"],"applications":["Pharmacokinetic modeling"],"published":"2025Oct","summary":"Deep learning model directly estimates pharmacokinetic parameter maps from DCE-MRI in gliomas, bypassing traditional post-processing while providing uncertainty estimation.","is_review":false},{"id":290,"title":"Microsensor Array for the Electrochemical Analysis of Hydroxyurea in Blood Samples of Children Affected by Sickle Cell Anemia.","url":"https://pubmed.ncbi.nlm.nih.gov/41060845/","methodologies":["Model selection","Supervised learning","Feature selection","Tree-based models"],"applications":["Pharmacokinetic modeling"],"published":"2025Nov11","summary":"Machine learning models (elastic net, random forest, PLSR) are used to predict hydroxyurea levels from electrochemical microsensor data for pharmacokinetic analysis.","is_review":false},{"id":291,"title":"Advancing the development of deep learning and machine learning models for oral drugs through diverse descriptor classes: a focus on pharmacokinetic parameters (Vdss and PPB).","url":"https://pubmed.ncbi.nlm.nih.gov/40498231/","methodologies":["Deep learning","Feature selection","Ensemble learning","Tree-based models"],"applications":["Pharmacokinetic modeling"],"published":"2025Jun11","summary":"This paper develops deep learning and machine learning models to predict pharmacokinetic parameters (Vdss and PPB) for oral drugs using molecular descriptors and feature engineering.","is_review":false},{"id":292,"title":"LSTM-Based Prediction of Human PK Profiles and Parameters for Intravenous Small Molecule Drugs Using ADME and Physicochemical Properties.","url":"https://pubmed.ncbi.nlm.nih.gov/41147737/","methodologies":["Deep learning","Neural networks","Time-series modeling"],"applications":["Pharmacokinetic modeling"],"published":"2025Dec","summary":"LSTM neural networks are used to predict human pharmacokinetic concentration-time profiles and parameters for IV drugs using ADME and physicochemical properties.","is_review":false},{"id":293,"title":"Gastric stress events impact the bioavailability of a poorly soluble weak base dabigatran from pellet-filled capsules: An outcome from pharmacokinetic simulations based on biorelevant dissolution testing, machine learning, and a novel timewise first-order dissolution model.","url":"https://pubmed.ncbi.nlm.nih.gov/40086652/","methodologies":["Surrogate modeling"],"applications":["Pharmacokinetic modeling"],"published":"2025Apr15","summary":"Machine learning generates dissolution profiles to overcome experimental limitations in biorelevant testing for PBBM-based pharmacokinetic simulations of dabigatran bioavailability.","is_review":false},{"id":294,"title":"Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans.","url":"https://pubmed.ncbi.nlm.nih.gov/40146185/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":["Pharmacokinetic modeling"],"published":"2025Apr10","summary":"This paper develops machine learning models combined with physiologically based pharmacokinetic modeling to predict human IV pharmacokinetic profiles from compound properties.","is_review":false},{"id":295,"title":"SERS based determination of ceftriaxone, ampicillin, and vancomycin in serum using WS2/Au@Ag nanocomposites and a 2D-CNN regression model.","url":"https://pubmed.ncbi.nlm.nih.gov/39929115/","methodologies":["Deep learning","Neural networks"],"applications":["Pharmacokinetic modeling","Precision medicine / optimized treatment regimen"],"published":"2025May15","summary":"A 2D-CNN regression model is used with SERS spectroscopy to predict antibiotic concentrations in serum for therapeutic drug monitoring and personalized treatment.","is_review":false},{"id":296,"title":"Highly Sensitive and Interference-Free Detection of Multiple Drug Molecules in Serum Using Dual-Modified SERS Substrates Combined with AI Algorithm Analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/39901357/","methodologies":[],"applications":["Pharmacokinetic modeling"],"published":"2025Feb18","summary":"AI algorithm is integrated to automatically recognize and analyze Raman spectral features for detecting multiple drug molecules in serum using SERS technology.","is_review":false},{"id":297,"title":"Application of surface-enhanced Raman scattering combined with artificial intelligence for multiplex detection of chemotherapeutic agents used in solid tumors.","url":"https://pubmed.ncbi.nlm.nih.gov/41324706/","methodologies":["Deep learning","Neural networks"],"applications":["Postmarketing surveillance"],"published":"2025Dec01","summary":"The paper uses convolutional neural networks to analyze SERS spectra for automated detection and quantification of multiple chemotherapeutic drugs in serum.","is_review":false},{"id":298,"title":"Assessing GPT-4's accuracy in answering clinical pharmacological questions on pain therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/40066678/","methodologies":["LLM"],"applications":["Precision medicine / optimized treatment regimen"],"published":"2025Aug","summary":"This study evaluates GPT-4's accuracy in answering clinical pharmacological questions about pain therapy to assess its potential as a patient-facing medical information tool.","is_review":false},{"id":299,"title":"A Novel Perspective on Using Artificial Intelligence and Nanoinformatics to Develop Nanomedicines.","url":"https://pubmed.ncbi.nlm.nih.gov/41568483/","methodologies":["Supervised learning"],"applications":[],"published":"2026Jan09","summary":"This review surveys AI/ML applications in nanomedicine development, focusing on QSAR/QSPR models and PBPK modeling for optimizing physicochemical properties and predicting biodistribution.","is_review":true},{"id":300,"title":"A Review on AI-Based Data-Driven Models for Optimization of Nanocarriers as Drug Delivery Systems.","url":"https://pubmed.ncbi.nlm.nih.gov/41668335/","methodologies":["Unsupervised learning","Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2026Feb10","summary":"This review surveys AI/ML approaches for optimizing nanocarrier drug delivery systems, covering supervised/unsupervised learning and hybrid models for PK/PD, toxicity prediction, and personalized medicine.","is_review":true},{"id":301,"title":"A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models.","url":"https://pubmed.ncbi.nlm.nih.gov/40574059/","methodologies":[],"applications":[],"published":"2025Jun06","summary":"This review surveys conventional and AI-enhanced methods for predicting drug-drug interactions, highlighting artificial intelligence applications in DDI safety evaluations.","is_review":true},{"id":302,"title":"A new chapter in pharmacology: Artificial intelligence's expanding role in pharmacokinetics, pharmacodynamics, and pharmacovigilance.","url":"https://pubmed.ncbi.nlm.nih.gov/41093670/","methodologies":["Deep learning","Supervised learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":[],"published":"2025Sep16","summary":"This narrative review surveys AI applications in pharmacokinetics, pharmacodynamics, and pharmacovigilance, highlighting machine learning and neural network approaches.","is_review":true},{"id":303,"title":"A new perspective on antimicrobial therapeutic drug monitoring: Surface-enhanced Raman spectroscopy.","url":"https://pubmed.ncbi.nlm.nih.gov/40154051/","methodologies":["Supervised learning"],"applications":[],"published":"2025Sep01","summary":"This review surveys SERS techniques for antimicrobial therapeutic drug monitoring, including machine learning data processing methods for personalized treatment.","is_review":true},{"id":304,"title":"AAV Gene Therapy Drug Development and Translation of Engineered Ocular and Neurotropic Capsids: A Systematic Review Using Natural Language Processing.","url":"https://pubmed.ncbi.nlm.nih.gov/41316525/","methodologies":["Supervised learning"],"applications":[],"published":"2025Dec","summary":"This systematic review uses Natural Language Processing to identify and categorize engineered AAV capsids for neurotropic and ocular applications from PubMed abstracts.","is_review":true},{"id":305,"title":"AI for NONMEM Coding in Pharmacometrics Research and Education: Shortcut or Pitfall?","url":"https://pubmed.ncbi.nlm.nih.gov/41187068/","methodologies":["LLM"],"applications":[],"published":"2025Dec","summary":"This paper evaluates seven Large Language Models for generating NONMEM code in pharmacometric modeling tasks and discusses AI applications in pharmacometrics education.","is_review":true},{"id":306,"title":"AI screening of nuclear medicine safety breaches: patterns, causes, and opportunities for improved protocols: a systematic review.","url":"https://pubmed.ncbi.nlm.nih.gov/41166047/","methodologies":[],"applications":[],"published":"2026Jan","summary":"A systematic review examining AI applications for screening, predicting, and preventing nuclear medicine safety incidents and occupational exposure risks for healthcare professionals.","is_review":true},{"id":307,"title":"AI-driven precision in prostate brachytherapy: A systematic review of 70 studies.","url":"https://pubmed.ncbi.nlm.nih.gov/41474559/","methodologies":["Deep learning","Reinforcement learning"],"applications":[],"published":"2025Oct01","summary":"Systematic review of 70 studies evaluating AI/ML applications in prostate brachytherapy for imaging, treatment planning, and outcome prediction using deep learning and reinforcement learning.","is_review":true},{"id":308,"title":"AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare.","url":"https://pubmed.ncbi.nlm.nih.gov/41441931/","methodologies":["Deep learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":[],"published":"2025Dec24","summary":"This review explores AI-powered in silico twins that integrate mechanistic modeling with ML for personalized medicine, predictive diagnostics, and therapeutic optimization.","is_review":true},{"id":309,"title":"Advancements in radiation dose reduction for pediatric CT head Imaging: A scoping review of emerging Technologies, Protocols, and optimization strategies.","url":"https://pubmed.ncbi.nlm.nih.gov/41567817/","methodologies":["Deep learning"],"applications":[],"published":"2026Mar","summary":"A scoping review of radiation dose reduction techniques in pediatric CT head imaging, highlighting deep learning image reconstruction algorithms as advanced AI-based solutions.","is_review":true},{"id":310,"title":"Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review.","url":"https://pubmed.ncbi.nlm.nih.gov/41463612/","methodologies":["Supervised learning"],"applications":[],"published":"2025Dec01","summary":"This review surveys AI-enabled modeling for cancer drug response prediction, biomarker development, and rational drug combinations in precision oncology screening platforms.","is_review":true},{"id":311,"title":"Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models.","url":"https://pubmed.ncbi.nlm.nih.gov/41303685/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov19","summary":"This review surveys advances in cytotoxicity testing including AI/ML methods like QSAR and machine learning for drug toxicity prediction and computational toxicology.","is_review":true},{"id":312,"title":"Advances in nanorobotics for gastrointestinal surgery: a new frontier in precision medicine and minimally invasive therapeutics.","url":"https://pubmed.ncbi.nlm.nih.gov/40660043/","methodologies":["AI Agents"],"applications":[],"published":"2025Jul14","summary":"This review surveys AI-integrated nanorobotics for precision gastrointestinal surgery, focusing on intelligent autonomous agents for minimally invasive therapeutics.","is_review":true},{"id":313,"title":"Advancing Drug-Drug Interaction Prediction with Biomimetic Improvements: Leveraging the Latest Artificial Intelligence Techniques to Guide Researchers in the Field.","url":"https://pubmed.ncbi.nlm.nih.gov/41589955/","methodologies":["Deep learning","Supervised learning","Ensemble learning","Neural networks"],"applications":[],"published":"2026Jan05","summary":"This review comprehensively surveys AI/ML methods for drug-drug interaction prediction, covering classical ML, deep learning, graph-based models, and biomimetic approaches.","is_review":true},{"id":314,"title":"Advancing PROTAC Discovery Through Artificial Intelligence: Opportunities, Challenges, and Future Directions.","url":"https://pubmed.ncbi.nlm.nih.gov/41471282/","methodologies":["Deep learning","Neural networks","Supervised learning"],"applications":[],"published":"2025Nov25","summary":"This review surveys AI/ML applications in PROTAC drug discovery, covering structure prediction, degradability prediction, linker design, and ADME property estimation.","is_review":true},{"id":315,"title":"Advancing antibiotic discovery with bacterial cytological profiling: a high-throughput solution to antimicrobial resistance.","url":"https://pubmed.ncbi.nlm.nih.gov/40018674/","methodologies":["Deep learning"],"applications":[],"published":"2025","summary":"This review surveys bacterial cytological profiling for antibiotic discovery and discusses how AI/deep learning techniques could enhance analysis of BCP data.","is_review":true},{"id":316,"title":"Advancing drug development with \"Fit-for-Purpose\" modeling informed approaches.","url":"https://pubmed.ncbi.nlm.nih.gov/40952534/","methodologies":[],"applications":[],"published":"2025Sep15","summary":"This review surveys MIDD approaches across drug development stages and explores the evolving role of AI/ML in enhancing traditional pharmacometric modeling methodologies.","is_review":true},{"id":317,"title":"Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences.","url":"https://pubmed.ncbi.nlm.nih.gov/40055986/","methodologies":["AI Agents"],"applications":[],"published":"2025Mar","summary":"This review explores how AI-powered agentic workflows can transform quantitative clinical pharmacology and translational sciences by automating routine tasks and streamlining analyses.","is_review":true},{"id":318,"title":"Antimicrobial peptides and proteins: Mechanism of action and therapeutic potential.","url":"https://pubmed.ncbi.nlm.nih.gov/41581931/","methodologies":[],"applications":[],"published":"2026","summary":"This review discusses antimicrobial peptides and proteins as therapeutic solutions, briefly mentioning AI-based computational tools for peptide prediction and AMP discovery.","is_review":true},{"id":319,"title":"Antimicrobial peptides: Bioinformatic advances and translational therapeutics to combat antibiotic resistance.","url":"https://pubmed.ncbi.nlm.nih.gov/41581929/","methodologies":["Deep learning","Supervised learning"],"applications":[],"published":"2026","summary":"This review surveys machine learning and deep learning applications in antimicrobial peptide research for therapeutic development against antibiotic resistance.","is_review":true},{"id":320,"title":"Application and research progress on artificial intelligence in the quality of Traditional Chinese Medicine.","url":"https://pubmed.ncbi.nlm.nih.gov/41181603/","methodologies":["Deep learning","Unsupervised learning","Supervised learning"],"applications":[],"published":"2025","summary":"This review surveys AI/ML applications in Traditional Chinese Medicine quality control, covering machine learning and deep learning methods for quality assessment and safety evaluation.","is_review":true},{"id":321,"title":"Application of Surface-Enhanced Raman Spectroscopy in Head and Neck Cancer Diagnosis.","url":"https://pubmed.ncbi.nlm.nih.gov/39951652/","methodologies":["Deep learning"],"applications":[],"published":"2025Feb25","summary":"This review examines SERS applications in head and neck cancer diagnosis and explores its integration with AI including machine learning and deep learning for precision oncology.","is_review":true},{"id":322,"title":"Approaches to Scaffold Hopping for Identifying New Bioactive Compounds and the Contribution of Artificial Intelligence.","url":"https://pubmed.ncbi.nlm.nih.gov/41208066/","methodologies":["Deep learning"],"applications":[],"published":"2025Nov05","summary":"This review surveys AI/ML applications, particularly deep learning, in scaffold hopping strategies for identifying new bioactive compounds in drug development.","is_review":true},{"id":323,"title":"Artificial Intelligence (AI) in Pharmaceutical Formulation and Dosage Calculations.","url":"https://pubmed.ncbi.nlm.nih.gov/41304779/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Nov07","summary":"This review surveys AI/ML applications in pharmaceutical formulation and dosage calculations, covering ML, DL, and NLP for drug property prediction, PK/PD modeling, and precision medicine.","is_review":true},{"id":324,"title":"Artificial Intelligence Models and Tools for the Assessment of Drug-Herb Interactions.","url":"https://pubmed.ncbi.nlm.nih.gov/40143062/","methodologies":[],"applications":[],"published":"2025Feb20","summary":"This review discusses AI approaches for predicting drug-herb interactions and associated adverse reactions by analyzing chemical structures and pharmacological properties.","is_review":true},{"id":325,"title":"Artificial Intelligence and Predictive Modelling for Precision Dosing of Immunosuppressants in Kidney Transplantation.","url":"https://pubmed.ncbi.nlm.nih.gov/41599762/","methodologies":["Explainable AI","Bayesian ML","Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2026Jan16","summary":"This review assesses AI/ML approaches including Bayesian models, machine learning, and hybrid AI frameworks for precision dosing of immunosuppressants in kidney transplantation.","is_review":true},{"id":326,"title":"Artificial Intelligence in Ocular Drug Delivery: Precision Drug Delivery's New Horizon.","url":"https://pubmed.ncbi.nlm.nih.gov/41388211/","methodologies":[],"applications":[],"published":"2025Dec12","summary":"This review paper surveys AI applications in ocular drug delivery, focusing on optimizing drug combinations, designing smart delivery systems, and personalizing ophthalmic therapies.","is_review":true},{"id":327,"title":"Artificial Intelligence in Pharmaceutical Drug Development: Transforming Formulation and Innovation.","url":"https://pubmed.ncbi.nlm.nih.gov/40873220/","methodologies":["Supervised learning"],"applications":[],"published":"2025Aug25","summary":"This review surveys AI applications in pharmaceutical drug development, covering drug discovery, formulation design, PK/toxicity prediction, and personalized medicine approaches.","is_review":true},{"id":328,"title":"Artificial Intelligence to Guide Repurposing of Drugs.","url":"https://pubmed.ncbi.nlm.nih.gov/41592930/","methodologies":["Deep learning","Unsupervised learning","Supervised learning"],"applications":[],"published":"2026Jan","summary":"This review surveys AI/ML applications in drug repurposing, discussing how artificial intelligence can guide the identification of new therapeutic uses for existing drugs.","is_review":true},{"id":329,"title":"Artificial Intelligence-Driven Nanoarchitectonics for Smart Targeted Drug Delivery.","url":"https://pubmed.ncbi.nlm.nih.gov/40772340/","methodologies":["Deep learning","Supervised learning","Mechanism-informed machine learning"],"applications":[],"published":"2025Oct","summary":"This perspective introduces an AI-driven nanoarchitectonics framework for targeted drug delivery using ML for surface engineering and in silico modeling of delivery dynamics.","is_review":true},{"id":330,"title":"Artificial intelligence and machine learning for precision warfarin dosing: a comprehensive narrative review.","url":"https://pubmed.ncbi.nlm.nih.gov/41649565/","methodologies":["Supervised learning"],"applications":[],"published":"2026Feb06","summary":"This comprehensive narrative review surveys AI/ML methods for precision warfarin dosing to optimize anticoagulation therapy and improve patient outcomes.","is_review":true},{"id":331,"title":"Artificial intelligence coupled to pharmacometrics modelling to tailor malaria and tuberculosis treatment in Africa.","url":"https://pubmed.ncbi.nlm.nih.gov/41115876/","methodologies":["Supervised learning","LLM"],"applications":[],"published":"2025Oct20","summary":"Proposes coupling machine learning and LLMs with PBPK/NLME modeling to identify drug-gene pairs and optimize dosing for malaria/tuberculosis treatment in African populations.","is_review":true},{"id":332,"title":"Artificial intelligence for radiopharmaceutical and molecular imaging.","url":"https://pubmed.ncbi.nlm.nih.gov/41477342/","methodologies":["Deep learning","Neural networks"],"applications":[],"published":"2025Dec","summary":"This review surveys AI/ML applications in radiopharmaceutical development and molecular imaging, focusing on deep learning methods for drug discovery and image analytics.","is_review":true},{"id":333,"title":"Artificial intelligence guided dosing decisions: a qualitative study on health care provider perspectives.","url":"https://pubmed.ncbi.nlm.nih.gov/41033693/","methodologies":[],"applications":[],"published":"2025Sep30","summary":"A qualitative study examining healthcare providers' perspectives on AI-guided precision dosing, identifying barriers and enablers for clinical adoption.","is_review":true},{"id":334,"title":"Artificial intelligence in clinical pharmacy-A systematic review of current scenario and future perspectives.","url":"https://pubmed.ncbi.nlm.nih.gov/41146680/","methodologies":[],"applications":[],"published":"2025Jan-Dec","summary":"A systematic review synthesizing current AI applications in clinical pharmacy, focusing on medication error reduction, drug dosing optimization, and personalized medicine implementation.","is_review":true},{"id":335,"title":"Artificial intelligence in the development of small nucleic acid therapeutics: toward smarter and safer medicines.","url":"https://pubmed.ncbi.nlm.nih.gov/41077123/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Nov","summary":"This review surveys AI methodologies for designing and optimizing small nucleic acid therapeutics, comparing approaches for improving drug stability and pharmacokinetics.","is_review":true},{"id":336,"title":"Artificial intelligence to predict inhibitors of drug-metabolizing enzymes and transporters for safer drug design.","url":"https://pubmed.ncbi.nlm.nih.gov/40241626/","methodologies":["Supervised learning"],"applications":[],"published":"2025May","summary":"This review paper surveys AI techniques for predicting inhibitors of drug-metabolizing enzymes and transporters to improve drug safety in development.","is_review":true},{"id":337,"title":"Artificial intelligence-enabled nanomedicine: enhancing drug design and predictive modeling in pharmaceutics.","url":"https://pubmed.ncbi.nlm.nih.gov/41353571/","methodologies":["Deep learning","Neural networks","Reinforcement learning"],"applications":[],"published":"2025Dec07","summary":"This review explores AI-driven methods integrated with nanomedicine for enhanced drug delivery, pharmacokinetic predictions, and personalized therapeutics development.","is_review":true},{"id":338,"title":"Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence.","url":"https://pubmed.ncbi.nlm.nih.gov/40256889/","methodologies":[],"applications":[],"published":"2025Apr","summary":"This review surveys LC-MS bioanalytical methods for antihypertensive drugs with only a brief mention of AI/ML potential in bioanalysis without specific applications or methods.","is_review":true},{"id":339,"title":"Building Hybrid Pharmacometric-Machine Learning Models in Oncology Drug Development: Current State and Recommendations.","url":"https://pubmed.ncbi.nlm.nih.gov/41104621/","methodologies":["Model selection","Hybrid mechanistic\u2013ML models","Feature selection","Explainable AI"],"applications":[],"published":"2026Jan","summary":"This tutorial reviews hybrid pharmacometric-machine learning models in oncology drug development and proposes standardized workflows and reporting checklists for improved reliability.","is_review":true},{"id":340,"title":"Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery?","url":"https://pubmed.ncbi.nlm.nih.gov/41542102/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov","summary":"This review surveys alternative methods to animal testing including machine learning approaches for drug discovery, PK/PD modeling, and predicting drug efficacy and interactions.","is_review":true},{"id":341,"title":"Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling - Part II: Environmental pollutants on animal and human health assessments.","url":"https://pubmed.ncbi.nlm.nih.gov/40106874/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Apr","summary":"Review of PBPK models for environmental pollutants in food animals that discusses future integration of machine learning and AI to enhance human health risk assessment.","is_review":true},{"id":342,"title":"Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making.","url":"https://pubmed.ncbi.nlm.nih.gov/41085467/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Dec","summary":"This paper proposes a framework integrating AI/ML with traditional modeling approaches for mRNA therapeutic development and decision making across the drug development lifecycle.","is_review":true},{"id":343,"title":"Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores.","url":"https://pubmed.ncbi.nlm.nih.gov/40070575/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025","summary":"This perspective proposes combining QSP mechanistic models with machine learning to predict IBD clinical scores like CDAI and Mayo scores.","is_review":true},{"id":344,"title":"Computational approaches for toxicology and Pharmacokinetic properties prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/40908375/","methodologies":["Supervised learning"],"applications":[],"published":"2025Sep04","summary":"This review surveys in-silico computational approaches and methodologies for predicting pharmacokinetic properties and toxicological endpoints in drug development.","is_review":true},{"id":345,"title":"Computational approaches to DMPK: A realistic assessment of current methods and their practical impact. Part I: Physicochemical and in vitro properties.","url":"https://pubmed.ncbi.nlm.nih.gov/40602659/","methodologies":["Supervised learning"],"applications":[],"published":"2025Aug","summary":"This review assesses AI/ML computational approaches for predicting DMPK properties including physicochemical parameters and in vitro assay outcomes in drug discovery.","is_review":true},{"id":346,"title":"Computational modeling of drug-eluting balloons in peripheral artery disease: Mechanisms, optimization, and translational insights.","url":"https://pubmed.ncbi.nlm.nih.gov/40895288/","methodologies":["Mechanism-informed machine learning","Neural networks","Surrogate modeling"],"applications":[],"published":"2025","summary":"Review of computational modeling for drug-eluting balloons, examining ML methods including physics-informed neural networks for patient-specific predictions and surrogate modeling.","is_review":true},{"id":347,"title":"Conquering PROTAC molecular design and drugability.","url":"https://pubmed.ncbi.nlm.nih.gov/40114295/","methodologies":["Supervised learning"],"applications":[],"published":"2025Apr","summary":"This perspective explores PROTAC molecular design advancements, integrating AI-driven modeling with traditional approaches to accelerate drug development for precision medicine.","is_review":true},{"id":348,"title":"Covariate Model Selection Approaches for Population Pharmacokinetics: A Systematic Review of Existing Methods, From SCM to AI.","url":"https://pubmed.ncbi.nlm.nih.gov/39831409/","methodologies":["Model selection","Feature selection"],"applications":[],"published":"2025Apr","summary":"A systematic review comparing AI/ML and traditional methods for covariate selection in population pharmacokinetic modeling, finding ML-based approaches superior.","is_review":true},{"id":349,"title":"Development and application of artificial intelligence in traditional Chinese medicine research and development.","url":"https://pubmed.ncbi.nlm.nih.gov/41508020/","methodologies":[],"applications":[],"published":"2026Jan08","summary":"This review paper surveys the integration of AI technologies into traditional Chinese medicine research and development to address formulation complexity and standardization challenges.","is_review":true},{"id":350,"title":"Development of Prediction Capabilities for High-Throughput Screening of Physiochemical Properties by Biomimetic Chromatography.","url":"https://pubmed.ncbi.nlm.nih.gov/41375127/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov24","summary":"This review surveys machine learning approaches for predicting pharmacokinetic and pharmacodynamic properties using biomimetic chromatography data in drug discovery.","is_review":true},{"id":351,"title":"Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium.","url":"https://pubmed.ncbi.nlm.nih.gov/41076365/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Sep26","summary":"This perspective paper explores digital pharmacological twins that integrate mechanistic and ML models for personalized treatment optimization in precision medicine.","is_review":true},{"id":352,"title":"Emerging Approaches in Data-Driven Drug Discovery for Rare Diseases.","url":"https://pubmed.ncbi.nlm.nih.gov/40873216/","methodologies":["Machine learning"],"applications":[],"published":"2025Aug25","summary":"This review examines integration of AI/ML with PK data and multi-omics approaches for data-driven drug discovery in rare diseases to enable personalized therapeutic strategies.","is_review":true},{"id":353,"title":"Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review.","url":"https://pubmed.ncbi.nlm.nih.gov/40457118/","methodologies":[],"applications":[],"published":"2025Jun02","summary":"This systematic review evaluates the impact of AI-based model-informed drug development methods compared to traditional approaches across different stages of drug development.","is_review":true},{"id":354,"title":"Every Compound a Candidate: experience-led risk-taking approaches to accelerate small-molecule drug discovery.","url":"https://pubmed.ncbi.nlm.nih.gov/40209934/","methodologies":[],"applications":[],"published":"2025May","summary":"This perspective advocates for leveraging AI/ML alongside risk-taking approaches to accelerate small-molecule drug discovery through an 'Every Compound a Candidate' strategy.","is_review":true},{"id":355,"title":"Exploring the Role of LLMs Like ChatGPT in Pharmacy Education for Supporting Students' Therapeutic Decision-making.","url":"https://pubmed.ncbi.nlm.nih.gov/40617506/","methodologies":["LLM"],"applications":[],"published":"2025Aug","summary":"This study evaluates the utility of large language models like ChatGPT as training tools for pharmacy students in therapeutic decision-making and drug dosage adjustment.","is_review":true},{"id":356,"title":"Food contaminants: mechanisms of toxicity, computational assessment, and mitigation.","url":"https://pubmed.ncbi.nlm.nih.gov/41602274/","methodologies":["Supervised learning"],"applications":[],"published":"2025","summary":"This review surveys computational methods including machine learning frameworks for predicting food contaminant toxicity as alternatives to animal testing.","is_review":true},{"id":357,"title":"Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation.","url":"https://pubmed.ncbi.nlm.nih.gov/40244539/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Apr17","summary":"This review surveys AI/ML-linked PBPK approaches for BCS class II drug formulation design and discusses mechanistic modeling strategies for absorption and dissolution.","is_review":true},{"id":358,"title":"From mechanism to application: Harnessing oxidative stress signaling for innovative food design.","url":"https://pubmed.ncbi.nlm.nih.gov/41508505/","methodologies":["Deep learning"],"applications":[],"published":"2026Feb01","summary":"This perspective proposes a data-driven framework using deep learning and computational prediction for designing personalized functional foods targeting oxidative stress pathways.","is_review":true},{"id":359,"title":"FtsZ as a novel target for antibiotics development: Promises and challenges.","url":"https://pubmed.ncbi.nlm.nih.gov/40893674/","methodologies":["Supervised learning"],"applications":[],"published":"2025Aug","summary":"Review of FtsZ as antibiotic target that mentions leveraging machine learning with high-throughput screening for future drug development efforts.","is_review":true},{"id":360,"title":"Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.","url":"https://pubmed.ncbi.nlm.nih.gov/41537599/","methodologies":[],"applications":[],"published":"2026Jan15","summary":"This perspective paper discusses future prospects for using AI-integrated algorithms alongside clinical phenotypes to enable precision medicine and stratified treatment approaches in tuberculosis.","is_review":true},{"id":361,"title":"G protein-coupled receptor digital twins for precision and personalized medicine.","url":"https://pubmed.ncbi.nlm.nih.gov/41357836/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025","summary":"Reviews how AI and digital twin technologies can advance precision GPCR-based medicine by integrating multi-omics data to create patient-specific virtual models for personalized therapies.","is_review":true},{"id":362,"title":"Harnessing AI for precision medicine and its applications in genomics, systems pharmacology, and drug discovery.","url":"https://pubmed.ncbi.nlm.nih.gov/40983121/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov05","summary":"This review surveys how AI/ML accelerates drug development through target identification, compound design, ADMET modeling, and PK/PD simulations for precision medicine applications.","is_review":true},{"id":363,"title":"Harnessing ChatGPT for digital tools in pharmacy practice.","url":"https://pubmed.ncbi.nlm.nih.gov/40581507/","methodologies":["LLM"],"applications":[],"published":"2025Nov","summary":"This commentary demonstrates how pharmacists can use ChatGPT to create digital tools for practice tasks including pharmacokinetic calculators and drug interaction checks.","is_review":true},{"id":364,"title":"Heterogeneity Assessment of Breast Cancer Tumor Microenvironment: Multiparametric Quantitative Analysis with DCE-MRI and Discovery of Radiomics Biomarkers.","url":"https://pubmed.ncbi.nlm.nih.gov/40657027/","methodologies":["Supervised learning","Feature selection"],"applications":[],"published":"2025","summary":"This review examines the integration of DCE-MRI quantitative analysis with radiomics machine learning approaches for discovering biomarkers to assess breast cancer tumor microenvironment heterogeneity.","is_review":true},{"id":365,"title":"How AI Transforms Regulatory Submission: Current Clinical Implementation and Future Prospects.","url":"https://pubmed.ncbi.nlm.nih.gov/41340328/","methodologies":[],"applications":[],"published":"2025Dec","summary":"This perspective paper surveys AI's current applications and future prospects in transforming regulatory submissions and drug development processes.","is_review":true},{"id":366,"title":"How to Expedite Drug Discovery: Integrating Innovative Approaches to Accelerate Modern Drug Development.","url":"https://pubmed.ncbi.nlm.nih.gov/41047976/","methodologies":["Supervised learning"],"applications":[],"published":"2025Aug31","summary":"This review surveys how AI/ML methods including predictive modeling and machine learning algorithms are being integrated to accelerate drug discovery and development processes.","is_review":true},{"id":367,"title":"In Silico Research Is Rewriting the Rules of Drug Development: Is It the End of Human Trials?","url":"https://pubmed.ncbi.nlm.nih.gov/40364863/","methodologies":["Explainable AI"],"applications":[],"published":"2025May","summary":"This editorial argues that AI-driven in silico methods, including digital twins and explainable AI, are transforming drug development by replacing traditional animal and human trials.","is_review":true},{"id":368,"title":"Integrative and Emerging Models in Antibody Research: A Comprehensive Review.","url":"https://pubmed.ncbi.nlm.nih.gov/41367414/","methodologies":["Supervised learning"],"applications":[],"published":"2025Oct","summary":"This review surveys computational biology and machine learning approaches for accelerating antibody design, prediction, and therapeutic development across multiple disease areas.","is_review":true},{"id":369,"title":"Interpretable multimodal learning for tumor protein-metal binding: Progress, challenges, and perspectives.","url":"https://pubmed.ncbi.nlm.nih.gov/40701309/","methodologies":["Deep learning","Supervised learning","Explainable AI"],"applications":[],"published":"2025Oct","summary":"This review paper surveys ML applications for predicting tumor protein-metal binding in cancer therapeutics, focusing on multimodal data integration and interpretability challenges.","is_review":true},{"id":370,"title":"Leveraging Artificial Intelligence for decision support in neonatal and pediatric pharmacotherapy: A scoping review.","url":"https://pubmed.ncbi.nlm.nih.gov/41344999/","methodologies":["Supervised learning"],"applications":[],"published":"2026Feb","summary":"A scoping review systematically mapping AI applications in pediatric and neonatal pharmacology for precision dosing, drug efficacy prediction, and adverse event reduction.","is_review":true},{"id":371,"title":"Leveraging In Silico and Artificial Intelligence Models to Advance Drug Disposition and Response Predictions Across the Lifespan.","url":"https://pubmed.ncbi.nlm.nih.gov/40539740/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Jun","summary":"This review discusses the application of in silico models integrated with AI/ML to predict drug exposure and responses across different populations and lifespans.","is_review":true},{"id":372,"title":"Leveraging artificial intelligence in antibody-drug conjugate development: from target identification to clinical translation in oncology.","url":"https://pubmed.ncbi.nlm.nih.gov/41272032/","methodologies":["Unsupervised learning","Deep learning","Neural networks","Supervised learning"],"applications":[],"published":"2025Nov21","summary":"This review surveys AI/ML applications across the entire ADC development pipeline, from target discovery to clinical translation in oncology.","is_review":true},{"id":373,"title":"Leveraging large language models to compare perspectives on integrating QSP and AI/ML.","url":"https://pubmed.ncbi.nlm.nih.gov/40325298/","methodologies":["LLM"],"applications":[],"published":"2025May05","summary":"Uses Large Language Models to analyze and synthesize contrasting perspectives on integrating QSP and AI/ML methodologies in drug development.","is_review":true},{"id":374,"title":"Leveraging machine learning models in evaluating ADMET properties for drug discovery and development.","url":"https://pubmed.ncbi.nlm.nih.gov/40585410/","methodologies":["Supervised learning"],"applications":[],"published":"2025","summary":"This review surveys machine learning models for predicting ADMET properties to accelerate drug discovery and reduce experimental costs.","is_review":true},{"id":375,"title":"Leveraging machine learning predicted confidence for boosting assay submission and decision-making efficiencies.","url":"https://pubmed.ncbi.nlm.nih.gov/40639290/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov05","summary":"The paper describes Roche's experience using ML with uncertainty quantification to optimize pharmacokinetic assay submission decisions, reducing costs by excluding low-confidence predictions.","is_review":true},{"id":376,"title":"Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos.","url":"https://pubmed.ncbi.nlm.nih.gov/39842696/","methodologies":["Deep learning"],"applications":[],"published":"2025Mar","summary":"This review examines LSFM applications in drug delivery monitoring during embryonic development, highlighting machine learning integration and AI-driven data analysis for tracking pharmacokinetics.","is_review":true},{"id":377,"title":"Machine Learning and Artificial Intelligence in Nanomedicine.","url":"https://pubmed.ncbi.nlm.nih.gov/40813104/","methodologies":["Deep learning","Supervised learning","Machine learning"],"applications":[],"published":"2025Jul-Aug","summary":"This review surveys AI/ML applications in nanomedicine development, covering nanoparticle design optimization, biodistribution prediction, and clinical translation challenges.","is_review":true},{"id":378,"title":"Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology.","url":"https://pubmed.ncbi.nlm.nih.gov/41012523/","methodologies":["Deep learning","Unsupervised learning","Supervised learning"],"applications":[],"published":"2025Sep12","summary":"This review surveys machine learning techniques including deep learning and graph-based methods for multi-target drug discovery in systems pharmacology applications.","is_review":true},{"id":379,"title":"Machine Learning for Prediction of Drug Concentrations: Application and Challenges.","url":"https://pubmed.ncbi.nlm.nih.gov/39901656/","methodologies":["Tree-based models","Ensemble learning","Neural networks"],"applications":[],"published":"2025May","summary":"This review surveys machine learning applications for predicting drug concentrations in pharmacokinetics, focusing on tree-based algorithms, neural networks, and ensemble methods.","is_review":true},{"id":380,"title":"Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World.","url":"https://pubmed.ncbi.nlm.nih.gov/40314361/","methodologies":["Supervised learning"],"applications":[],"published":"2025May19","summary":"This perspective paper discusses machine learning approaches for predicting molecular toxicity from chemical structures in drug discovery applications.","is_review":true},{"id":381,"title":"Machine learning in antimicrobial therapy for critically ill patients: optimizing early empirical regimens, individualized dosing, and de-escalation strategies.","url":"https://pubmed.ncbi.nlm.nih.gov/41015133/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Dec","summary":"Review of ML applications in antimicrobial therapy for critically ill patients, covering resistance prediction, personalized dosing, and de-escalation strategies using hybrid ML-PopPK models.","is_review":true},{"id":382,"title":"Machine learning in targeted protein degradation drug design: a technical review of PROTACs and molecular glues.","url":"https://pubmed.ncbi.nlm.nih.gov/41318024/","methodologies":["Deep learning","Neural networks","Supervised learning"],"applications":[],"published":"2026Jan","summary":"This review surveys ML applications in targeted protein degradation drug design, covering predictive modeling, virtual screening, and generative design for PROTACs and molecular glues.","is_review":true},{"id":383,"title":"Machine learning to predict food effects during drug development: a comprehensive review.","url":"https://pubmed.ncbi.nlm.nih.gov/41372958/","methodologies":["Explainable AI","Unsupervised learning","Reinforcement learning","Supervised learning","Deep learning"],"applications":[],"published":"2025Dec10","summary":"This review evaluates machine learning methods for predicting food effects on drug absorption compared to traditional approaches in drug development.","is_review":true},{"id":384,"title":"Mastering the complexities of cancer nanomedicine with text mining, AI and automation.","url":"https://pubmed.ncbi.nlm.nih.gov/39848590/","methodologies":["Unsupervised learning","Supervised learning"],"applications":[],"published":"2025Mar10","summary":"Personal perspective on using text mining and AI to master complexities in cancer nanomedicine for hypothesis generation, drug combination optimization, and automated nanoparticle discovery.","is_review":true},{"id":385,"title":"Metabolic phenotypes: Molecular bridges between health homeostasis and disease imbalance.","url":"https://pubmed.ncbi.nlm.nih.gov/41245891/","methodologies":[],"applications":[],"published":"2025","summary":"This review discusses metabolic phenotypes in disease and mentions future integration of AI and big data mining but does not survey specific AI/ML methodologies.","is_review":true},{"id":386,"title":"Methodological Techniques Used in Machine Learning to Support Individualized Drug Dosing Regimens Based on Pharmacokinetic Data: A Scoping Review.","url":"https://pubmed.ncbi.nlm.nih.gov/40810920/","methodologies":["Supervised learning"],"applications":[],"published":"2025Sep","summary":"A scoping review examining machine learning methodological approaches used in pharmacokinetic modeling for individualized drug dose optimization strategies.","is_review":true},{"id":387,"title":"Mitigate Japan's Drug Loss With Model-Informed Drug Development.","url":"https://pubmed.ncbi.nlm.nih.gov/41076586/","methodologies":[],"applications":[],"published":"2025Nov","summary":"This perspective paper discusses how Model-Informed Drug Development enhanced with AI/ML can help mitigate Japan's drug loss problem, but doesn't specify particular AI/ML methods or applications.","is_review":true},{"id":388,"title":"Modernizing Preclinical Drug Development: The Role of New Approach Methodologies.","url":"https://pubmed.ncbi.nlm.nih.gov/40567279/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Jun13","summary":"This perspective paper proposes integrating AI/ML with mechanistic models in a structured workflow to improve preclinical drug development and translational success.","is_review":true},{"id":389,"title":"Moving From Point-Based Analysis to Systems-Based Modeling: Knowledge Integration to Address Antimicrobial Resistance.","url":"https://pubmed.ncbi.nlm.nih.gov/40751366/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Oct","summary":"This perspective discusses integrating machine learning with pharmacometrics to build systems-level models for optimizing antibiotic therapy and addressing antimicrobial resistance.","is_review":true},{"id":390,"title":"Nanomaterials in Drug Delivery: Leveraging Artificial Intelligence and Big Data for Predictive Design.","url":"https://pubmed.ncbi.nlm.nih.gov/41303604/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Nov17","summary":"This review surveys AI/ML applications in nanomaterial drug delivery, focusing on predictive modeling for nanocarrier design, biodistribution, and clinical optimization.","is_review":true},{"id":391,"title":"New Targets for Imaging in Nuclear Medicine.","url":"https://pubmed.ncbi.nlm.nih.gov/40335357/","methodologies":["Deep learning"],"applications":[],"published":"2025Sep","summary":"This editorial surveys AI/ML integration in nuclear medicine for tracer development, image analysis, and personalized radiotheranostic strategies.","is_review":true},{"id":392,"title":"Next-generation experimental and computational strategies for drug-drug interaction prophecy.","url":"https://pubmed.ncbi.nlm.nih.gov/40945385/","methodologies":["Supervised learning"],"applications":[],"published":"2025Oct","summary":"This review surveys machine learning approaches alongside PBPK models for predicting drug-drug interactions to improve safety assessment in drug development.","is_review":true},{"id":393,"title":"Ophthalmic drug discovery and development using artificial intelligence and digital health technologies.","url":"https://pubmed.ncbi.nlm.nih.gov/40998989/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Sep25","summary":"Review of AI/ML applications across ophthalmic drug discovery and development phases, from target identification to personalized treatment monitoring.","is_review":true},{"id":394,"title":"Opportunities and Challenges in Precision Neurotherapeutics.","url":"https://pubmed.ncbi.nlm.nih.gov/41543941/","methodologies":[],"applications":[],"published":"2026Jan16","summary":"Review examining precision neurotherapeutics approaches including AI convergence with computational modeling for personalized mental health care and biomarker development.","is_review":true},{"id":395,"title":"Opportunities for machine learning and artificial intelligence in physiologically-based pharmacokinetic (PBPK) modeling.","url":"https://pubmed.ncbi.nlm.nih.gov/41093240/","methodologies":["Unsupervised learning","Supervised learning","Bayesian ML","Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025Dec","summary":"This review paper surveys ML/AI opportunities in PBPK modeling for parameter estimation, model learning, and uncertainty quantification to address current limitations.","is_review":true},{"id":396,"title":"Optimized therapeutic drug monitoring: the role of machine learning models.","url":"https://pubmed.ncbi.nlm.nih.gov/41460893/","methodologies":["Supervised learning"],"applications":[],"published":"2025Dec29","summary":"This review examines how machine learning models can enhance therapeutic drug monitoring to optimize dosing and minimize toxicity for drugs with narrow therapeutic indices.","is_review":true},{"id":397,"title":"Optimizing vedolizumab therapy in ulcerative colitis: A critical synthesis of trial evidence and the emerging role of artificial intelligence.","url":"https://pubmed.ncbi.nlm.nih.gov/41642870/","methodologies":[],"applications":[],"published":"2026Feb","summary":"This review synthesizes trial evidence for vedolizumab therapy in ulcerative colitis and discusses the emerging role of AI in personalizing treatment strategies.","is_review":true},{"id":398,"title":"Organoids in drug development: from predictive models to regulatory integration.","url":"https://pubmed.ncbi.nlm.nih.gov/41577171/","methodologies":[],"applications":[],"published":"2026Jan21","summary":"This review discusses organoids in drug development with mention of AI-driven modeling integration but does not focus on specific AI/ML methodologies or applications.","is_review":true},{"id":399,"title":"Peptide-based drug design using generative AI.","url":"https://pubmed.ncbi.nlm.nih.gov/41376388/","methodologies":["Deep learning","Neural networks"],"applications":[],"published":"2026Jan13","summary":"This review surveys AI/ML methods for peptide-based drug design, focusing on generative architectures like transformers and diffusion models for novel sequence generation.","is_review":true},{"id":400,"title":"Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes.","url":"https://pubmed.ncbi.nlm.nih.gov/41440979/","methodologies":[],"applications":[],"published":"2025Dec10","summary":"This review synthesizes evidence on integrating pharmacogenetics, therapeutic drug monitoring, and AI to enable model-informed precision dosing for antidepressant therapy in MDD.","is_review":true},{"id":401,"title":"Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities.","url":"https://pubmed.ncbi.nlm.nih.gov/41618547/","methodologies":["Supervised learning"],"applications":[],"published":"2026Feb","summary":"This review surveys AI-guided customized dosing technologies for vancomycin in hematological malignancy patients, focusing on personalized pharmacokinetic approaches.","is_review":true},{"id":402,"title":"Pharmacometrics in the Age of Large Language Models: A Vision of the Future.","url":"https://pubmed.ncbi.nlm.nih.gov/41155911/","methodologies":["LLM"],"applications":[],"published":"2025Sep29","summary":"This perspective paper explores the potential applications of Large Language Models across pharmacometrics workflows, from data processing to model development and reporting.","is_review":true},{"id":403,"title":"Physics-Informed Machine Learning in Biomedical Science and Engineering.","url":"https://pubmed.ncbi.nlm.nih.gov/41281212/","methodologies":["Deep learning","Mechanism-informed machine learning","Hybrid mechanistic\u2013ML models","Neural networks"],"applications":[],"published":"2025Oct06","summary":"This review surveys physics-informed machine learning frameworks (PINNs, NODEs, neural operators) that integrate physical laws with data-driven methods for biomedical applications.","is_review":true},{"id":404,"title":"Pirana and Integrated PMX Tools, a Workbench for NONMEM, NLME, pyDarwin, and RsNLME.","url":"https://pubmed.ncbi.nlm.nih.gov/40613737/","methodologies":["Model selection"],"applications":[],"published":"2025Aug","summary":"Tutorial on using Pirana workbench with integrated pyDarwin machine learning package for automated pharmacometric model structure and covariate selection.","is_review":true},{"id":405,"title":"Progress of machine learning in the application of small molecule druggability prediction.","url":"https://pubmed.ncbi.nlm.nih.gov/39808972/","methodologies":["Supervised learning","Feature selection"],"applications":[],"published":"2025Mar05","summary":"This review surveys machine learning applications for predicting small molecule pharmaceutical properties including solubility, activity, toxicity, and pharmacokinetics.","is_review":true},{"id":406,"title":"Recent Advances in Machine Learning Models for Predicting Toxicity of Inorganic Nanoparticles.","url":"https://pubmed.ncbi.nlm.nih.gov/41340632/","methodologies":["Supervised learning","Feature selection","Ensemble learning"],"applications":[],"published":"2025Nov27","summary":"A comprehensive review of machine learning models for predicting cytotoxicity of inorganic nanoparticles, covering ML-accelerated nanoQSAR, PBPK, and meta-analysis approaches.","is_review":true},{"id":407,"title":"Recent Techniques to Improve Amorphous Dispersion Performance with Quality Design, Physicochemical Monitoring, Molecular Simulation, and Machine Learning.","url":"https://pubmed.ncbi.nlm.nih.gov/41155888/","methodologies":["Supervised learning"],"applications":[],"published":"2025Sep24","summary":"This review surveys how machine learning and AI are transforming amorphous solid dispersion formulation design by enabling predictions of drug-polymer interactions and stability.","is_review":true},{"id":408,"title":"Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle.","url":"https://pubmed.ncbi.nlm.nih.gov/41639361/","methodologies":["Supervised learning"],"applications":[],"published":"2026Feb04","summary":"This review discusses how AI/ML methods are being used to optimize polymeric nanoparticle formulations, predict drug release patterns, and accelerate clinical development.","is_review":true},{"id":409,"title":"Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice.","url":"https://pubmed.ncbi.nlm.nih.gov/39568428/","methodologies":[],"applications":[],"published":"2025Apr","summary":"This review consolidates recommendations for integrating population PK modeling with precision dosing in clinical practice, with brief consideration of future ML applications.","is_review":true},{"id":410,"title":"Redefining Breast Cancer Care by Harnessing Computational Drug Repositioning.","url":"https://pubmed.ncbi.nlm.nih.gov/41011031/","methodologies":["Deep learning","Unsupervised learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Sep10","summary":"This review surveys computational drug repositioning strategies for breast cancer, examining AI/ML methods including network-based approaches and machine learning techniques.","is_review":true},{"id":411,"title":"Remote Monitoring Model Based on Artificial Intelligence to Optimize DOAC Therapy: A Working Hypothesis for Safer Anticoagulation.","url":"https://pubmed.ncbi.nlm.nih.gov/41303819/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov05","summary":"Proposes an AI-integrated remote monitoring model for DOAC therapy that uses pattern recognition to identify high-risk clinical trends and enable early intervention for safer anticoagulation.","is_review":true},{"id":412,"title":"Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.","url":"https://pubmed.ncbi.nlm.nih.gov/40884276/","methodologies":["Deep learning"],"applications":[],"published":"2025Oct","summary":"This review surveys antimicrobial peptides as antifungal therapeutics, discussing computational tools including machine learning and deep learning for rational AMP design.","is_review":true},{"id":413,"title":"Review of Precision Medicine and Diagnosis of Neonatal Illness.","url":"https://pubmed.ncbi.nlm.nih.gov/40002629/","methodologies":["Supervised learning"],"applications":[],"published":"2025Feb16","summary":"Review of precision medicine approaches for neonatal illness diagnosis, mentioning machine learning algorithms as ongoing research tools for NICU applications.","is_review":true},{"id":414,"title":"Review on electrochemical sensors for anticancer drug susceptibility testing.","url":"https://pubmed.ncbi.nlm.nih.gov/41526129/","methodologies":["Supervised learning"],"applications":[],"published":"2026Feb01","summary":"This review surveys electrochemical sensors for anticancer drug testing, briefly mentioning machine learning as one approach to boost sensor performance.","is_review":true},{"id":415,"title":"Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology.","url":"https://pubmed.ncbi.nlm.nih.gov/40774584/","methodologies":["Hybrid mechanistic\u2013ML models","Explainable AI","Surrogate modeling"],"applications":[],"published":"2025Sep","summary":"This review evaluates AI integration within quantitative systems pharmacology, highlighting surrogate modeling, virtual patients, and digital twins for enhanced drug discovery.","is_review":true},{"id":416,"title":"Revolutionizing prostate cancer therapy: Artificial intelligence - Based nanocarriers for precision diagnosis and treatment.","url":"https://pubmed.ncbi.nlm.nih.gov/39923922/","methodologies":["Explainable AI"],"applications":[],"published":"2025Apr","summary":"This review surveys AI applications in nanocarrier-based drug delivery for prostate cancer, covering design optimization, toxicity prediction, and personalized treatment approaches.","is_review":true},{"id":417,"title":"Rising Role of Artificial Intelligence in Clinical Pharmacometrics and Model-Informed Precision Dosing in Pediatrics.","url":"https://pubmed.ncbi.nlm.nih.gov/41675469/","methodologies":[],"applications":[],"published":"2026Feb","summary":"This review examines the rising role of AI in clinical pharmacometrics and model-informed precision dosing specifically in pediatric populations.","is_review":true},{"id":418,"title":"Role of Artificial Intelligence in Musculoskeletal Interventions.","url":"https://pubmed.ncbi.nlm.nih.gov/40427114/","methodologies":["Deep learning","Supervised learning"],"applications":[],"published":"2025May10","summary":"This review explores AI/ML applications in musculoskeletal interventions, covering diagnostic processes, intervention guidance, and personalized treatment approaches.","is_review":true},{"id":419,"title":"SERS-powered precision: revolutionizing therapeutic drug monitoring with nanoscale sensitivity.","url":"https://pubmed.ncbi.nlm.nih.gov/41251787/","methodologies":["Supervised learning"],"applications":[],"published":"2025Nov18","summary":"This review surveys SERS-based therapeutic drug monitoring, including machine learning-assisted analysis approaches for improving analytical performance.","is_review":true},{"id":420,"title":"Should LLMs be over empowered for high-stake regulatory research?","url":"https://pubmed.ncbi.nlm.nih.gov/40576029/","methodologies":["LLM"],"applications":[],"published":"2025May01","summary":"This perspective critically evaluates the feasibility and challenges of implementing open-source LLMs for extracting pharmacokinetic information from FDA drug labels in regulatory research.","is_review":true},{"id":421,"title":"Spatial proteomics in precision medicine: technologies, bioinformatics, and translational applications.","url":"https://pubmed.ncbi.nlm.nih.gov/41647441/","methodologies":["Unsupervised learning","Deep learning","Neural networks"],"applications":[],"published":"2026Mar","summary":"This review surveys spatial proteomics technologies and their AI/ML computational methods including graph neural networks for precision medicine applications.","is_review":true},{"id":422,"title":"State of Art of Dose Individualization to Support tacrolimus drug monitoring: What's Next?","url":"https://pubmed.ncbi.nlm.nih.gov/40959818/","methodologies":["Bayesian ML"],"applications":[],"published":"2025","summary":"This review surveys tacrolimus dose individualization methods including emerging machine learning and AI technologies alongside traditional pharmacokinetic modeling approaches.","is_review":true},{"id":423,"title":"Systems immunology: When systems biology meets immunology.","url":"https://pubmed.ncbi.nlm.nih.gov/40977698/","methodologies":["Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2025","summary":"This mini-review surveys systems immunology approaches that integrate AI/ML with mechanistic models to understand immune networks and guide therapeutic innovation.","is_review":true},{"id":424,"title":"Target-Controlled Infusion of Propofol: A Systematic Review of Recent Results.","url":"https://pubmed.ncbi.nlm.nih.gov/40289063/","methodologies":["Supervised learning"],"applications":[],"published":"2025Apr28","summary":"Systematic review of PK-PD models for propofol target-controlled infusion, including studies that incorporate machine learning techniques for adaptive dosing strategies.","is_review":true},{"id":425,"title":"The Emerging Role of Artificial Intelligence in Drug Discovery and Development: Implications for Cardiovascular Pharmacology.","url":"https://pubmed.ncbi.nlm.nih.gov/41632854/","methodologies":["Deep learning","LLM","Neural networks","Reinforcement learning"],"applications":[],"published":"2026Feb03","summary":"This review surveys AI/ML applications across cardiovascular drug development, covering target identification, compound screening, PK/toxicity prediction, and clinical trial optimization.","is_review":true},{"id":426,"title":"The Role of Artificial Intelligence in Drug Discovery and Pharmaceutical Development: A Paradigm Shift in the History of Pharmaceutical Industries.","url":"https://pubmed.ncbi.nlm.nih.gov/40360908/","methodologies":[],"applications":[],"published":"2025May14","summary":"This paper reviews the paradigm shift of AI integration across drug development stages, discussing applications in PK/PD modeling, toxicity prediction, and clinical trial acceleration.","is_review":true},{"id":427,"title":"The dawn of a new era: can machine learning and large language models reshape QSP modeling?","url":"https://pubmed.ncbi.nlm.nih.gov/40524056/","methodologies":["Hybrid mechanistic\u2013ML models","AI Agents","LLM","Surrogate modeling"],"applications":[],"published":"2025Jun16","summary":"This perspective explores how AI/ML and LLMs can transform QSP modeling through hybrid models, surrogate modeling, and democratizing workflows for drug development.","is_review":true},{"id":428,"title":"The predictive edge: modeling and simulation in drug product development.","url":"https://pubmed.ncbi.nlm.nih.gov/41592638/","methodologies":["Deep learning","Supervised learning","Machine learning"],"applications":[],"published":"2026Mar","summary":"This review surveys AI/ML applications in drug product development, covering predictive modeling and simulation techniques for improving drug performance, safety, and success rates.","is_review":true},{"id":429,"title":"The roles of biomarkers in Alzheimer's disease clinical trials.","url":"https://pubmed.ncbi.nlm.nih.gov/41449005/","methodologies":[],"applications":[],"published":"2025Dec24","summary":"This review discusses biomarkers in Alzheimer's disease clinical trials and briefly mentions AI/ML as a potential approach for enhancing biomarker data integration.","is_review":true},{"id":430,"title":"Toward Integrated Clinical-Computational Nuclear Medicine.","url":"https://pubmed.ncbi.nlm.nih.gov/41284557/","methodologies":["Deep learning"],"applications":[],"published":"2026Jan","summary":"This perspective paper surveys AI/ML applications in nuclear medicine, highlighting artificial intelligence's role in improving imaging quality, automating detection, and enabling personalized therapy.","is_review":true},{"id":431,"title":"Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel Disease.","url":"https://pubmed.ncbi.nlm.nih.gov/41665578/","methodologies":[],"applications":[],"published":"2026Feb10","summary":"This perspective paper outlines how AI-assisted tools can integrate molecular measures with clinical endpoints to improve IBD treatment assessment and enable precision medicine approaches.","is_review":true},{"id":432,"title":"Toward indole postbiotics precision therapy via AI-powered drug delivery technologies.","url":"https://pubmed.ncbi.nlm.nih.gov/41223607/","methodologies":[],"applications":[],"published":"2026Feb","summary":"This review examines indole postbiotics and suggests using AI as a framework for translating these compounds into precision therapeutic applications.","is_review":true},{"id":433,"title":"Towards Pharmaceutical Industry 5.0: Impact of Artificial Intelligence in Drug Discovery and Development.","url":"https://pubmed.ncbi.nlm.nih.gov/41185503/","methodologies":["Deep learning","Supervised learning","Neural networks"],"applications":[],"published":"2025Nov03","summary":"This review surveys AI applications across drug discovery and development, covering machine learning, deep learning, and NLP for accelerating drug development in Industry 5.0.","is_review":true},{"id":434,"title":"Tumor organoids on-a-chip and the role of AI in predictive oncology and personalized cancer medicine.","url":"https://pubmed.ncbi.nlm.nih.gov/41512327/","methodologies":["Deep learning"],"applications":[],"published":"2026Jan09","summary":"This review surveys AI applications in tumor organoids-on-chip for predictive oncology and personalized cancer medicine, focusing on drug response prediction.","is_review":true},{"id":435,"title":"Unlocking Antimicrobial Peptides from Marine Invertebrates: A Comprehensive Review of Antimicrobial Discovery.","url":"https://pubmed.ncbi.nlm.nih.gov/41009902/","methodologies":["Deep learning","Supervised learning"],"applications":[],"published":"2025Sep12","summary":"This review examines antimicrobial peptides from marine invertebrates and highlights AI's role in accelerating AMP discovery, design, and production through predictive modeling.","is_review":true},{"id":436,"title":"Use of Artificial Intelligence in Current Fight Against Antimicrobial Resistance.","url":"https://pubmed.ncbi.nlm.nih.gov/40354275/","methodologies":["Supervised learning"],"applications":[],"published":"2025May12","summary":"This review surveys AI/ML applications in antimicrobial resistance, focusing on optimizing dosing through PK modeling and therapeutic drug monitoring to improve outcomes.","is_review":true},{"id":437,"title":"Vancomycin resistance in gram-positive infections: evolutionary strategies of survival.","url":"https://pubmed.ncbi.nlm.nih.gov/41563485/","methodologies":["Supervised learning","Hybrid mechanistic\u2013ML models"],"applications":[],"published":"2026Jan21","summary":"This review examines vancomycin resistance mechanisms and highlights AI/ML applications in antimicrobial discovery, resistance surveillance, and rational drug design.","is_review":true}],"applications":["Adherence to drug regimen","Automation of PK/PD modeling","Covariate selection / confounding adjustment","Data imputation","Discovery of subpatient groups","Disease progression modeling","Dose selection / optimization","Drug repurposing","Drug toxicity prediction","Endpoint / biomarker assessment","Enrichment design","Exposure\u2013response analysis","Other/General","Outcome prediction","Patient risk stratification / management","Pharmacodynamic modeling","Pharmacokinetic modeling","Postmarketing surveillance","Precision medicine / optimized treatment regimen","RWD phenotyping","Survival analysis"],"methodologies":["AI Agents","Bayesian ML","Deep learning","Ensemble learning","Explainable AI","Feature selection","Gaussian processes","Hybrid mechanistic\u2013ML models","LLM","Machine learning","Mechanism-informed machine learning","Model selection","Neural networks","Reinforcement learning","Supervised learning","Surrogate modeling","Time-series modeling","Transfer learning","Tree-based models","Unsupervised learning"],"matrix":{"Adherence to drug regimen":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":1,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":1,"Reinforcement learning":0,"Supervised learning":1,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":1,"Unsupervised learning":0},"Automation of PK/PD modeling":{"AI Agents":1,"Bayesian ML":1,"Deep learning":6,"Ensemble learning":0,"Explainable AI":1,"Feature selection":1,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":3,"LLM":3,"Machine learning":0,"Mechanism-informed machine learning":1,"Model selection":2,"Neural networks":3,"Reinforcement learning":0,"Supervised learning":1,"Surrogate modeling":1,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Covariate selection / confounding adjustment":{"AI Agents":0,"Bayesian ML":0,"Deep learning":4,"Ensemble learning":0,"Explainable AI":3,"Feature selection":4,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":1,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":1,"Neural networks":3,"Reinforcement learning":0,"Supervised learning":5,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":4,"Unsupervised learning":1},"Data imputation":{"AI Agents":0,"Bayesian ML":0,"Deep learning":1,"Ensemble learning":0,"Explainable AI":0,"Feature selection":1,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":2,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":1,"Unsupervised learning":0},"Discovery of subpatient groups":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":1,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":3,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":4},"Disease progression modeling":{"AI Agents":1,"Bayesian ML":0,"Deep learning":1,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":1,"Reinforcement learning":1,"Supervised learning":0,"Surrogate modeling":0,"Time-series modeling":1,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Dose selection / optimization":{"AI Agents":1,"Bayesian ML":0,"Deep learning":19,"Ensemble learning":10,"Explainable AI":5,"Feature selection":4,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":10,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":1,"Model selection":1,"Neural networks":7,"Reinforcement learning":5,"Supervised learning":29,"Surrogate modeling":2,"Time-series modeling":4,"Transfer learning":0,"Tree-based models":16,"Unsupervised learning":1},"Drug repurposing":{"AI Agents":0,"Bayesian ML":0,"Deep learning":27,"Ensemble learning":16,"Explainable AI":5,"Feature selection":8,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":1,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":7,"Reinforcement learning":3,"Supervised learning":46,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":18,"Unsupervised learning":7},"Drug toxicity prediction":{"AI Agents":1,"Bayesian ML":1,"Deep learning":46,"Ensemble learning":22,"Explainable AI":14,"Feature selection":12,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":13,"LLM":6,"Machine learning":0,"Mechanism-informed machine learning":1,"Model selection":0,"Neural networks":28,"Reinforcement learning":4,"Supervised learning":66,"Surrogate modeling":0,"Time-series modeling":1,"Transfer learning":0,"Tree-based models":22,"Unsupervised learning":4},"Endpoint / biomarker assessment":{"AI Agents":0,"Bayesian ML":0,"Deep learning":8,"Ensemble learning":2,"Explainable AI":3,"Feature selection":3,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":2,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":3,"Reinforcement learning":0,"Supervised learning":11,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":3,"Unsupervised learning":3},"Enrichment design":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":1,"Reinforcement learning":0,"Supervised learning":0,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Exposure\u2013response analysis":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":0,"Explainable AI":1,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":2,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":1,"Unsupervised learning":0},"Other/General":{"AI Agents":0,"Bayesian ML":0,"Deep learning":3,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":2,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":0,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Outcome prediction":{"AI Agents":0,"Bayesian ML":0,"Deep learning":10,"Ensemble learning":4,"Explainable AI":5,"Feature selection":5,"Gaussian processes":1,"Hybrid mechanistic\u2013ML models":5,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":4,"Reinforcement learning":0,"Supervised learning":21,"Surrogate modeling":1,"Time-series modeling":2,"Transfer learning":0,"Tree-based models":9,"Unsupervised learning":2},"Patient risk stratification / management":{"AI Agents":0,"Bayesian ML":0,"Deep learning":1,"Ensemble learning":3,"Explainable AI":2,"Feature selection":2,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":3,"LLM":1,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":1,"Reinforcement learning":0,"Supervised learning":11,"Surrogate modeling":0,"Time-series modeling":1,"Transfer learning":0,"Tree-based models":5,"Unsupervised learning":3},"Pharmacodynamic modeling":{"AI Agents":0,"Bayesian ML":0,"Deep learning":10,"Ensemble learning":0,"Explainable AI":4,"Feature selection":0,"Gaussian processes":1,"Hybrid mechanistic\u2013ML models":7,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":2,"Model selection":0,"Neural networks":9,"Reinforcement learning":1,"Supervised learning":9,"Surrogate modeling":1,"Time-series modeling":2,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Pharmacokinetic modeling":{"AI Agents":1,"Bayesian ML":0,"Deep learning":46,"Ensemble learning":17,"Explainable AI":14,"Feature selection":9,"Gaussian processes":1,"Hybrid mechanistic\u2013ML models":29,"LLM":2,"Machine learning":0,"Mechanism-informed machine learning":1,"Model selection":3,"Neural networks":32,"Reinforcement learning":2,"Supervised learning":56,"Surrogate modeling":3,"Time-series modeling":5,"Transfer learning":1,"Tree-based models":18,"Unsupervised learning":2},"Postmarketing surveillance":{"AI Agents":0,"Bayesian ML":0,"Deep learning":2,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":1,"Reinforcement learning":0,"Supervised learning":1,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":0},"Precision medicine / optimized treatment regimen":{"AI Agents":2,"Bayesian ML":1,"Deep learning":16,"Ensemble learning":9,"Explainable AI":7,"Feature selection":5,"Gaussian processes":1,"Hybrid mechanistic\u2013ML models":10,"LLM":1,"Machine learning":0,"Mechanism-informed machine learning":1,"Model selection":1,"Neural networks":6,"Reinforcement learning":6,"Supervised learning":26,"Surrogate modeling":1,"Time-series modeling":3,"Transfer learning":0,"Tree-based models":13,"Unsupervised learning":4},"RWD phenotyping":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":0,"Explainable AI":0,"Feature selection":0,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":1,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":0,"Unsupervised learning":1},"Survival analysis":{"AI Agents":0,"Bayesian ML":0,"Deep learning":0,"Ensemble learning":1,"Explainable AI":0,"Feature selection":1,"Gaussian processes":0,"Hybrid mechanistic\u2013ML models":0,"LLM":0,"Machine learning":0,"Mechanism-informed machine learning":0,"Model selection":0,"Neural networks":0,"Reinforcement learning":0,"Supervised learning":2,"Surrogate modeling":0,"Time-series modeling":0,"Transfer learning":0,"Tree-based models":1,"Unsupervised learning":0}},"lastUpdated":"2026-02-24"};
let state = { selectedApp: null, selectedMeth: null, searchQuery: '', reviewFilter: 'all' };
function init() {
  document.getElementById('lastUpdated').textContent = DATA.lastUpdated;
  const nonReview = DATA.papers.filter(p => !p.is_review);
  const reviews = DATA.papers.filter(p => p.is_review);
  document.getElementById('stats').innerHTML = `
    <div class="stat"><span class="stat-value">${DATA.papers.length}</span><span class="stat-label">Total papers</span></div>
    <div class="stat"><span class="stat-value">${nonReview.length}</span><span class="stat-label">Original research</span></div>
    <div class="stat"><span class="stat-value">${reviews.length}</span><span class="stat-label">Reviews & perspectives</span></div>
    <div class="stat"><span class="stat-value">${DATA.applications.length}</span><span class="stat-label">Application areas</span></div>
    <div class="stat"><span class="stat-value">${DATA.methodologies.length}</span><span class="stat-label">Methodology types</span></div>`;
  renderHeatmap(); renderPapers();
  document.getElementById('searchBox').addEventListener('input', (e) => { state.searchQuery = e.target.value.toLowerCase(); renderPapers(); });
}
function getHeatColor(value, maxVal) {
  if (value === 0) return 'var(--heat-0)';
  const ratio = Math.log(value + 1) / Math.log(maxVal + 1);
  if (ratio < 0.15) return 'var(--heat-1)';
  if (ratio < 0.3) return 'var(--heat-2)';
  if (ratio < 0.5) return 'var(--heat-3)';
  if (ratio < 0.75) return 'var(--heat-4)';
  return 'var(--heat-5)';
}
function escAttr(s) { return s.replace(/'/g, "\\'").replace(/"/g, '&quot;'); }
function renderHeatmap() {
  const apps = DATA.applications, meths = DATA.methodologies, matrix = DATA.matrix;
  let maxVal = 0;
  apps.forEach(app => meths.forEach(meth => { maxVal = Math.max(maxVal, matrix[app]?.[meth] || 0); }));
  let html = '<thead><tr><th class="corner"></th>';
  meths.forEach(meth => { html += `<th class="col-header ${state.selectedMeth === meth ? 'active' : ''}" onclick="clickMeth('${escAttr(meth)}')" title="${meth}">${meth}</th>`; });
  html += '<th class="col-header total-header">Total</th></tr></thead><tbody>';
  apps.forEach(app => {
    html += `<tr><th class="row-header ${state.selectedApp === app ? 'active' : ''}" onclick="clickApp('${escAttr(app)}')" title="${app}">${app}</th>`;
    let rowTotal = 0;
    meths.forEach(meth => {
      const val = matrix[app]?.[meth] || 0; rowTotal += val;
      const isActive = state.selectedApp === app && state.selectedMeth === meth;
      html += `<td class="${val === 0 ? 'zero' : ''} ${isActive ? 'active' : ''}" style="background:${getHeatColor(val, maxVal)};color:${val === 0 ? 'var(--text-muted)' : '#fff'}" onclick="clickCell('${escAttr(app)}','${escAttr(meth)}')" title="${app} × ${meth}: ${val} papers">${val}</td>`;
    });
    html += `<td class="row-total">${rowTotal}</td></tr>`;
  });
  html += '</tbody>';
  document.getElementById('heatmap').innerHTML = html;
}
function clickCell(app, meth) { if (state.selectedApp === app && state.selectedMeth === meth) { clearFilters(); return; } state.selectedApp = app; state.selectedMeth = meth; update(); }
function clickApp(app) { if (state.selectedApp === app && !state.selectedMeth) { clearFilters(); return; } state.selectedApp = app; state.selectedMeth = null; update(); }
function clickMeth(meth) { if (state.selectedMeth === meth && !state.selectedApp) { clearFilters(); return; } state.selectedApp = null; state.selectedMeth = meth; update(); }
function clearFilters() { state.selectedApp = null; state.selectedMeth = null; update(); }
function update() { renderHeatmap(); renderFilterBar(); renderPapers(); }
function renderFilterBar() {
  const el = document.getElementById('activeFilter'), tags = document.getElementById('filterTags');
  if (!state.selectedApp && !state.selectedMeth) { el.classList.remove('visible'); return; }
  el.classList.add('visible');
  let html = '';
  if (state.selectedApp) html += `<span class="filter-tag"><span class="type-label">App</span>${state.selectedApp}</span>`;
  if (state.selectedMeth) html += `<span class="filter-tag"><span class="type-label">Method</span>${state.selectedMeth}</span>`;
  tags.innerHTML = html;
}
function toggleReview(mode) { state.reviewFilter = mode; document.querySelectorAll('.toggle-btn').forEach(b => b.classList.remove('active')); event.target.classList.add('active'); renderPapers(); }
function parsePubDate(d) {
  if (!d) return 0;
  const months = {Jan:0,Feb:1,Mar:2,Apr:3,May:4,Jun:5,Jul:6,Aug:7,Sep:8,Oct:9,Nov:10,Dec:11};
  const m = d.match(/(\d{4})(\w{3})?(\d{1,2})?/);
  if (!m) return 0;
  return new Date(parseInt(m[1]), m[2] ? (months[m[2]] || 0) : 0, m[3] ? parseInt(m[3]) : 1).getTime();
}
function getFilteredPapers() {
  let papers = DATA.papers;
  if (state.selectedApp) papers = papers.filter(p => p.applications.includes(state.selectedApp));
  if (state.selectedMeth) papers = papers.filter(p => p.methodologies.includes(state.selectedMeth));
  if (state.reviewFilter === 'original') papers = papers.filter(p => !p.is_review);
  else if (state.reviewFilter === 'review') papers = papers.filter(p => p.is_review);
  if (state.searchQuery) papers = papers.filter(p => p.title.toLowerCase().includes(state.searchQuery) || p.summary.toLowerCase().includes(state.searchQuery));
  papers.sort((a, b) => parsePubDate(b.published) - parsePubDate(a.published));
  return papers;
}
function renderPapers() {
  const papers = getFilteredPapers();
  document.getElementById('paperCount').innerHTML = `Showing <strong>${papers.length}</strong> of ${DATA.papers.length} papers`;
  const grid = document.getElementById('papersGrid');
  if (papers.length === 0) { grid.innerHTML = '<div class="no-results">No papers match the current filters.</div>'; return; }
  const shown = papers.slice(0, 100);
  grid.innerHTML = shown.map(p => `<div class="paper-card"><div class="paper-title"><a href="${p.url}" target="_blank">${p.title}</a></div><div class="paper-meta">${p.published ? `<span class="tag tag-date">${p.published}</span>` : ''}${p.is_review ? '<span class="tag tag-review">Review</span>' : ''}${p.applications.map(a => `<span class="tag tag-app">${a}</span>`).join('')}${p.methodologies.map(m => `<span class="tag tag-meth">${m}</span>`).join('')}</div>${p.summary ? `<div class="paper-summary">${p.summary}</div>` : ''}</div>`).join('') + (papers.length > 100 ? `<div class="no-results">Showing first 100 of ${papers.length} results. Use search to narrow down.</div>` : '');
}
init();
</script>
</body>
</html>